<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archivearticle1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Genet</journal-id><journal-id journal-id-type="iso-abbrev">PLoS Genet</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosgen</journal-id><journal-title-group><journal-title>PLoS Genetics</journal-title></journal-title-group><issn pub-type="ppub">1553-7390</issn><issn pub-type="epub">1553-7404</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4546604</article-id><article-id pub-id-type="pmid">26295846</article-id><article-id pub-id-type="doi">10.1371/journal.pgen.1005465</article-id><article-id pub-id-type="publisher-id">PGENETICS-D-15-00886</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>YAP1 Exerts Its Transcriptional Control via TEAD-Mediated Activation of Enhancers</article-title><alt-title alt-title-type="running-head">YAP1/TEAD1 Enhancer Binding</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Stein</surname><given-names>Claudia</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup>
</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Bardet</surname><given-names>Ana&#x000ef;s Flore</given-names></name><xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Roma</surname><given-names>Guglielmo</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Bergling</surname><given-names>Sebastian</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Clay</surname><given-names>Ieuan</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ruchti</surname><given-names>Alexandra</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Agarinis</surname><given-names>Claudia</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Schmelzle</surname><given-names>Tobias</given-names></name><xref ref-type="aff" rid="aff003">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Bouwmeester</surname><given-names>Tewis</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Sch&#x000fc;beler</surname><given-names>Dirk</given-names></name><xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref><xref ref-type="aff" rid="aff004">
<sup>4</sup>
</xref><xref rid="cor001" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Bauer</surname><given-names>Andreas</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref><xref rid="cor001" ref-type="corresp">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label><addr-line>Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Novartis Pharma AG, Basel, Switzerland</addr-line></aff><aff id="aff002"><label>2</label><addr-line>Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland</addr-line></aff><aff id="aff003"><label>3</label><addr-line>Oncology, Novartis Institutes for Biomedical Research, Novartis Pharma AG, Basel, Switzerland</addr-line></aff><aff id="aff004"><label>4</label><addr-line>University of Basel, Faculty of Sciences, Basel, Switzerland</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Copenhaver</surname><given-names>Gregory P.</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>The University of North Carolina at Chapel Hill, UNITED STATES</addr-line></aff><author-notes><fn fn-type="conflict" id="coi001"><p>The authors of this manuscript have read the journal's policy and have the following competing interests: CS, GR, SB, IC, AR, CA, TS, TB and AB are employees of Novartis Pharmaceuticals.</p></fn><fn fn-type="con" id="contrib001"><p>Conceived and designed the experiments: CS AFB DS AB. Performed the experiments: CS AR CA. Analyzed the data: AFB GR SB IC. Wrote the paper: CS AFB TB DS AB. Commented on and revised the manuscript: CS AFB GR SB IC AR CA TS TB DS AB. Supervised the project and revised the manuscript: TS TB DS AB. Supported design, data acquisition and analysis for the RNA-seq and ChIP-seq experiments: GR SB.</p></fn><corresp id="cor001">* E-mail: <email>dirk.schubeler@fmi.ch</email> (DS); <email>andreas-1.bauer@novartis.com</email> (AB)</corresp></author-notes><pub-date pub-type="epub"><day>21</day><month>8</month><year>2015</year></pub-date><pub-date pub-type="collection"><month>8</month><year>2015</year></pub-date><volume>11</volume><issue>8</issue><elocation-id>e1005465</elocation-id><history><date date-type="received"><day>10</day><month>4</month><year>2015</year></date><date date-type="accepted"><day>23</day><month>7</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; 2015 Stein et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Stein et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="pgen.1005465.pdf"/><abstract><p>YAP1 is a major effector of the Hippo pathway and a well-established oncogene. Elevated YAP1 activity due to mutations in Hippo pathway components or <italic>YAP1</italic> amplification is observed in several types of human cancers. Here we investigated its genomic binding landscape in YAP1-activated cancer cells, as well as in non-transformed cells. We demonstrate that TEAD transcription factors mediate YAP1 chromatin-binding genome-wide, further explaining their dominant role as primary mediators of YAP1-transcriptional activity. Moreover, we show that YAP1 largely exerts its transcriptional control via distal enhancers that are marked by H3K27 acetylation and that YAP1 is necessary for this chromatin mark at bound enhancers and the activity of the associated genes. This work establishes YAP1-mediated transcriptional regulation at distal enhancers and provides an expanded set of target genes resulting in a fundamental source to study YAP1 function in a normal and cancer setting.</p></abstract><abstract abstract-type="summary"><title>Author Summary</title><p>The YAP1/Hippo signaling pathway is a key regulator of organ size and tissue homeostasis, and its dysregulation is linked to cancer development. Elevated activity of YAP1, a transcriptional coactivator and well-established oncogene has been reported to occur in human cancers. Comprehensive identification of YAP1 regulated genes and its mode of action will be of high importance to uncover YAP1 biology that could be exploited for a therapeutic intervention. To this end, we performed genome-wide analyses to identify YAP1 occupied sites in cancer cell lines representing different YAP1/Hippo pathway tumor etiologies and in non-transformed fibroblasts. Our data demonstrate that YAP1 activity is mediated predominantly via TEAD transcription factors supporting the importance of TEADs as main mediators of YAP1-coactivator activity. We further show that YAP1 and TEAD1 exert their transcriptional control via binding to enhancers, leading to characteristic chromatin changes and distal activation of genes. By linking enhancers to genes, we provide a list of novel YAP1 target genes in an oncogenic setting that we show can readily be exploited in tumor classification and provides a foundation for further investigations.</p></abstract><funding-group><funding-statement>CS is a NIBR presidential postdoctoral fellow. AFB is an EMBO long-term postdoctoral fellow. Research in the DS laboratory is supported by the Novartis Research Foundation, the European Union (NoE &#x02018;&#x02018;EpiGeneSys&#x02019;&#x02019; FP7- HEALTH-2010-257082, and the &#x02018;&#x02018;Blueprint&#x02019;&#x02019; consortium FP7-282510), the European Research Council (EpiGePlas) and Swiss Initiative in Systems Biology (RTD Cell Plasticity). CS, GR, SB, IC, AR, CA, TS, TB and AB are employees of Novartis Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="7"/><table-count count="7"/><page-count count="28"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>Raw and processed ChIP-seq data are deposited in the Gene Expression Omnibus (GEO) under the accession number GSE61852. The raw RNA-sequencing reads are available in the NCBI Short Read Archive under the accession number SRP056665.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>Raw and processed ChIP-seq data are deposited in the Gene Expression Omnibus (GEO) under the accession number GSE61852. The raw RNA-sequencing reads are available in the NCBI Short Read Archive under the accession number SRP056665.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>YAP1 (Yes-associated protein 1) is a major transcriptional effector of the evolutionary and functionally conserved Hippo pathway, which is a crucial regulator of organ size, proliferation but also tumor growth [<xref rid="pgen.1005465.ref001" ref-type="bibr">1</xref>&#x02013;<xref rid="pgen.1005465.ref003" ref-type="bibr">3</xref>]. Activation of the Hippo pathway leads to phosphorylation and inactivation of the transcriptional co-activator YAP1 by cytoplasmic retention or enhanced degradation [<xref rid="pgen.1005465.ref004" ref-type="bibr">4</xref>&#x02013;<xref rid="pgen.1005465.ref008" ref-type="bibr">8</xref>].</p><p>YAP1 has a potent growth promoting activity and the YAP1/Hippo pathway has been tightly linked to cancer [<xref rid="pgen.1005465.ref008" ref-type="bibr">8</xref>&#x02013;<xref rid="pgen.1005465.ref011" ref-type="bibr">11</xref>]. Loss of Hippo signaling by mutations or down-regulation of core pathway components is associated with cancer development, while YAP1 is reported as a potent oncogene that can promote tumorigenesis in a wide range of tissues [<xref rid="pgen.1005465.ref002" ref-type="bibr">2</xref>, <xref rid="pgen.1005465.ref012" ref-type="bibr">12</xref>, <xref rid="pgen.1005465.ref013" ref-type="bibr">13</xref>]. Elevated expression or activity of YAP1 occurs through multiple mechanisms. <italic>YAP1</italic> gene amplification and mutations in upstream pathway regulators, such as <italic>NF2</italic>, have been described in various human tumors [<xref rid="pgen.1005465.ref002" ref-type="bibr">2</xref>, <xref rid="pgen.1005465.ref014" ref-type="bibr">14</xref>&#x02013;<xref rid="pgen.1005465.ref020" ref-type="bibr">20</xref>].</p><p>YAP1 lacks an intrinsic DNA-binding domain and is thought to exert its co-activator function through binding to promoter sequences via interaction with transcription factors (TF), such as TEAD1/-2/-3/-4, Smads, Runx1/-2, p73, ErbB4, Pax3, AP-1, or TBX5 [<xref rid="pgen.1005465.ref012" ref-type="bibr">12</xref>, <xref rid="pgen.1005465.ref021" ref-type="bibr">21</xref>]. Among these the TEAD TF family members play a dominant role as primary mediators of YAP1-dependent gene regulation and YAP1 growth-promoting activity [<xref rid="pgen.1005465.ref022" ref-type="bibr">22</xref>&#x02013;<xref rid="pgen.1005465.ref028" ref-type="bibr">28</xref>]. Although the tumor-promoting function of YAP1 and TEAD by controlling a remarkable range of cellular processes is undisputed [<xref rid="pgen.1005465.ref001" ref-type="bibr">1</xref>, <xref rid="pgen.1005465.ref013" ref-type="bibr">13</xref>, <xref rid="pgen.1005465.ref027" ref-type="bibr">27</xref>], the comprehensive ensemble of direct downstream target genes and the underlying mechanisms of target gene regulation remain poorly understood.</p><p>In the past decade, gene expression studies have identified several YAP1-responsive genes [<xref rid="pgen.1005465.ref022" ref-type="bibr">22</xref>, <xref rid="pgen.1005465.ref029" ref-type="bibr">29</xref>&#x02013;<xref rid="pgen.1005465.ref031" ref-type="bibr">31</xref>]. In contrast, the number of validated direct target genes remains small. Besides validating YAP1 binding to proximal promoter regions of individual genes using ChIP-qPCR [<xref rid="pgen.1005465.ref022" ref-type="bibr">22</xref>, <xref rid="pgen.1005465.ref029" ref-type="bibr">29</xref>, <xref rid="pgen.1005465.ref031" ref-type="bibr">31</xref>&#x02013;<xref rid="pgen.1005465.ref038" ref-type="bibr">38</xref>], a ChIP-on-chip approach using a microarray consisting of promoter regions has been conducted to identify direct YAP1-target genes in MCF10A mammary epithelial cells [<xref rid="pgen.1005465.ref022" ref-type="bibr">22</xref>]. While focusing on YAP1-binding to promoter proximal regions a substantial set of functional YAP1 genomic binding sites might have been missed given the importance of distal regulatory elements in establishing a precise pattern of gene expression [<xref rid="pgen.1005465.ref039" ref-type="bibr">39</xref>&#x02013;<xref rid="pgen.1005465.ref043" ref-type="bibr">43</xref>].</p><p>Here, we comprehensively mapped YAP1 chromatin binding genome-wide, independent of gene location, using ChIP-seq in two human cancer cell lines from different lineages with elevated YAP1 activity (SF268 and NCI-H2052) as well as in non-transformed cells (IMR90) enabling an unbiased identification of YAP1 binding sites and their dependence on cellular context. We demonstrate that YAP1 chromatin recruitment is primarily mediated by binding of TEAD1 to single as well as double TEAD motifs with 3bp spacer at distal enhancers. Aside from presenting a global view of YAP1 and TEAD1 binding in a cancer context, our study also provides novel mechanistic insights into YAP1 transcriptional co-activation of TEAD TFs. We show that YAP1-dependent enhancer activation entails characteristic chromatin changes at lysine 27 of histone H3 and activation of associated genes. Finally we identify a set of YAP1 targets genes by expression profiling following YAP1 knockdown representing a gene signature that can predict YAP1 activity in tumor samples.</p></sec><sec sec-type="results" id="sec002"><title>Results</title><sec id="sec003"><title>Genome-wide YAP1 chromatin-binding in <italic>YAP1</italic>-amplified cancer cells</title><p>To gain insight into YAP1 genomic recruitment in a YAP1-relevant cancer context, we used SF268 glioblastoma cells, previously demonstrated to have elevated YAP1 activity due to a 13-fold genomic amplification of the <italic>YAP1</italic> locus [<xref rid="pgen.1005465.ref044" ref-type="bibr">44</xref>]. Accordingly, YAP1 mRNA and protein levels are increased in SF268 cells as compared to LN229 glioblastoma cells that do not harbor any genetic aberrations of YAP1/Hippo pathway components (<xref rid="pgen.1005465.g001" ref-type="fig">Fig 1A</xref> and <xref rid="pgen.1005465.s001" ref-type="supplementary-material">S1 Fig</xref>). As a consequence, YAP1 transcriptional activity appears significantly elevated, as suggested by an increased expression of known YAP1 target genes <italic>ANKRD1</italic>, <italic>CYR61</italic>, <italic>and NPPB</italic> but not of unrelated genes <italic>FAM171A1</italic> and <italic>HAX1</italic> (<xref rid="pgen.1005465.g001" ref-type="fig">Fig 1A</xref>).</p><fig id="pgen.1005465.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1005465.g001</object-id><label>Fig 1</label><caption><title>Genome-wide binding of YAP1 to chromatin in SF268 cells.</title><p>(A) Expression levels of <italic>YAP1</italic>, YAP1 target genes and non-target genes in SF268 (red) and LN229 (grey) cells measured by RNA-seq. (B) Correlation between replicates of YAP1 binding analysis by ChIP-seq. (C) Genomic views of YAP1 ChIP enrichment at gene promoters of known target genes. (D) Validation of YAP1 binding to known and novel sites, and control regions using ChIP-qPCR. Data are representative of at least three independent experiments. Error bars indicate the standard deviation of triplicate qPCR.</p></caption><graphic xlink:href="pgen.1005465.g001"/></fig><p>To identify YAP1 binding sites genome-wide we performed chromatin immunoprecipitation with a YAP1-specific antibody followed by high-throughput sequencing (ChIP-seq). The chosen antibody proved to be highly specific and sensitive as measured by western blot analysis as well as immunoprecipitation (<xref rid="pgen.1005465.s002" ref-type="supplementary-material">S2 Fig</xref>). We observed high reproducibility between two independent biological ChIP-seq replicates with a Pearson correlation coefficient (PCC) of 0.95 (<xref rid="pgen.1005465.g001" ref-type="fig">Fig 1B</xref>). We identified 2,498 binding sites enriched over matching input using the ChIP-seq peak-finder peakzilla [<xref rid="pgen.1005465.ref045" ref-type="bibr">45</xref>] (<xref rid="pgen.1005465.s014" ref-type="supplementary-material">S1</xref> and <xref rid="pgen.1005465.s015" ref-type="supplementary-material">S2</xref> Tables). To further benchmark our approach we have analyzed the dataset for the presence of peak regions in the most commonly described YAP1 target genes. As anticipated, peaks were identified in the vicinity of published YAP1 target genes, such as <italic>CTGF</italic> [<xref rid="pgen.1005465.ref022" ref-type="bibr">22</xref>], <italic>CYR61</italic> [<xref rid="pgen.1005465.ref006" ref-type="bibr">6</xref>], <italic>NPPB</italic> [<xref rid="pgen.1005465.ref032" ref-type="bibr">32</xref>], <italic>CCND1</italic> [<xref rid="pgen.1005465.ref031" ref-type="bibr">31</xref>], <italic>AXL</italic> [<xref rid="pgen.1005465.ref036" ref-type="bibr">36</xref>], <italic>DKK1</italic> [<xref rid="pgen.1005465.ref033" ref-type="bibr">33</xref>], <italic>ITGB2</italic> [<xref rid="pgen.1005465.ref022" ref-type="bibr">22</xref>], <italic>WWC1</italic> [<xref rid="pgen.1005465.ref035" ref-type="bibr">35</xref>], <italic>and ANKRD1</italic> (<xref rid="pgen.1005465.g001" ref-type="fig">Fig 1C</xref> and <xref rid="pgen.1005465.s003" ref-type="supplementary-material">S3 Fig</xref>). Although <italic>ANKRD1</italic> expression is commonly used to monitor YAP1 transcriptional activity, to our knowledge, it has not formerly been proven as a direct YAP1 target gene. Our data proofs direct YAP1 binding to the promoter of <italic>ANKRD1</italic> (<xref rid="pgen.1005465.g001" ref-type="fig">Fig 1C and 1D</xref>). ChIP-qPCR validation for several randomly selected loci confirmed YAP1 occupancy at those sites (<xref rid="pgen.1005465.g001" ref-type="fig">Fig 1D</xref>), further supporting the specificity of binding and overall reliability of the dataset.</p></sec><sec id="sec004"><title>The TEAD consensus motif is enriched in YAP1 binding sites</title><p>YAP1 does not contain a DNA-binding domain and thus, relies on interactions with other TFs for recruitment to chromatin. To investigate which TFs mediate binding in SF268 cells we searched the YAP1 peak regions for motifs <italic>de novo</italic> using MEME [<xref rid="pgen.1005465.ref046" ref-type="bibr">46</xref>]. This identified <italic>CATTCC</italic>, the known consensus motif for TEAD, as the predominant hit (<xref rid="pgen.1005465.g002" ref-type="fig">Fig 2A</xref>). When allowing for 1 base pair (bp) mismatches to the TEAD consensus motif (<xref rid="pgen.1005465.s016" ref-type="supplementary-material">S3 Table</xref>) we observed that more than 86% of all YAP1 peak regions contained at least one TEAD binding site. This represents a 2.3-fold enrichment over random control regions (hypergeometric <italic>P</italic> &#x0003c; 10<sup>&#x02212;288</sup>) and provides evidence that TEADs are the predominant co-factors facilitating YAP1 association with chromatin in <italic>YAP1</italic>-amplified glioblastoma cancer cells.</p><fig id="pgen.1005465.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1005465.g002</object-id><label>Fig 2</label><caption><title>TEAD single and double motifs occur within most YAP1 binding sites.</title><p>(A and B) Enrichment of (A) TEAD and (B) AP-1 motifs in YAP1 peaks. Full list provided in <xref rid="pgen.1005465.s017" ref-type="supplementary-material">S4 Table</xref>. (C) YAP1 ChIP enrichment as determined by peak score in YAP1 peaks with/without TEAD and AP-1 motifs. (D) Number of TEAD motifs in YAP1 peaks. (E) Enrichment of TEAD double motif with several spacer lengths in YAP1 peaks. (F) Sequence conservation of YAP1 peak regions. (G) Sequence conservation of TEAD single and double motifs in YAP1 peak regions. (H) YAP1 ChIP enrichment as determined by peak score in YAP1 peaks with/without single/double TEAD motifs. (I) Luciferase reporter assay for two YAP1 binding regions with either intact double motif or with single or double mutations. Relative luciferase activity represents the ratio of Firefly and Renilla luciferase activity for each sample. The red line indicates the highest mean activity of the two negative control regions. Data are representative of at least three independent experiments. Error bars indicate the standard deviation of triplicate qPCR data.</p></caption><graphic xlink:href="pgen.1005465.g002"/></fig><p>To ask whether additional TFs might recruit YAP1, we searched YAP1 peak regions for enrichment of other known TF motifs. Besides the TEAD consensus motif, we identified only the AP-1/JDP2 motif <italic>TGACTCA</italic> to be significantly enriched (<xref rid="pgen.1005465.g002" ref-type="fig">Fig 2B</xref> and <xref rid="pgen.1005465.s017" ref-type="supplementary-material">S4</xref> and <xref rid="pgen.1005465.s018" ref-type="supplementary-material">S5</xref> Tables). AP-1 is a heterodimeric protein complex composed of c-Fos and c-Jun, both highly expressed in SF268 cells (<xref rid="pgen.1005465.s018" ref-type="supplementary-material">S5 Table</xref>). Cooperative binding of AP-1 with other TFs has been previously reported as a mechanism of context specific gene regulation [<xref rid="pgen.1005465.ref047" ref-type="bibr">47</xref>]. Therefore YAP1/TEAD might act cooperatively with AP-1 in a stimulation-dependent manner or dependent on the pathway genetic context of the analyzed cell type to regulate context-specific gene expression programs. In support of this, c-Fos has recently been described to regulate YAP1 transcriptional activity in the context of <italic>KRAS</italic>-driven cancers [<xref rid="pgen.1005465.ref030" ref-type="bibr">30</xref>] and AP-1/TEAD were found to act as regulators of the invasive gene network in melanoma [<xref rid="pgen.1005465.ref048" ref-type="bibr">48</xref>]. When allowing for 1bp mismatches we identified <italic>TGACTCA</italic> motifs in 60% of YAP1 peak regions that do not contain a TEAD motif but observed the motif as well in 45% of peak regions with a TEAD binding motif. Furthermore we observe that peak regions containing a TEAD binding motif have significantly higher YAP1 ChIP occupancy (as defined by the peakzilla peak score), while the presence of an AP-1 motif does not significantly increase YAP1 occupancy (<xref rid="pgen.1005465.g002" ref-type="fig">Fig 2C</xref>). Our genome-wide binding data therefore do not provide convincing evidence that AP-1 might serve as an alternative factor for the recruitment of YAP1 to chromatin. However we cannot exclude that AP-1 might serve as a co-factor for YAP1/TEAD under specific experimental conditions.</p><p>Taken together, our genome-wide binding data support the notion that TEADs account for the vast majority of YAP1 binding to chromatin.</p></sec><sec id="sec005"><title>A double TEAD motif with a 3bp spacer is enriched and functional in YAP1 binding sites</title><p>We noted that 52% of peak regions contained more than one TEAD binding motif (<xref rid="pgen.1005465.g002" ref-type="fig">Fig 2D</xref>) with two consecutive sites (double motif) being particularly prevalent. Binding of TEADs and other TFs to double motifs has been recently shown <italic>in vitro</italic> using high-throughput SELEX [<xref rid="pgen.1005465.ref049" ref-type="bibr">49</xref>]. Indeed, we found a specific enrichment of double motifs oriented in the same direction separated by a 3bp spacer (18%) as compared to other spacing or random control regions (hypergeometric P &#x0003c;10<sup>&#x02212;145</sup> vs. control and P &#x0003c; 10<sup>&#x02212;40</sup> vs. other spacer lengths) (<xref rid="pgen.1005465.g002" ref-type="fig">Fig 2E</xref>). This is consistent with a cooperative mechanism of TEAD1 binding to DNA that has previously been suggested based on structural analyses [<xref rid="pgen.1005465.ref050" ref-type="bibr">50</xref>] and <italic>in vitro</italic> binding experiments [<xref rid="pgen.1005465.ref051" ref-type="bibr">51</xref>, <xref rid="pgen.1005465.ref052" ref-type="bibr">52</xref>].</p><p>We observed that peak regions are significantly conserved as compared to random control regions especially at their peak summit (<xref rid="pgen.1005465.g002" ref-type="fig">Fig 2F and 2G</xref>). Further, in contrast to peaks without a TEAD motif, peaks with single or double motifs had significantly higher ChIP occupancies (<xref rid="pgen.1005465.g002" ref-type="fig">Fig 2H</xref>).</p><p>To directly investigate the functionality of the TEAD double motif we utilized a luciferase reporter gene assay. Double motifs from two independent peak regions (CATTCC-NNN-CATTCC) were cloned upstream of a luciferase reporter. Both constructs caused an increase in luciferase reporter expression as compared to control regions. Importantly, mutations in either one or both of the double motif sites reduced reporter gene expression to the levels of control regions (<xref rid="pgen.1005465.g002" ref-type="fig">Fig 2I</xref>, red line), indicating that both sites of the double motif are required to enhance transcription.</p><p>We conclude that, at a subset of binding sites, TEAD binds homotypic clusters of motifs as previously shown for other human TFs [<xref rid="pgen.1005465.ref053" ref-type="bibr">53</xref>].</p></sec><sec id="sec006"><title>YAP1 binding sites are co-occupied by TEAD1 genome-wide</title><p>The four different TEAD proteins display distinct expression patterns in cultured cell lines even though they have been suggested to be functionally redundant [<xref rid="pgen.1005465.ref054" ref-type="bibr">54</xref>]. To establish which TEADs are essential for YAP1-mediated transcriptional activity in SF268 cells, we assessed the expression of the TEAD-dependent MCAT-luciferase reporter upon siRNA-mediated depletion of individual TEADs. This revealed that the depletion of TEAD1 had a potent effect on reporter gene activity, while knockdown of TEAD4 had only marginal effects (<xref rid="pgen.1005465.g003" ref-type="fig">Fig 3A</xref>).</p><fig id="pgen.1005465.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1005465.g003</object-id><label>Fig 3</label><caption><title>YAP1 peaks are co-occupied by TEAD1.</title><p>(A) Expression changes of a YAP1/TEAD responsive luciferase reporter upon siRNA-mediated knockdown of YAP1 or TEADs normalized to a negative control siRNA in SF268 cells. (B) Correlation between TEAD1 and YAP1 SF268 ChIP-seq samples. (C) Genomic views of YAP1 and TEAD1 ChIP enrichment at gene promoters of known target genes. (D and E) Validation of (D) TEAD1 and (E) YAP1 binding to known and novel sites and control regions following siRNA depletion of TEADs as compared to control siRNA treated cells by ChIP-qPCR. Data are representative of at least three independent experiments. Error bars indicate the standard deviation of triplicate qPCR data.</p></caption><graphic xlink:href="pgen.1005465.g003"/></fig><p>As TEAD1 appears to be the primary transcriptionally active TEAD family member in SF268 cells, we next mapped its genome-wide binding profile by ChIP-seq (<xref rid="pgen.1005465.s004" ref-type="supplementary-material">S4 Fig</xref>). This led to the identification of 2,652 TEAD1 binding sites based on two independent, but highly reproducible biological replicates and matching input (<xref rid="pgen.1005465.s014" ref-type="supplementary-material">S1 Table</xref>). We first noted a high similarity between TEAD1 and YAP1 ChIP samples, which is reflected in a high positive correlation (PCC = 0.71) (<xref rid="pgen.1005465.g003" ref-type="fig">Fig 3B</xref>) and a remarkable overlap of 90% with YAP1 peaks regions (<xref rid="pgen.1005465.g003" ref-type="fig">Fig 3C</xref> and <xref rid="pgen.1005465.s003" ref-type="supplementary-material">S3 Fig</xref>). siRNA-mediated depletion of TEADs strongly reduced TEAD1 binding to all tested loci, thereby confirming the specific binding of TEAD1 to the identified peak regions (<xref rid="pgen.1005465.g003" ref-type="fig">Fig 3D</xref> and <xref rid="pgen.1005465.s005" ref-type="supplementary-material">S5 Fig</xref>). Reduction of TEADs also reduced YAP1 levels at all tested sites (<xref rid="pgen.1005465.g003" ref-type="fig">Fig 3E</xref>). This further argues that YAP1 association with chromatin is mainly mediated via TEAD TFs and specifically by TEAD1 in the tested glioblastoma setting. Reciprocally, we observed that the majority of TEAD1 peaks overlap with YAP1 peaks arguing that all TEAD1 binding sites recruit YAP1.</p></sec><sec id="sec007"><title>YAP1 and TEAD1 bind and activate distal enhancers</title><p>Previous studies focused primarily on the association of YAP1 with proximal promoters [<xref rid="pgen.1005465.ref022" ref-type="bibr">22</xref>, <xref rid="pgen.1005465.ref031" ref-type="bibr">31</xref>, <xref rid="pgen.1005465.ref033" ref-type="bibr">33</xref>, <xref rid="pgen.1005465.ref034" ref-type="bibr">34</xref>, <xref rid="pgen.1005465.ref036" ref-type="bibr">36</xref>, <xref rid="pgen.1005465.ref038" ref-type="bibr">38</xref>, <xref rid="pgen.1005465.ref055" ref-type="bibr">55</xref>&#x02013;<xref rid="pgen.1005465.ref057" ref-type="bibr">57</xref>]. It is therefore not surprising that the majority of target genes described up to now contain a YAP1/TEAD1 peak in their promoter region. However, less than 4% of the YAP1/TEAD1 peaks identified in our study are actually located within 2Kb of a gene TSS, and only 15% are located in the 5&#x02019;UTR of known genes (<xref rid="pgen.1005465.g004" ref-type="fig">Fig 4A</xref> and <xref rid="pgen.1005465.s006" ref-type="supplementary-material">S6 Fig</xref>). Thus, the majority of YAP1/TEAD1 binding sites reside distal to gene TSSs (<xref rid="pgen.1005465.g004" ref-type="fig">Fig 4B</xref>, top) providing evidence that YAP1 acts at distal enhancers, which account for a large fraction of regulatory regions [<xref rid="pgen.1005465.ref058" ref-type="bibr">58</xref>].</p><fig id="pgen.1005465.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1005465.g004</object-id><label>Fig 4</label><caption><title>YAP1/TEAD1 associate with active enhancers.</title><p>(A) Genomic distribution of YAP1/TEAD1 peaks. Promoter class defined as 2kb upstream of gene TSS. (B) Distance of YAP1/TEAD1 peaks and H3K27ac regions to closest gene TSS. (C) Genomic views of H3K27ac, YAP1 and TEAD1 ChIP enrichment at gene promoters of known target genes. (D) YAP1, TEAD1 and H3K27ac ChIP enrichment at all YAP1 peak regions centered on peak summit. (E) Luciferase reporter assay of six YAP1/TEAD1 distal enhancer binding sites containing single or double TEAD motifs in cells treated with YAP1 or TEADs siRNA compared to control siRNA. Data are representative of at least three independent experiments. Error bars indicate the standard deviation of triplicate qPCR data.</p></caption><graphic xlink:href="pgen.1005465.g004"/></fig><p>To evaluate whether these distal binding sites occur indeed within functional regions such as enhancers, we took advantage of the fact that acetylation at lysine 27 of histone H3 (H3K27ac) can serve as a signature mark of active enhancers [<xref rid="pgen.1005465.ref059" ref-type="bibr">59</xref>, <xref rid="pgen.1005465.ref060" ref-type="bibr">60</xref>]. We performed ChIP-seq in SF268 cells using an H3K27ac-specific antibody in two independent biological replicates and matched input (<xref rid="pgen.1005465.s014" ref-type="supplementary-material">S1 Table</xref>). This identified 38,331 H3K27ac positive regions both proximal and distal to gene TSSs (<xref rid="pgen.1005465.g004" ref-type="fig">Fig 4B</xref>, bottom). Intersecting this dataset with YAP1 and TEAD1 reveals that 95% of the YAP1/TEAD1 peaks overlap with H3K27ac in particular on nucleosomes flanking YAP1/TEAD1 peaks (<xref rid="pgen.1005465.g004" ref-type="fig">Fig 4C and 4D</xref> and <xref rid="pgen.1005465.s003" ref-type="supplementary-material">S3 Fig</xref>). Thus, most of YAP1/TEAD1 binding appear to occur within active enhancers and likely represent functional binding events.</p><p>To test this hypothesis, we inserted several YAP1/TEAD1 occupied putative enhancer regions into reporter plasmids. In this experiment indeed five out of six tested elements were able to activate the transcription of a luciferase reporter. Notably, siRNA-mediated depletion of YAP1 or TEADs blunted their enhancer activity demonstrating their necessity for proper enhancer function (<xref rid="pgen.1005465.g004" ref-type="fig">Fig 4E</xref>). These results provide experimental evidence that YAP1/TEAD1 bind primarily at active distal regulatory regions, contributing to enhancer activity.</p></sec><sec id="sec008"><title>YAP1/TEAD1 regulate the H3K27ac enhancer chromatin mark</title><p>To gain further mechanistic insight into YAP1/TEAD1 transcriptional regulation, we assessed the impact of YAP1 inactivation on TEAD1 chromatin recruitment, target gene expression, and the H3K27ac enhancer chromatin mark. More specifically we took advantage of contact inhibition as a physiological impetus to control YAP1 activity [<xref rid="pgen.1005465.ref007" ref-type="bibr">7</xref>]. Although SF268 cells overexpress <italic>YAP1</italic>, they are nevertheless fully responsive to contact inhibition. When cultivated at high density, YAP1 translocates to the cytoplasm and is degraded as reflected by decreased protein levels (<xref rid="pgen.1005465.g005" ref-type="fig">Fig 5A and 5B</xref>). This results in reduced target gene expression (<xref rid="pgen.1005465.g005" ref-type="fig">Fig 5C</xref>) and coincides with diminished YAP1 recruitment (<xref rid="pgen.1005465.g005" ref-type="fig">Fig 5D</xref>). Interestingly, inactivation of YAP1 also leads to a reduction of <italic>TEAD1</italic> expression (<xref rid="pgen.1005465.g005" ref-type="fig">Fig 5C</xref>), which resulted in reduced cellular TEAD1 protein levels (<xref rid="pgen.1005465.g005" ref-type="fig">Fig 5B</xref>) and subsequently diminished chromatin occupancy (<xref rid="pgen.1005465.g005" ref-type="fig">Fig 5E</xref>).</p><fig id="pgen.1005465.g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1005465.g005</object-id><label>Fig 5</label><caption><title>YAP1 mediates active enhancer chromatin and expression of target genes.</title><p>(A) YAP1 immunofluorescence staining in SF268 cells grown at low (LD) or high density (HD). The corresponding DNA Hoechst 33342 staining is shown. Scale bar = 100&#x003bc;m. (B) Western blot analysis of YAP1, TEAD1 and H3K27ac from LD and HD SF268 cells. &#x003b2;-Actin and histone H3 served as loading controls. (C) mRNA expression of <italic>YAP1</italic>, <italic>TEAD1</italic>, <italic>KISS1</italic>, <italic>NEXN</italic>, <italic>PAWR</italic>, <italic>S1PR1</italic>, and <italic>SNAPC1</italic> from cells cultured at LD or HD (normalized to <italic>Ubiquitin C</italic> (<italic>UBC</italic>)). Data are representative of at least three independent experiments. Error bars indicate the standard deviation of triplicate qPCR data.(D, E, F and G) Analysis of (D) YAP1, (E) TEAD1, (F) H3K27ac, and (G) p300 occupancy at YAP1/TEAD1 peak regions from cells cultured at LD or HD by ChIP-qPCR. Data are representative of at least three independent experiments. Error bars indicate the standard deviation of triplicate qPCR data.</p></caption><graphic xlink:href="pgen.1005465.g005"/></fig><p>Importantly, YAP1 nuclear depletion also decreases H3K27ac at YAP1/TEAD1 peaks (<xref rid="pgen.1005465.g005" ref-type="fig">Fig 5F</xref>). This observation appears highly specific since global H3K27ac levels were not affected and regions not bound by YAP1/TEAD1 showed no reduction (<xref rid="pgen.1005465.g005" ref-type="fig">Fig 5B and 5F</xref>). To gain further mechanistic insight into how YAP1 affects H3K27ac we performed ChIP-qPCR for p300, the major histone acetyltransferase that has been linked to enhancers [<xref rid="pgen.1005465.ref061" ref-type="bibr">61</xref>, <xref rid="pgen.1005465.ref062" ref-type="bibr">62</xref>]. This reveals that p300 indeed binds to YAP1 positive H3K27 acetylated sites <bold>(</bold>
<xref rid="pgen.1005465.g005" ref-type="fig">Fig 5G</xref>
<bold>)</bold>. Next we asked if p300 recruitment to these sites is YAP1-dependent by testing p300 occupancy upon YAP1 inactivation under high cell density conditions. This revealed reduced p300 levels mirroring the reduction in H3K27 acetylation. To independently test the link between YAP1 activity and enhancer chromatin, we furthermore depleted YAP1 using siRNA, which similarly led to reduced chromatin binding (<xref rid="pgen.1005465.s007" ref-type="supplementary-material">S7 Fig</xref>). In agreement with YAP1 inactivation by high cell density, siRNA-mediated depletion of YAP1 resulted in diminished H3K27ac levels, p300 occupancy, and reduced <italic>TEAD1</italic> expression and chromatin occupancy probably through disruption of a positive feedback loop (<xref rid="pgen.1005465.s003" ref-type="supplementary-material">S3</xref> and <xref rid="pgen.1005465.s007" ref-type="supplementary-material">S7</xref> Figs). Together, these data confirm the link between YAP1 chromatin binding and transcriptional activation of target genes and establish a requirement for YAP1 for proper chromatin structure at enhancers.</p></sec><sec id="sec009"><title>YAP1 binds similar sites in YAP1-activated cancer cells</title><p>Next, we asked if the observed YAP1 binding to distal enhancers is specific for cellular situations with extensive <italic>YAP1</italic> amplification such as in SF268 cells. Towards this goal we investigated YAP1 binding in NCI-H2052 malignant mesothelioma cells, a cell line of different lineage and with a different mechanism of YAP1 activation (<italic>NF2</italic> mutation, <italic>LATS2</italic> deletion) [<xref rid="pgen.1005465.ref063" ref-type="bibr">63</xref>]. ChIP-seq analysis of YAP1 in two independent biological replicates and matching input identified 16,470 binding sites (<xref rid="pgen.1005465.s014" ref-type="supplementary-material">S1 Table</xref>). This larger number of peak regions is due to many weak peaks that were not detected in SF268 cells. However, YAP1 binding is well conserved between SF268 and NCI-H2052 cells particularly at strong peaks. This is evident in a global positive correlation (PCC = 0.32) but also at the level of individual loci (<xref rid="pgen.1005465.g006" ref-type="fig">Fig 6A and 6B</xref>). Indeed 82% of the YAP1 peaks identified in SF268 overlap with peaks in NCI-H2052 cells. As expected, we also identified 1,142 SF268- and 2,510 NCI-H2052-specific YAP1 binding sites using stringent thresholds but only 48% and 36%, respectively, were assigned to genes not targeted by shared peaks (<xref rid="pgen.1005465.s008" ref-type="supplementary-material">S8 Fig</xref>) suggesting a common function for YAP1 in cancer cells. We also found that YAP1 binds mainly to distal regulatory regions in NCI-H2052 cells (<xref rid="pgen.1005465.s008" ref-type="supplementary-material">S8 Fig</xref>) and that occupied sites were also enriched in TEAD single and double motifs as well as AP-1 motifs (<xref rid="pgen.1005465.s008" ref-type="supplementary-material">S8 Fig</xref>). Similarly to SF268 cells, genetic knockdown of TEADs resulted in reduced YAP1 chromatin binding to NCI-H2052-specific and shared loci with SF268 cells, supporting that TEADs are the main mediators of YAP1 binding also in NCI-H2052 cells (<xref rid="pgen.1005465.s009" ref-type="supplementary-material">S9 Fig</xref>).</p><fig id="pgen.1005465.g006" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1005465.g006</object-id><label>Fig 6</label><caption><title>YAP1 binding sites largely overlap in cancer cell lines from distinct lineages.</title><p>(A) Correlation between SF268 and NCI-H2052 YAP1 ChIP-seq samples. (B) Genomic views of YAP1 shared, SF268-, NCI-H2052 and IMR90-specific regions. (C) Correlation between SF268 and IMR90 YAP1 ChIP-seq samples. (D) H3K27ac ChIP enrichment at YAP1 peak regions (centered on peak summit) that are shared, SF268-specific or IMR90-specific.</p></caption><graphic xlink:href="pgen.1005465.g006"/></fig><p>Cell-type and context-dependent binding of TFs involves chromatin architecture and epigenetic modifications which are often altered during tumor development [<xref rid="pgen.1005465.ref064" ref-type="bibr">64</xref>]. Thus, YAP1 binding in cancer cells might differ from non-transformed cells. To investigate whether YAP1 also binds primarily at TEAD-mediated enhancers in non-transformed cells, we investigated its binding profile in non-transformed lung fibroblast cells (IMR90) as primary cells for which many genomic datasets exist [<xref rid="pgen.1005465.ref065" ref-type="bibr">65</xref>, <xref rid="pgen.1005465.ref066" ref-type="bibr">66</xref>]. ChIP-seq analysis of YAP1 in two independent biological replicates and matching input identified 1,111 binding sites (<xref rid="pgen.1005465.s014" ref-type="supplementary-material">S1 Table</xref>). Notably, we found no significant global correlation (PCC = 0.002) of YAP1 binding profiles between SF268 and IMR90 (<xref rid="pgen.1005465.g006" ref-type="fig">Fig 6B and 6C</xref>). Indeed only 42% of YAP1 peaks in SF268 overlapped peaks in IMR90. This difference in binding also holds true at the gene level (<xref rid="pgen.1005465.s008" ref-type="supplementary-material">S8 Fig</xref>). Despite these differences binding nevertheless takes place predominantly at distal regulatory regions (<xref rid="pgen.1005465.s008" ref-type="supplementary-material">S8 Fig</xref>). Furthermore, cell type-specific binding generates cell type-specific presence of the H3K27ac mark suggesting that those sites are functional (<xref rid="pgen.1005465.g006" ref-type="fig">Fig 6D</xref>). Finally, YAP1 binding sites in IMR90 are also predominantly enriched in TEAD motifs. Importantly, depletion of TEADs using siRNAs resulted in reduced YAP1 occupancy at cell type-specific and shared loci confirming the general observations made in the cancer cell lines (<xref rid="pgen.1005465.s009" ref-type="supplementary-material">S9 Fig</xref>). Different from the cancer cell lines the consensus motif for forkhead TFs (FOX) is significantly enriched as a secondary motif at IMR90-specific sites (<xref rid="pgen.1005465.s008" ref-type="supplementary-material">S8D Fig</xref>). This might indicate that FOX factors act as cell type-specific contributors to YAP1/TEAD transcriptional regulation. This is compatible with a recent publication that shows a functional interaction of YAP1 and FoxO1 in cardiomyocytes [<xref rid="pgen.1005465.ref067" ref-type="bibr">67</xref>]. This however remains challenging to test experimentally due to the fact that more than 20 FOX TFs are expressed in these particular cells that are all predicted to bind to this consensus motif. While it remains to be determined if FOX TFs contribute to cell type-specific TEAD binding our data clearly reveal that also YAP1 binding in non-transformed cells is mainly mediated by TEAD (<xref rid="pgen.1005465.s008" ref-type="supplementary-material">S8 Fig</xref>).</p><p>Taken together, these findings indicate that YAP1 binding to enhancers, as well as the presence of double TEAD motifs with a 3bp spacer, are general features of YAP1-mediated transcription in YAP1-activated cancer as well as non-transformed cells even though targeted enhancers can largely differ.</p></sec><sec id="sec010"><title>A novel set of YAP1/TEAD1 target genes</title><p>The high occurrences of YAP1 binding sites that we identify at distal enhancers suggest that the number of direct YAP1 target genes is much larger than previously anticipated based on studies that focused on promoter regions. While it is undisputed that enhancers are highly relevant for gene activation it remains challenging to correctly assign their target genes due to the fact that enhancers can regulate genes over long distances [<xref rid="pgen.1005465.ref068" ref-type="bibr">68</xref>]. Nevertheless, assigning enhancers to the gene in their nearest vicinity is a useful approximation that is correct in the majority of cases [<xref rid="pgen.1005465.ref062" ref-type="bibr">62</xref>, <xref rid="pgen.1005465.ref069" ref-type="bibr">69</xref>]. Based on this observation we assigned each YAP1/TEAD1 peak to its nearest gene TSS, yielding 1,738 genes in SF268 cells (<xref rid="pgen.1005465.s015" ref-type="supplementary-material">S2 Table</xref>). In agreement with the notion that YAP1 mainly functions as a transcriptional co-activator this gene set was expressed at a significantly higher level as compared to a random control set (<xref rid="pgen.1005465.g007" ref-type="fig">Fig 7A</xref>) indicating that the peak-to-gene assignment is overall accurate. Distal YAP1/TEAD1 peaks (over 2Kb away from gene TSS) were assigned to 1580 genes, 52 of which also had a proximal peak. Importantly, the 1528 genes with only distal YAP1/TEAD1 peaks were also more highly expressed than a random control set (<xref rid="pgen.1005465.g007" ref-type="fig">Fig 7A</xref>). To further, determine the accuracy of the peak to gene assignment we directly tested the expression of 19 randomly selected genes upon YAP1 or TEAD siRNA-mediated depletion (<xref rid="pgen.1005465.s010" ref-type="supplementary-material">S10 Fig</xref>). Gene expression levels were affected in all tested cases arguing for a direct link between binding events and target gene expression.</p><fig id="pgen.1005465.g007" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1005465.g007</object-id><label>Fig 7</label><caption><title>YAP1/TEAD1 target genes.</title><p>(A) Gene expression of target genes from all, proximal (&#x02264;2Kb), distal (&#x0003e;2Kb) or random YAP1/TEAD1 peaks. Peaks were assigned to their closest gene TSS. (B and C) Gene enrichment analysis of YAP1/TEAD1 target genes for (B) gene ontology biological processes and (C) WikiPathways. (D) Number of genes at selected expression fold change also targeted by YAP1/TEAD1 peaks. (E) Prediction of <italic>YAP1</italic> expression (high: purple vs. low: green) in glioblastoma and head and neck squamous cell tumor samples using the gene features extracted from 70 genes 2-fold down-regulated in YAP1 siRNA knockdowns and targeted by a YAP1/TEAD1 peak.</p></caption><graphic xlink:href="pgen.1005465.g007"/></fig><p>Gene Ontology (GO) analysis of this gene set showed enrichment for previously reported YAP1 functions such as regulation of cell migration (hypergeometric <italic>P</italic> &#x0003c; 10<sup>&#x02212;17</sup>), extracellular matrix organization (<italic>P</italic> &#x0003c; 10<sup>&#x02212;15</sup>), actin cytoskeleton organization (<italic>P</italic> &#x0003c; 10<sup>&#x02212;07</sup>), and regulation of epithelial cell proliferation (<italic>P</italic> &#x0003c; 10<sup>&#x02212;6</sup>) (<xref rid="pgen.1005465.g007" ref-type="fig">Fig 7B</xref> and <xref rid="pgen.1005465.s019" ref-type="supplementary-material">S6 Table</xref>). In agreement with recent studies demonstrating a complex interaction network between the YAP1/Hippo and others signaling pathways such as WNT, BMP, TGF-&#x003b2; and PI3K-mTOR [<xref rid="pgen.1005465.ref070" ref-type="bibr">70</xref>], our analysis reveals an enrichment of terms associated with signaling (<xref rid="pgen.1005465.g007" ref-type="fig">Fig 7B and 7C</xref> and <xref rid="pgen.1005465.s019" ref-type="supplementary-material">S6 Table</xref>). We noted that this set of genes contains a number of core components and downstream targets of diverse signaling pathways (<xref rid="pgen.1005465.s011" ref-type="supplementary-material">S11 Fig</xref>). In addition, a number of YAP1/Hippo pathway components including <italic>WWC1</italic>, <italic>LATS</italic>, <italic>NF2</italic>, and <italic>AMOT</italic> are bound by YAP1/TEAD1. This suggests an extensive feedback mechanism in vertebrates and confirms previous reports in <italic>Drosophila</italic> [<xref rid="pgen.1005465.ref071" ref-type="bibr">71</xref>, <xref rid="pgen.1005465.ref072" ref-type="bibr">72</xref>].</p></sec><sec id="sec011"><title>Gene Signature Analysis predicts YAP1 levels in primary tumor samples</title><p>Next we set out to determine which genes are transcriptionally activated by YAP1 and performed RNA-seq profiling following YAP1 siRNA-mediated depletion in SF268 cells (<xref rid="pgen.1005465.g007" ref-type="fig">Fig 7D</xref> and <xref rid="pgen.1005465.s012" ref-type="supplementary-material">S12 Fig</xref>). This identified 219 and 360 genes that were down- or up-regulated by at least 2-fold, respectively, upon YAP1 knockdown compared to control siRNA-treated cells. Among the down-regulated genes, 70 (32%) contained a YAP1/TEAD1 peak assignment in SF268 cells (<xref rid="pgen.1005465.g007" ref-type="fig">Fig 7D</xref>).</p><p>To evaluate the physiological relevance of these YAP1-activated target genes, we sought to predict YAP1 expression in tumor samples using expression data for 528 primary glioblastoma and 279 head and neck squamous cell tumor samples [<xref rid="pgen.1005465.ref073" ref-type="bibr">73</xref>]. For each indication, we labeled the samples as <italic>YAP1</italic> &#x0201c;high&#x0201d; or &#x0201c;low&#x0201d; expression and divided the datasets into training and test datasets (2/3 and 1/3 of the samples respectively) over 1000 randomized iterations. Using a na&#x000ef;ve Bayes classifier this allowed to predict <italic>YAP1</italic> expression level with high accuracy (an area under the receiver operating characteristics curve (AUC) = 0.83 for glioblastoma samples and AUC = 0.78 for head and neck squamous tumor samples) (<xref rid="pgen.1005465.s013" ref-type="supplementary-material">S13 Fig</xref>). Feature selection allowed reducing the full YAP1 gene signature to ten genes without losing prediction performance. Hierarchical clustering of the samples shows consistent patterns of expression depending on <italic>YAP1</italic> &#x0201c;high&#x0201d; or &#x0201c;low&#x0201d; expression (<xref rid="pgen.1005465.g007" ref-type="fig">Fig 7D</xref>). This result supports the use of the acquired gene signature to identify YAP1-activated cancers.</p></sec></sec><sec sec-type="conclusions" id="sec012"><title>Discussion</title><p>By providing a comprehensive account of YAP1 genomic binding and its impact on transcription this study establishes that transcriptional regulation of YAP1 target genes is predominantly mediated by TEAD binding to distal enhancers. In addition to demonstrating this mode of regulation we show that this activity entails the establishment of chromatin marks typical to enhancers linking YAP1 activity to H3K27ac. The identified distal regions enabled us to largely expand the set of YAP1 target genes, which we foresee to be a valuable source for functional studies and which we show to have predictive power to identify YAP1-activated cancers.</p><p>Due to lack of a DNA-binding domain, YAP1 requires TFs for genomic recruitment. TEAD family members are considered the main TFs for YAP1-mediated regulation of gene expression [<xref rid="pgen.1005465.ref022" ref-type="bibr">22</xref>, <xref rid="pgen.1005465.ref023" ref-type="bibr">23</xref>, <xref rid="pgen.1005465.ref025" ref-type="bibr">25</xref>]. In support of a dominant function of TEADs in cancer cells, overexpression of an artificial TEAD2-VP16 construct in NIH3T3 cells was reported to mimic the effects of YAP1 overexpression at the transcriptional level and lead to cell transformation [<xref rid="pgen.1005465.ref023" ref-type="bibr">23</xref>]. Furthermore, mutations in YAP1 that prevent binding to TEAD were shown to abolish YAP1-induced transcription and cell transformation in NIH3T3 and MCF10A cells [<xref rid="pgen.1005465.ref022" ref-type="bibr">22</xref>].</p><p>Here, we comprehensively mapped YAP1 chromatin binding genome-wide in two different cancer cell lines and in non-transformed cells, enabling an unbiased assessment of the sequence features that direct YAP1-mediated regulation. Our genome-wide map of TEAD1 binding sites revealed that the vast majority of YAP1 binding sites were co-occupied by TEAD1 confirming the dominant role of TEAD factors in the control of YAP1 transcriptional activity. To the best of our knowledge this is the first study demonstrating a genome-wide co-occupancy of both factors in cancer cells. Our data extends the results from a previous ChIP-on-chip study that used a promoter specific microarray and demonstrated a comparable overlap of &#x0003e;80% for YAP1 and TEAD1 binding around start sites in MCF10A mammary epithelial cells [<xref rid="pgen.1005465.ref022" ref-type="bibr">22</xref>].</p><p>Despite the major role of TEADs to mediate YAP1 co-activator activity, additional TFs are described to interact with YAP1 (reviewed in [<xref rid="pgen.1005465.ref012" ref-type="bibr">12</xref>]). Our data, however, do not provide evidence for the importance of additional TFs in targeting YAP1 chromatin binding. We demonstrate that this finding is not just limited to a cellular situation where <italic>YAP1</italic> is amplified since we observe a similar predominant enrichment of TEAD motifs in YAP1 peak regions in a YAP1-activated NCI-H2052 cancer cell line as well as in non-transformed IMR90 cells.</p><p>TEAD1 also referred to as TEF-1, for transcription enhancer factor 1, was first cloned in HeLa cells as an activator of the simian virus 40 (SV40) &#x0201c;enhancer&#x0201d;, which is a short 72bp sequence element that is a component of the viral early promoter [<xref rid="pgen.1005465.ref054" ref-type="bibr">54</xref>, <xref rid="pgen.1005465.ref074" ref-type="bibr">74</xref>, <xref rid="pgen.1005465.ref075" ref-type="bibr">75</xref>]. So far, however, binding and function at endogenous elements that by the current definition of an enhancer act distal to promoters had not been investigated.</p><p>Our genome-wide analysis of YAP1/TEAD1 binding indicates that the vast majority of endogenous sites, in cancer and non-cancer cells (SF268, NCI-H2052 and IMR90), are actually located within distal regulatory regions representing enhancer elements. This mimics the typical distribution of sequence-specific TFs and is in line with the concept that distal TF and co-activator binding are key determinants of enhancer activity and in turn cell-type specific gene expression patterns [<xref rid="pgen.1005465.ref039" ref-type="bibr">39</xref>, <xref rid="pgen.1005465.ref068" ref-type="bibr">68</xref>, <xref rid="pgen.1005465.ref076" ref-type="bibr">76</xref>]. Recent efforts in mapping enhancers in different tissues revealed that the human genome contains up to several hundred thousand distal regulatory regions, most of which are cell-type specific [<xref rid="pgen.1005465.ref077" ref-type="bibr">77</xref>]. Their misregulation can be highly disease relevant since mutations in these regions have extensively been associated with disease susceptibility [<xref rid="pgen.1005465.ref078" ref-type="bibr">78</xref>].</p><p>Distal binding has not been reported for Yki (Yorki) the <italic>Drosophila</italic> homolog of YAP1 and it remains open if this reflects a functional difference or the organization of the smaller and gene denser fly genome [<xref rid="pgen.1005465.ref057" ref-type="bibr">57</xref>, <xref rid="pgen.1005465.ref079" ref-type="bibr">79</xref>]. Similarly, enhancer binding of Yap1 has not been reported in mouse embryonic stem cells [<xref rid="pgen.1005465.ref055" ref-type="bibr">55</xref>]. However, when reanalyzing an available list of Yap1 peak regions from Lin <italic>et al</italic>., we observed that a large fraction of these Yap1 binding sites are located in regions distal from promoters. In support of our data two recent reports demonstrated that YAP1/TEAD regulate transcription by binding to distal enhancers [<xref rid="pgen.1005465.ref067" ref-type="bibr">67</xref>, <xref rid="pgen.1005465.ref080" ref-type="bibr">80</xref>]. Together this argues that YAP1 distal binding is a general feature of YAP1/TEAD-driven transcription activation also in non-transformed cells and is not an acquired feature of cancer cells.</p><p>Distinct chromatin modifications are associated with various aspects of gene expression. In particular H3K27ac was found to be an effective means to determine enhancer activity [<xref rid="pgen.1005465.ref059" ref-type="bibr">59</xref>, <xref rid="pgen.1005465.ref081" ref-type="bibr">81</xref>]. Our data show that the vast majority of YAP1 binding sites overlap H3K27ac positive regions and that cell-type specific YAP1 sites match cell type specific H3K27ac regions. Interestingly we show that, in SF268 cells, YAP1 chromatin association is a prerequisite for the deposition of H3K27ac supporting the fact that YAP1 binding sites represent functional enhancers.</p><p>Interestingly, genome-wide binding analysis in <italic>Drosophila</italic> revealed a correlation between Yki chromatin binding and trimethylation of H3K4 (H3K4me3) [<xref rid="pgen.1005465.ref057" ref-type="bibr">57</xref>]. Consistent with this finding, nuclear receptor coactivator 6 (Ncoa6), a subunit of the Trithorax-related H3K4 methyltransferase complex, has been identified as a Yki binding protein that is required for transcriptional regulation [<xref rid="pgen.1005465.ref079" ref-type="bibr">79</xref>]. Importantly, besides the H3K4 methyltransferases, the mammalian Ncoa6 has been reported to enhance the activity of TFs by interacting with histone acetyltransferases CBP/p300 [<xref rid="pgen.1005465.ref082" ref-type="bibr">82</xref>]. Whether this NCOA6 function possibly facilitates YAP1-dependent acetylation of H3K27 (H3K27ac) and which additional cofactors are recruited to trigger transcriptional activity warrants further investigations.</p><p>The determination of genes targeted by specific enhancers remains a challenge. We observed that only a minority of genes nearest to binding sites was transcriptionally affected by depletion of YAP1. Notably however, only 10&#x02013;25% of TF binding events in higher eukaryotes contribute to the expression of the closest proximal gene in any given cell type. This is likely to be an underestimate given the nature of enhancers and the complexity of transcription regulatory networks [<xref rid="pgen.1005465.ref076" ref-type="bibr">76</xref>]. Besides the uncertainty of assigning binding sites to target genes, enhancers function in a modular manner such that they contribute additively and redundantly to the expression of their target genes [<xref rid="pgen.1005465.ref076" ref-type="bibr">76</xref>, <xref rid="pgen.1005465.ref083" ref-type="bibr">83</xref>]. Therefore YAP1/TEAD contribution to transcriptional activity might not be apparent at many target genes.</p><p>In addition to shedding light on basic principles of YAP1 transcriptional regulation, the identification of distal regulation as the primary means of YAP1 transcriptional control enabled us to identify an extended list of target genes based on both YAP1 chromatin binding and gene expression changes. This novel YAP1 signature from YAP1-amplified glioblastoma cells should have predictive potential for the identification of YAP1-dependent tumors.</p></sec><sec sec-type="materials|methods" id="sec013"><title>Materials and Methods</title><sec id="sec014"><title>Cell culture and transfections</title><p>SF268 cells (NCI DCTD tumor/cell line repository) were maintained in RPMI 1640 Medium, GlutaMAX supplement, 25 mM HEPES, 10% (v/v) fetal calf serum and 1 mM sodium pyruvate. NCI-H2052 cells (ATCC) were maintained in RPMI, 10% (v/v) fetal calf serum, 1% (v/v) non-essential amino acids, 1 mM sodium pyruvate. IMR90 cells (ATCC) were maintained in EMEM (Sigma M 4655) supplemented with 1% non-essential amino acids (NEAA) and 10% FBS. All media and supplements were from Life Technologies. To obtain low density (LD) or high density (HD) cultures, SF268 cells were plated at 10.000 cells/cm<sup>2</sup> or 100.000 cells/cm<sup>2</sup>, respectively and harvested 48h or 96 hours after seeding. Transient transfections of SF268, IMR90 and NCI-H2052 cells with siRNA (final concentration: 25 nM) were performed using Lipofectamine RNAiMAX (Life Technologies). Transient transfection of SF268 cells with plasmid DNA was performed using Cell Avalanche Transfection Reagent (EZ Biosystems). Cells were harvested at 48 hours or 72 hours post-transfection.</p></sec><sec id="sec015"><title>Antibodies</title><p>The following antibodies were used for western blot, immunoprecipitation and chromatin immunoprecipitation (ChIP): anti-YAP1 [EP1674Y] (ab52771), anti-KAT3B/p300 (ab14984), and anti-H3 (ab1791) from Abcam; anti-TEAD1 (610922) from BD Transduction Laboratories; anti-TEAD4 (ARP33426_P050) from Aviva Biosystems; anti-&#x003b2;-Actin (A2066) from Sigma-Aldrich; anti-H3K27ac (AM 39133) from Active Motif. YAP1 and TEAD1 antibodies for ChIP-seq were characterized in western blot, immunoprecipitation and ChIP-qPCR (<xref rid="pgen.1005465.s002" ref-type="supplementary-material">S2</xref> and <xref rid="pgen.1005465.s004" ref-type="supplementary-material">S4</xref> Figs).</p></sec><sec id="sec016"><title>Chromatin immunoprecipitation (ChIP)</title><p>ChIP was essentially carried out as previously described [<xref rid="pgen.1005465.ref084" ref-type="bibr">84</xref>], with slight modifications. Chromatin was sonicated for 14 minutes using a Covaris E210 (Settings: 5% duty cycle, intensity 4). 60&#x003bc;g of chromatin were incubated over night at 4&#x000b0;C with 5&#x003bc;g of the corresponding antibody and for 2 hours with preblocked (tRNA, BSA) Dynabeads protein G. DNA was purified using the Minielute PCR purification kit (Qiagen).</p></sec><sec id="sec017"><title>ChIP-qPCR</title><p>Quantitative PCR was performed using Maxima SYBR Green / ROX qPCR Master Mix (Thermo Scientific) and the ViiA 7 Real-Time PCR System (Life Technologies) and 1/80th of the ChIP sample or 0.01% of input chromatin per PCR, respectively. Amplifications were performed in triplicate, and mean values were expressed as percentage input. Standard deviation was calculated from the triplicates, and error bars are indicated accordingly. Primers are listed in <xref rid="pgen.1005465.t001" ref-type="table">Table 1</xref> and <xref rid="pgen.1005465.t002" ref-type="table">Table 2</xref>.</p><table-wrap id="pgen.1005465.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1005465.t001</object-id><label>Table 1</label><caption><title>Primers used for ChIP-qPCR.</title></caption><alternatives><graphic id="pgen.1005465.t001g" xlink:href="pgen.1005465.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Name</th><th align="center" rowspan="1" colspan="1">Forward primer</th><th align="center" rowspan="1" colspan="1">Reverse primer</th><th align="center" rowspan="1" colspan="1">Size (bp)</th><th align="center" rowspan="1" colspan="1">Genomic coordinates</th></tr></thead><tbody><tr><td align="justify" rowspan="1" colspan="1">ANKRD1 #1</td><td align="justify" rowspan="1" colspan="1">GAGGGGAGGACAAGCTAACC</td><td align="justify" rowspan="1" colspan="1">CGATGTGATCACCACCAAAG</td><td align="center" rowspan="1" colspan="1">83</td><td align="justify" rowspan="1" colspan="1">chr10:92681001&#x02013;92681083</td></tr><tr><td align="justify" rowspan="1" colspan="1">CTGF</td><td align="justify" rowspan="1" colspan="1">GCCAATGAGCTGAATGGAGT</td><td align="justify" rowspan="1" colspan="1">CAATCCGGTGTGAGTTGATG</td><td align="center" rowspan="1" colspan="1">88</td><td align="justify" rowspan="1" colspan="1">chr6:132272566&#x02013;132272653</td></tr><tr><td align="justify" rowspan="1" colspan="1">CYR61 #1</td><td align="justify" rowspan="1" colspan="1">AGCAAACAGCTCACTGCCTT</td><td align="justify" rowspan="1" colspan="1">ATGGTAGTTGGAGGGTCGTG</td><td align="center" rowspan="1" colspan="1">169</td><td align="justify" rowspan="1" colspan="1">chr1:86045890&#x02013;86046058</td></tr><tr><td align="justify" rowspan="1" colspan="1">NPPB</td><td align="justify" rowspan="1" colspan="1">TCTGGAATGCTGACCCTTCT</td><td align="justify" rowspan="1" colspan="1">CTTGGGTGACTTCGTCATCA</td><td align="center" rowspan="1" colspan="1">96</td><td align="justify" rowspan="1" colspan="1">chr1:11919755&#x02013;11919850</td></tr><tr><td align="justify" rowspan="1" colspan="1">ANKRD1 #2</td><td align="justify" rowspan="1" colspan="1">ATGGCCTGCCACTTTGTTAC</td><td align="justify" rowspan="1" colspan="1">TTTTCAGAACTGGGGTCTGG</td><td align="center" rowspan="1" colspan="1">96</td><td align="justify" rowspan="1" colspan="1">chr10:92691054&#x02013;92691149</td></tr><tr><td align="justify" rowspan="1" colspan="1">CYR61 #2</td><td align="justify" rowspan="1" colspan="1">CCCTTGGCTGTTATGAGGAA</td><td align="justify" rowspan="1" colspan="1">CCTTGCATTCCTTTGCATTT</td><td align="center" rowspan="1" colspan="1">139</td><td align="justify" rowspan="1" colspan="1">chr1:86049930&#x02013;86050068</td></tr><tr><td align="justify" rowspan="1" colspan="1">CYR61 #3</td><td align="justify" rowspan="1" colspan="1">AGGAGTGAGAGAAGCAAGCG</td><td align="justify" rowspan="1" colspan="1">TGCTTGTGAGCTTGTCATCC</td><td align="center" rowspan="1" colspan="1">118</td><td align="justify" rowspan="1" colspan="1">chr1:86072824&#x02013;86072941</td></tr><tr><td align="justify" rowspan="1" colspan="1">KISS1</td><td align="justify" rowspan="1" colspan="1">GCCGACCTGCTGTAGACAAT</td><td align="justify" rowspan="1" colspan="1">CAAGGGCATCTACCTACCCA</td><td align="center" rowspan="1" colspan="1">142</td><td align="justify" rowspan="1" colspan="1">chr1:204164957&#x02013;204165098</td></tr><tr><td align="justify" rowspan="1" colspan="1">NEXN</td><td align="justify" rowspan="1" colspan="1">TTTAGGGCATGGCTCACTTC</td><td align="justify" rowspan="1" colspan="1">AAGAGGGATTTTCATGGCCT</td><td align="center" rowspan="1" colspan="1">126</td><td align="justify" rowspan="1" colspan="1">chr1:78567437&#x02013;78567562</td></tr><tr><td align="justify" rowspan="1" colspan="1">PAWR</td><td align="justify" rowspan="1" colspan="1">CAGCATTCCTGTCATTCCCT</td><td align="justify" rowspan="1" colspan="1">CAGGCTTCTTTTCTTGCACC</td><td align="center" rowspan="1" colspan="1">195</td><td align="justify" rowspan="1" colspan="1">chr12:79941168&#x02013;79941362</td></tr><tr><td align="justify" rowspan="1" colspan="1">S1PR1</td><td align="justify" rowspan="1" colspan="1">GTTCAGGATCAAGCTCCACC</td><td align="justify" rowspan="1" colspan="1">GCTGAGAGCAGCCTGAGAAT</td><td align="center" rowspan="1" colspan="1">156</td><td align="justify" rowspan="1" colspan="1">chr1:101666161&#x02013;101666316</td></tr><tr><td align="justify" rowspan="1" colspan="1">SNAPC1</td><td align="justify" rowspan="1" colspan="1">TCTTCCAGCCTCTGCTCATT</td><td align="justify" rowspan="1" colspan="1">CAGCTTGACTTTTCCCTTGG</td><td align="center" rowspan="1" colspan="1">100</td><td align="justify" rowspan="1" colspan="1">chr14:62222431&#x02013;62222530</td></tr><tr><td align="justify" rowspan="1" colspan="1">SKP2</td><td align="justify" rowspan="1" colspan="1">GCACAGAGGGAAACCAATGT</td><td align="justify" rowspan="1" colspan="1">GTCCCTCATCCTGCATCACT</td><td align="center" rowspan="1" colspan="1">96</td><td align="justify" rowspan="1" colspan="1">chr5:36156228&#x02013;36156323</td></tr><tr><td align="justify" rowspan="1" colspan="1">Ctrl chr10</td><td align="justify" rowspan="1" colspan="1">ACCAACACTCTTCCCTCAGC</td><td align="justify" rowspan="1" colspan="1">TTATTTTGGTTCAGGTGGTTGA</td><td align="center" rowspan="1" colspan="1">100</td><td align="justify" rowspan="1" colspan="1">chr10:60902566&#x02013;60902665</td></tr><tr><td align="justify" rowspan="1" colspan="1">Ctrl chr14</td><td align="justify" rowspan="1" colspan="1">GTGGGCCTTTGGAATATCCT</td><td align="justify" rowspan="1" colspan="1">GACCTTGGCTGTGTTGTCCT</td><td align="center" rowspan="1" colspan="1">128</td><td align="justify" rowspan="1" colspan="1">chr14:66894932&#x02013;66895059</td></tr></tbody></table></alternatives></table-wrap><table-wrap id="pgen.1005465.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1005465.t002</object-id><label>Table 2</label><caption><title>Primers used for ChIP-qPCR (Figs <xref rid="pgen.1005465.g005" ref-type="fig">5</xref> and <xref rid="pgen.1005465.s007" ref-type="supplementary-material">S7</xref> and <xref rid="pgen.1005465.s009" ref-type="supplementary-material">S9</xref>).</title></caption><alternatives><graphic id="pgen.1005465.t002g" xlink:href="pgen.1005465.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Name</th><th align="center" rowspan="1" colspan="1">Forward primer</th><th align="center" rowspan="1" colspan="1">Reverse primer</th><th align="center" rowspan="1" colspan="1">Size (bp)</th><th align="center" rowspan="1" colspan="1">Genomic coordinates</th></tr></thead><tbody><tr><td align="justify" rowspan="1" colspan="1">KISS1</td><td align="justify" rowspan="1" colspan="1">CTTTCCATCCTCCACACCCT</td><td align="justify" rowspan="1" colspan="1">ACTAGGTGTGTCTGTGGCTC</td><td align="center" rowspan="1" colspan="1">145</td><td align="justify" rowspan="1" colspan="1">chr1:204165829&#x02013;204165973</td></tr><tr><td align="justify" rowspan="1" colspan="1">NEXN</td><td align="justify" rowspan="1" colspan="1">GGGCAGAAAGAGAAGGAGGA</td><td align="justify" rowspan="1" colspan="1">GAACATCTGCTCGTGGGACA</td><td align="center" rowspan="1" colspan="1">120</td><td align="justify" rowspan="1" colspan="1">chr1:78566826&#x02013;78566945</td></tr><tr><td align="justify" rowspan="1" colspan="1">PAWR</td><td align="justify" rowspan="1" colspan="1">CAGCATTCCTGTCATTCCCT</td><td align="justify" rowspan="1" colspan="1">CAGGCTTCTTTTCTTGCACC</td><td align="center" rowspan="1" colspan="1">195</td><td align="justify" rowspan="1" colspan="1">chr12:79941168&#x02013;79941362</td></tr><tr><td align="justify" rowspan="1" colspan="1">S1PR1</td><td align="justify" rowspan="1" colspan="1">AGCGGTAGTATCACATCTCTCT</td><td align="justify" rowspan="1" colspan="1">TCTTCTCCTTTACTCCTGTTCTC</td><td align="center" rowspan="1" colspan="1">81</td><td align="justify" rowspan="1" colspan="1">chr1:101666049&#x02013;101666129</td></tr><tr><td align="justify" rowspan="1" colspan="1">SNAPC1</td><td align="justify" rowspan="1" colspan="1">TCTTCCAGCCTCTGCTCATT</td><td align="justify" rowspan="1" colspan="1">CAGCTTGACTTTTCCCTTGG</td><td align="center" rowspan="1" colspan="1">100</td><td align="justify" rowspan="1" colspan="1">chr14:62222431&#x02013;62222530</td></tr><tr><td align="justify" rowspan="1" colspan="1">IFIT1</td><td align="justify" rowspan="1" colspan="1">TGACTGATCCTCCACACTGG</td><td align="justify" rowspan="1" colspan="1">ACCATGACCACCATCCATCT</td><td align="center" rowspan="1" colspan="1">111</td><td align="justify" rowspan="1" colspan="1">chr10:91157752&#x02013;91157862</td></tr><tr><td align="justify" rowspan="1" colspan="1">FAM150B</td><td align="justify" rowspan="1" colspan="1">CAATGCCCATGTTTGTGTGT</td><td align="justify" rowspan="1" colspan="1">GCAGTGGAGATGATCCAGGT</td><td align="center" rowspan="1" colspan="1">102</td><td align="justify" rowspan="1" colspan="1">chr2:285749&#x02013;285850</td></tr><tr><td align="justify" rowspan="1" colspan="1">PLA2G16</td><td align="justify" rowspan="1" colspan="1">TAAACAACCCCAAACCCTCA</td><td align="justify" rowspan="1" colspan="1">TCACTCAAGGCTATGCAGGA</td><td align="center" rowspan="1" colspan="1">82</td><td align="justify" rowspan="1" colspan="1">chr11:63376086&#x02013;63376167</td></tr><tr><td align="justify" rowspan="1" colspan="1">MFAP5</td><td align="justify" rowspan="1" colspan="1">AGCAACTGCAAATTCCCATC</td><td align="justify" rowspan="1" colspan="1">CCGCTGAAACAATGAGATGA</td><td align="center" rowspan="1" colspan="1">105</td><td align="justify" rowspan="1" colspan="1">chr12:8815358&#x02013;8815462</td></tr><tr><td align="justify" rowspan="1" colspan="1">PPP2R5A</td><td align="justify" rowspan="1" colspan="1">GTCCTAAGGGCAAACAGCAA</td><td align="justify" rowspan="1" colspan="1">ATGAAACTGCCTGAGGATGC</td><td align="center" rowspan="1" colspan="1">143</td><td align="justify" rowspan="1" colspan="1">chr1:212485630&#x02013;212485772</td></tr><tr><td align="justify" rowspan="1" colspan="1">DHTKD1</td><td align="justify" rowspan="1" colspan="1">AAGCCCAAGACATCCTCCTT</td><td align="justify" rowspan="1" colspan="1">AGGGCAGAAACTGTGCCTTA</td><td align="center" rowspan="1" colspan="1">95</td><td align="justify" rowspan="1" colspan="1">chr10:12109374&#x02013;12109468</td></tr><tr><td align="justify" rowspan="1" colspan="1">NPC1</td><td align="justify" rowspan="1" colspan="1">ACTGGGTTGGGAGGAGAAGT</td><td align="justify" rowspan="1" colspan="1">TTTCAGCGAAGGGTAGTGCT</td><td align="center" rowspan="1" colspan="1">119</td><td align="justify" rowspan="1" colspan="1">chr18:21166727&#x02013;21166845</td></tr><tr><td align="justify" rowspan="1" colspan="1">TCOF1</td><td align="justify" rowspan="1" colspan="1">CTACCGACAGGGATTCCAAA</td><td align="justify" rowspan="1" colspan="1">GCTCAACTTTGCCAGACACA</td><td align="center" rowspan="1" colspan="1">133</td><td align="justify" rowspan="1" colspan="1">chr5:149814163&#x02013;149814295</td></tr><tr><td align="justify" rowspan="1" colspan="1">EPB41L2#1</td><td align="justify" rowspan="1" colspan="1">AAGGGAGAAACGTTGGAGGT</td><td align="justify" rowspan="1" colspan="1">TGGGTGGCATACACAGTTTG</td><td align="center" rowspan="1" colspan="1">138</td><td align="justify" rowspan="1" colspan="1">chr6:131374839&#x02013;131374976</td></tr><tr><td align="justify" rowspan="1" colspan="1">EPB41L2#2</td><td align="justify" rowspan="1" colspan="1">GGAATGACCTCAGTGTCTCAAA</td><td align="justify" rowspan="1" colspan="1">TGACAGTCACCAGCAAAGGA</td><td align="center" rowspan="1" colspan="1">94</td><td align="justify" rowspan="1" colspan="1">chr6:131175088&#x02013;131175181</td></tr><tr><td align="justify" rowspan="1" colspan="1">C1orf198</td><td align="justify" rowspan="1" colspan="1">TGCCACATTCATGACATTCC</td><td align="justify" rowspan="1" colspan="1">CAGGGTCTTTGCCTGGATAG</td><td align="center" rowspan="1" colspan="1">132</td><td align="justify" rowspan="1" colspan="1">chr1:231005302&#x02013;231005433</td></tr><tr><td align="justify" rowspan="1" colspan="1">CCL2</td><td align="justify" rowspan="1" colspan="1">GAAAGTGACTTGGCCTTTGC</td><td align="justify" rowspan="1" colspan="1">AAGTGGGAGGCAGACAGCTA</td><td align="center" rowspan="1" colspan="1">109</td><td align="justify" rowspan="1" colspan="1">chr17:29603882&#x02013;29603990</td></tr><tr><td align="justify" rowspan="1" colspan="1">RNF144A</td><td align="justify" rowspan="1" colspan="1">CATACCAATGCTGGGTGAAA</td><td align="justify" rowspan="1" colspan="1">ACCCAGTCTCCACACAAAGG</td><td align="center" rowspan="1" colspan="1">143</td><td align="justify" rowspan="1" colspan="1">chr2:6684254&#x02013;6684396</td></tr><tr><td align="justify" rowspan="1" colspan="1">ITPR3</td><td align="justify" rowspan="1" colspan="1">GGAAGGAGTCCAGTGGCTTA</td><td align="justify" rowspan="1" colspan="1">ATGAGGGTCAGAAGGGAGGA</td><td align="center" rowspan="1" colspan="1">87</td><td align="justify" rowspan="1" colspan="1">chr6:33685319&#x02013;33685405</td></tr><tr><td align="justify" rowspan="1" colspan="1">MAN1C1</td><td align="justify" rowspan="1" colspan="1">TTCCCAATTCTGTCTCATGATCT</td><td align="justify" rowspan="1" colspan="1">GTCTTGGTGGGAGGAAGTGA</td><td align="center" rowspan="1" colspan="1">120</td><td align="justify" rowspan="1" colspan="1">chr1:26038242&#x02013;26038361</td></tr><tr><td align="justify" rowspan="1" colspan="1">Ctrl chr10</td><td align="justify" rowspan="1" colspan="1">ACCAACACTCTTCCCTCAGC</td><td align="justify" rowspan="1" colspan="1">TTATTTTGGTTCAGGTGGTTGA</td><td align="center" rowspan="1" colspan="1">100</td><td align="justify" rowspan="1" colspan="1">chr10:60902566&#x02013;60902665</td></tr><tr><td align="justify" rowspan="1" colspan="1">Ctrl chr14</td><td align="justify" rowspan="1" colspan="1">GTGGGCCTTTGGAATATCCT</td><td align="justify" rowspan="1" colspan="1">GACCTTGGCTGTGTTGTCCT</td><td align="center" rowspan="1" colspan="1">128</td><td align="justify" rowspan="1" colspan="1">chr14:66894932&#x02013;66895059</td></tr><tr><td align="justify" rowspan="1" colspan="1">Ctrl UCP2</td><td align="justify" rowspan="1" colspan="1">GCGTTTACTCCTTCGTTCCC</td><td align="justify" rowspan="1" colspan="1">AAGGCAAGAGGTGTGTGACT</td><td align="center" rowspan="1" colspan="1">145</td><td align="justify" rowspan="1" colspan="1">chr11:73694084&#x02013;73694228</td></tr></tbody></table></alternatives></table-wrap></sec><sec id="sec018"><title>ChIP-seq</title><p>YAP1, TEAD1 and H3K27ac ChIPs from SF268 cells and YAP1 ChIPs from NCI-H2052 and IMR90 cells were subjected to high-throughput sequencing on a 356R Illumina HiSeq 2500 sequencer using standard NEB library preparation kits and protocols.</p></sec><sec id="sec019"><title>ChIP-seq data processing</title><p>Additional ChIP-seq dataset for H3K27ac in IMR90 cells was obtained from the Gene Expression Omnibus under the accession number GSM469967. We mapped the ChIP-seq sequencing reads (single-end, 50bp) to the human reference genome (hg19 only chromosomes 1 to 22, X, Y and M) using bowtie [<xref rid="pgen.1005465.ref085" ref-type="bibr">85</xref>] version 1.0.0 with parameters-v 3-m 1&#x02014;best&#x02014;strata. We extended the reads to 150bp (average estimated fragment length) and calculated for each genomic position the read density normalized to one million reads in the library to generate wiggle files. Genome screenshots were taken using the UCSC genome browser [<xref rid="pgen.1005465.ref086" ref-type="bibr">86</xref>].</p></sec><sec id="sec020"><title>Peak calling and overlap</title><p>We identified peaks in YAP1 and TEAD1 ChIP samples compared to the corresponding input samples using peakzilla [<xref rid="pgen.1005465.ref045" ref-type="bibr">45</xref>] and in H3K27ac ChIP using MACS [<xref rid="pgen.1005465.ref087" ref-type="bibr">87</xref>] version 1.4.2. The strategy used to define and overlap peak regions is described in [<xref rid="pgen.1005465.ref088" ref-type="bibr">88</xref>] and <xref rid="pgen.1005465.s014" ref-type="supplementary-material">S1 Table</xref>. We defined control peak regions by shuffling the peaks randomly within the same chromosome. We calculated the Pearson correlation coefficient (PCC) and plotted scatterplots between two samples using the mean fragment density of each peak region from all samples. Differentially bound regions were identified with the R package DESeq [<xref rid="pgen.1005465.ref089" ref-type="bibr">89</xref>] using an adjusted p-value threshold of 10<sup>&#x02212;5</sup> and a 2-fold enrichment with enrichment in the reference sample below 100 normalized reads per kilobase.</p></sec><sec id="sec021"><title>Motif enrichment analysis</title><p>We searched for motif de novo using MEME [<xref rid="pgen.1005465.ref046" ref-type="bibr">46</xref>] within 31bp around peak summits and for occurrences of the known motifs from Jaspar [<xref rid="pgen.1005465.ref090" ref-type="bibr">90</xref>], and [<xref rid="pgen.1005465.ref049" ref-type="bibr">49</xref>] using MAST [<xref rid="pgen.1005465.ref091" ref-type="bibr">91</xref>] (from the MEME suite programs version 4.1.1) with a P-value of 10<sup>&#x02212;3</sup> in an area of 151bp (average genomic fragment length) around each peak summit.</p></sec><sec id="sec022"><title>Functional analyses</title><p>We assigned each peak to its closest gene transcriptional start site (TSS) using the reference transcriptome (GRCh37.71). For each gene ontology biological processes [<xref rid="pgen.1005465.ref092" ref-type="bibr">92</xref>] and WikiPathways [<xref rid="pgen.1005465.ref093" ref-type="bibr">93</xref>], we calculated the enrichment and associated hypergeometric P-values of genes in each class compared to all genes. We calculated the conservation rate of regions using the PhastCons 46 way placental mammals [<xref rid="pgen.1005465.ref094" ref-type="bibr">94</xref>].</p></sec><sec id="sec023"><title>RT-qPCR</title><p>RNA was isolated using RNeasy Mini Kit (Qiagen) and cDNA synthesis was performed using the High-Capacity RNA-to-cDNA Kit (Applied Biosystems). cDNA was subjected to quantitative PCR (qPCR) analysis in triplicates with gene-specific primers (see <xref rid="pgen.1005465.t003" ref-type="table">Table 3</xref>) using Maxima SYBR Green / ROX qPCR Master Mix (Thermo Scientific) and the ViiA 7 Real-Time PCR System (Life Technologies).</p><table-wrap id="pgen.1005465.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1005465.t003</object-id><label>Table 3</label><caption><title>Primers used for RT-qPCR.</title></caption><alternatives><graphic id="pgen.1005465.t003g" xlink:href="pgen.1005465.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Gene</th><th align="center" rowspan="1" colspan="1">Forward primer</th><th align="center" rowspan="1" colspan="1">Reverse primer</th><th align="center" rowspan="1" colspan="1">Size (bp)</th></tr></thead><tbody><tr><td align="justify" rowspan="1" colspan="1">CYR61</td><td align="justify" rowspan="1" colspan="1">AAGAAACCCGGATTTGTGAG</td><td align="justify" rowspan="1" colspan="1">GCTGCATTTCTTGCCCTTT</td><td align="center" rowspan="1" colspan="1">77</td></tr><tr><td align="justify" rowspan="1" colspan="1">CTGF</td><td align="justify" rowspan="1" colspan="1">CTCCTGCAGGCTAGAGAAGC</td><td align="justify" rowspan="1" colspan="1">GATGCACTTTTTGCCCTTCTT</td><td align="center" rowspan="1" colspan="1">94</td></tr><tr><td align="justify" rowspan="1" colspan="1">NPPB</td><td align="justify" rowspan="1" colspan="1">GCTTTGGGAGGAAGATGGAC</td><td align="justify" rowspan="1" colspan="1">GCAGCCAGGACTTCCTCTTA</td><td align="center" rowspan="1" colspan="1">88</td></tr><tr><td align="justify" rowspan="1" colspan="1">YAP1</td><td align="justify" rowspan="1" colspan="1">GCAAATTCTCCAAAATGTCAGG</td><td align="justify" rowspan="1" colspan="1">CGGGAGAAGACACTGGATTT</td><td align="center" rowspan="1" colspan="1">94</td></tr><tr><td align="justify" rowspan="1" colspan="1">UBC</td><td align="justify" rowspan="1" colspan="1">AGGCAAAGATCCAAGATAAGGA</td><td align="justify" rowspan="1" colspan="1">GGACCAAGTGCAGAGTGGAC</td><td align="center" rowspan="1" colspan="1">132</td></tr><tr><td align="justify" rowspan="1" colspan="1">TEAD1</td><td align="justify" rowspan="1" colspan="1">CTGAGTCGCAGTTACCACCA</td><td align="justify" rowspan="1" colspan="1">AGCCTGGAGCCTTTTCAAG</td><td align="center" rowspan="1" colspan="1">92</td></tr><tr><td align="justify" rowspan="1" colspan="1">TEAD2</td><td align="justify" rowspan="1" colspan="1">ACATGATGAACAGCGTCCTG</td><td align="justify" rowspan="1" colspan="1">CAGCAGTTCCTGGGTGTCTC</td><td align="center" rowspan="1" colspan="1">74</td></tr><tr><td align="justify" rowspan="1" colspan="1">TEAD3</td><td align="justify" rowspan="1" colspan="1">CATCGAGCAGAGCTTCCAG</td><td align="justify" rowspan="1" colspan="1">CGTGCAATCAACTCATTTCG</td><td align="center" rowspan="1" colspan="1">111</td></tr><tr><td align="justify" rowspan="1" colspan="1">TEAD4</td><td align="justify" rowspan="1" colspan="1">GCCTTCCACAGTAGCATGG</td><td align="justify" rowspan="1" colspan="1">AAAGCTCCTTGCCAAAACC</td><td align="center" rowspan="1" colspan="1">74</td></tr><tr><td align="justify" rowspan="1" colspan="1">SNAPC1</td><td align="justify" rowspan="1" colspan="1">GAATGAAAGTTTGAGTGGAACAGA</td><td align="justify" rowspan="1" colspan="1">CCAGGCTCTTTGTTCAGTGTT</td><td align="center" rowspan="1" colspan="1">71</td></tr><tr><td align="justify" rowspan="1" colspan="1">SKP2</td><td align="justify" rowspan="1" colspan="1">CTGTCTCAAGGGGTGATTGC</td><td align="justify" rowspan="1" colspan="1">TGTACACGAAAAGGGCTGAA</td><td align="center" rowspan="1" colspan="1">86</td></tr><tr><td align="justify" rowspan="1" colspan="1">ANKRD1</td><td align="justify" rowspan="1" colspan="1">TTTGGCAATTGTGGAGAAGTTA</td><td align="justify" rowspan="1" colspan="1">AAACATCCAGGTTTCCTCCA</td><td align="center" rowspan="1" colspan="1">110</td></tr><tr><td align="justify" rowspan="1" colspan="1">KISS1</td><td align="justify" rowspan="1" colspan="1">GCCCACCCTCTGGACATT</td><td align="justify" rowspan="1" colspan="1">CAGGTCCTAGAAGTGCCTTGA</td><td align="center" rowspan="1" colspan="1">111</td></tr><tr><td align="justify" rowspan="1" colspan="1">DKK1</td><td align="justify" rowspan="1" colspan="1">CAGGCGTGCAAATCTGTCT</td><td align="justify" rowspan="1" colspan="1">AATGATTTTGATCAGAAGACACACATA</td><td align="center" rowspan="1" colspan="1">120</td></tr><tr><td align="justify" rowspan="1" colspan="1">LGR5</td><td align="justify" rowspan="1" colspan="1">CAGCGTCTTCACCTCCTACC</td><td align="justify" rowspan="1" colspan="1">TCCAGGAAGCGGAGACTG</td><td align="center" rowspan="1" colspan="1">87</td></tr><tr><td align="justify" rowspan="1" colspan="1">HAX1</td><td align="justify" rowspan="1" colspan="1">AGAGTGATGCAAGAAGTGAATCC</td><td align="justify" rowspan="1" colspan="1">GGGTCCATAGGCCATACATC</td><td align="center" rowspan="1" colspan="1">94</td></tr><tr><td align="justify" rowspan="1" colspan="1">S1PR1</td><td align="justify" rowspan="1" colspan="1">AACTTCGCCCTGCTTGAG</td><td align="justify" rowspan="1" colspan="1">TCCAGGCTTTTTGTGTAGCTT</td><td align="center" rowspan="1" colspan="1">77</td></tr><tr><td align="justify" rowspan="1" colspan="1">PAWR</td><td align="justify" rowspan="1" colspan="1">CGTCCCCTACAAGCTCCTC</td><td align="justify" rowspan="1" colspan="1">GATGCCAGGAGACGACCTC</td><td align="center" rowspan="1" colspan="1">83</td></tr><tr><td align="justify" rowspan="1" colspan="1">NEXN</td><td align="justify" rowspan="1" colspan="1">TGGAGAAACAAGAATTTGAACAAC</td><td align="justify" rowspan="1" colspan="1">TGCTCAATCCAAAGGTTTCA</td><td align="center" rowspan="1" colspan="1">78</td></tr><tr><td align="justify" rowspan="1" colspan="1">NTF3</td><td align="justify" rowspan="1" colspan="1">CCCTTGTATCTCATGGAGGATT</td><td align="justify" rowspan="1" colspan="1">TTTCCGCCGTGATGTTCT</td><td align="center" rowspan="1" colspan="1">66</td></tr><tr><td align="justify" rowspan="1" colspan="1">BMP4</td><td align="justify" rowspan="1" colspan="1">TCCACAGCACTGGTCTTGAG</td><td align="justify" rowspan="1" colspan="1">GGGATGTTCTCCAGATGTTCTT</td><td align="center" rowspan="1" colspan="1">94</td></tr><tr><td align="justify" rowspan="1" colspan="1">CALD1</td><td align="justify" rowspan="1" colspan="1">CTGCTCCCAAACCTTCTGAC</td><td align="justify" rowspan="1" colspan="1">GATTGCTTTTCCCAGAGGTTC</td><td align="center" rowspan="1" colspan="1">70</td></tr><tr><td align="justify" rowspan="1" colspan="1">FAM171A</td><td align="justify" rowspan="1" colspan="1">CCTGACCGCGTTTCTCAC</td><td align="justify" rowspan="1" colspan="1">GTCATGCCTGGTGCTGTTT</td><td align="center" rowspan="1" colspan="1">106</td></tr><tr><td align="justify" rowspan="1" colspan="1">ADRB2</td><td align="justify" rowspan="1" colspan="1">CCATGTCCAGAACCTTAGCC</td><td align="justify" rowspan="1" colspan="1">GATCTGCGGAGTCCATGC</td><td align="center" rowspan="1" colspan="1">63</td></tr><tr><td align="justify" rowspan="1" colspan="1">GPR126</td><td align="justify" rowspan="1" colspan="1">GGAACTACACGGTTTATGTCGTT</td><td align="justify" rowspan="1" colspan="1">GGCTTCTCTTGACTTTAATCTTGTC</td><td align="center" rowspan="1" colspan="1">78</td></tr><tr><td align="justify" rowspan="1" colspan="1">HAPLN1</td><td align="justify" rowspan="1" colspan="1">AGTCTACTTCTTCTGGTGCTGATTT</td><td align="justify" rowspan="1" colspan="1">TAGATGGGGGCCATTTTCT</td><td align="center" rowspan="1" colspan="1">114</td></tr><tr><td align="justify" rowspan="1" colspan="1">KDR</td><td align="justify" rowspan="1" colspan="1">GCTCAAGACAGGAAGACCAAG</td><td align="justify" rowspan="1" colspan="1">GGTGCCACACGCTCTAGG</td><td align="center" rowspan="1" colspan="1">71</td></tr><tr><td align="justify" rowspan="1" colspan="1">ZFP82</td><td align="justify" rowspan="1" colspan="1">GCCCAGGGGGTAAAGAGAG</td><td align="justify" rowspan="1" colspan="1">TCAGTCCTCCTTGGGGTTTA</td><td align="center" rowspan="1" colspan="1">75</td></tr><tr><td align="justify" rowspan="1" colspan="1">CPA</td><td align="justify" rowspan="1" colspan="1">TGACAGGGAGAAGGTGTTCC</td><td align="justify" rowspan="1" colspan="1">GGCACCTGGATACCAGAAGT</td><td align="center" rowspan="1" colspan="1">106</td></tr><tr><td align="justify" rowspan="1" colspan="1">PSG1</td><td align="justify" rowspan="1" colspan="1">CGTTTCACCTTCACCTTACACC</td><td align="justify" rowspan="1" colspan="1">GGAGTCTCAGGGTCACAGGTT</td><td align="center" rowspan="1" colspan="1">113</td></tr><tr><td align="justify" rowspan="1" colspan="1">CCDC80</td><td align="justify" rowspan="1" colspan="1">CAGGCGTGCAATTTTGGT</td><td align="justify" rowspan="1" colspan="1">AATTGGGAACAGTTCTAACACTCC</td><td align="center" rowspan="1" colspan="1">93</td></tr><tr><td align="justify" rowspan="1" colspan="1">PARVA</td><td align="justify" rowspan="1" colspan="1">TCCTTCTTGGGGAAACTCG</td><td align="justify" rowspan="1" colspan="1">CTCCTGCAGCTCGGACAC</td><td align="center" rowspan="1" colspan="1">72</td></tr><tr><td align="justify" rowspan="1" colspan="1">VGLL4</td><td align="justify" rowspan="1" colspan="1">ACTGCAACCTCTCGCACTG</td><td align="justify" rowspan="1" colspan="1">GGAAATGCTCCTCCACCA</td><td align="center" rowspan="1" colspan="1">120</td></tr><tr><td align="justify" rowspan="1" colspan="1">PLA2G16</td><td align="justify" rowspan="1" colspan="1">TCTACGCAGCGAAATCGAG</td><td align="justify" rowspan="1" colspan="1">AGGGCGAAAAATCTCAATCA</td><td align="center" rowspan="1" colspan="1">108</td></tr><tr><td align="justify" rowspan="1" colspan="1">C1orf198</td><td align="justify" rowspan="1" colspan="1">CAGAAGGTGGTGCGCTTC</td><td align="justify" rowspan="1" colspan="1">ACTGAACTCCATCTGACTCTTTGTT</td><td align="center" rowspan="1" colspan="1">96</td></tr><tr><td align="justify" rowspan="1" colspan="1">MFAP5</td><td align="justify" rowspan="1" colspan="1">CCAGCCAAAGTAGGAACAGC</td><td align="justify" rowspan="1" colspan="1">GGTCCCAAGAGCGACATATT</td><td align="center" rowspan="1" colspan="1">104</td></tr><tr><td align="justify" rowspan="1" colspan="1">PPP2R5A</td><td align="justify" rowspan="1" colspan="1">TGCTCAGCTAGCATATTGTGTTG</td><td align="justify" rowspan="1" colspan="1">GCCAAAATTTCAGCAGTCCT</td><td align="center" rowspan="1" colspan="1">89</td></tr><tr><td align="justify" rowspan="1" colspan="1">DHTKD1</td><td align="justify" rowspan="1" colspan="1">TGTCGAAACTAATGCTGGAATC</td><td align="justify" rowspan="1" colspan="1">TCCATATCGCTTCACTGTCG</td><td align="center" rowspan="1" colspan="1">77</td></tr><tr><td align="justify" rowspan="1" colspan="1">NPC1</td><td align="justify" rowspan="1" colspan="1">TTCGGCAGCTTCAGACACTA</td><td align="justify" rowspan="1" colspan="1">TTCAGTAGGTTATAAAAACAGGATGG</td><td align="center" rowspan="1" colspan="1">88</td></tr><tr><td align="justify" rowspan="1" colspan="1">TCOF1</td><td align="justify" rowspan="1" colspan="1">GCAGGGAAGCAGGATGACT</td><td align="justify" rowspan="1" colspan="1">TCATGGGATTCAAGAAGACTCC</td><td align="center" rowspan="1" colspan="1">111</td></tr><tr><td align="justify" rowspan="1" colspan="1">EPB41L2</td><td align="justify" rowspan="1" colspan="1">ACCATCAGGGAGGAACAGG</td><td align="justify" rowspan="1" colspan="1">GTTTTTACCACTGGTGGCTTG</td><td align="center" rowspan="1" colspan="1">80</td></tr><tr><td align="justify" rowspan="1" colspan="1">IFIT1</td><td align="justify" rowspan="1" colspan="1">AGAACGGCTGCCTAATTTACAG</td><td align="justify" rowspan="1" colspan="1">GCTCCAGACTATCCTTGACCTG</td><td align="center" rowspan="1" colspan="1">73</td></tr><tr><td align="justify" rowspan="1" colspan="1">CCL2</td><td align="justify" rowspan="1" colspan="1">CTGCTCATAGCAGCCACCTT</td><td align="justify" rowspan="1" colspan="1">GCACTGAGATCTTCCTATTGGTG</td><td align="center" rowspan="1" colspan="1">106</td></tr><tr><td align="justify" rowspan="1" colspan="1">FAM150B</td><td align="justify" rowspan="1" colspan="1">GATGCGCCAGGCTTCTTAC</td><td align="justify" rowspan="1" colspan="1">TGTACGGTCTGCTCACTGCT</td><td align="center" rowspan="1" colspan="1">74</td></tr><tr><td align="justify" rowspan="1" colspan="1">RNF144A</td><td align="justify" rowspan="1" colspan="1">TAAGCACAGCAGGACACCAG</td><td align="justify" rowspan="1" colspan="1">TGGTCATCGCAGAACAGTCT</td><td align="center" rowspan="1" colspan="1">86</td></tr><tr><td align="justify" rowspan="1" colspan="1">ITPR3</td><td align="justify" rowspan="1" colspan="1">CCAACATGAACCTGGATCG</td><td align="justify" rowspan="1" colspan="1">AGCATGCTGCTTGTCTTCC</td><td align="center" rowspan="1" colspan="1">73</td></tr><tr><td align="justify" rowspan="1" colspan="1">MAN1C1</td><td align="justify" rowspan="1" colspan="1">GAGGGCCGATGAGAGTCA</td><td align="justify" rowspan="1" colspan="1">GCCAAGCAAACTGCATCAT</td><td align="center" rowspan="1" colspan="1">83</td></tr></tbody></table></alternatives></table-wrap></sec><sec id="sec024"><title>RNA-seq</title><p>Total RNA of three biological replicates was extracted from SF268 cells 48h after transfection with two individual siRNAs targeting YAP1 and unspecific control siRNAs using the Total RNA purification kit from Norgen Biotek. RNAseq libraries were prepared using the Illumina TruSeq RNA Sample Prep kit v2 and sequenced using the Illumina HiSeq2500 platform (76-bp paired-end reads).</p></sec><sec id="sec025"><title>RNA-seq data processing</title><p>Additional RNA-seq datasets for SF268 and LN229 cells were obtained from the Cancer Genomics Hub (<ext-link ext-link-type="uri" xlink:href="https://browser.cghub.ucsc.edu/">https://browser.cghub.ucsc.edu</ext-link>). We mapped the RNA-seq sequencing reads (paired-end, 100bp) to the human reference transcriptome (GRCh37.71) using tophat [<xref rid="pgen.1005465.ref095" ref-type="bibr">95</xref>] version 1.3.1 with parameter&#x02014;no-novel-juncs. We calculated genes FPKMs (fragments per kilobase of transcript per million mapped reads) using cufflinks [<xref rid="pgen.1005465.ref096" ref-type="bibr">96</xref>] version 2.0.2 with parameter-G using the reference transcriptome (GRCh37.71). Differentially expressed genes in YAP1 knockdown were identified with the R package DESeq [<xref rid="pgen.1005465.ref089" ref-type="bibr">89</xref>]. Genes either down- or up-regulated were selected using an adjusted p-value threshold of 10<sup>&#x02212;5</sup> in all four pairwise comparisons of YAP1 and control siRNA treated samples and an at least 2-fold enrichment in one comparison and at least 1.2-fold in the other three.</p></sec><sec id="sec026"><title>Luciferase reporter assays</title><p>GeneArt Strings DNA fragments encompassing approximately 200bp of six distal enhancers bound by YAP1/TEAD1 (see <xref rid="pgen.1005465.t004" ref-type="table">Table 4</xref>) and two negative regions carrying BglII restriction sites were cloned into pGL3 promoter vector (E1761, Promega) upstream of the luciferase gene with SV40 minimal promoter. For two regions mutations were introduced in either one or both motif sites of the double TEAD motif with 3bp spacer (see <xref rid="pgen.1005465.t005" ref-type="table">Table 5</xref>). One day prior transfection SF268 cells were plated on 384-well plates (1800 cells/well). Cells were co-transfected with 28.5 ng of the respective reporter constructs and 1.5 ng pRenilla.</p><table-wrap id="pgen.1005465.t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1005465.t004</object-id><label>Table 4</label><caption><title>Luciferase reporters (<xref rid="pgen.1005465.g004" ref-type="fig">Fig 4E</xref>).</title></caption><alternatives><graphic id="pgen.1005465.t004g" xlink:href="pgen.1005465.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Name</th><th align="center" rowspan="1" colspan="1">Closest gene</th><th align="center" rowspan="1" colspan="1">Distance to gene (bp)</th><th align="center" rowspan="1" colspan="1">Genomic coordinates</th><th align="center" rowspan="1" colspan="1">Size (bp)</th><th align="center" rowspan="1" colspan="1">TEAD motif</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">E1</td><td align="center" rowspan="1" colspan="1">S1PR1</td><td align="center" rowspan="1" colspan="1">36000</td><td align="left" rowspan="1" colspan="1">chr1:101666139&#x02013;101666289</td><td align="center" rowspan="1" colspan="1">151</td><td align="center" rowspan="1" colspan="1">double</td></tr><tr><td align="center" rowspan="1" colspan="1">E2</td><td align="center" rowspan="1" colspan="1">PAWR</td><td align="center" rowspan="1" colspan="1">49133</td><td align="left" rowspan="1" colspan="1">chr12:79941090&#x02013;79941289</td><td align="center" rowspan="1" colspan="1">200</td><td align="center" rowspan="1" colspan="1">double</td></tr><tr><td align="center" rowspan="1" colspan="1">E3</td><td align="center" rowspan="1" colspan="1">ANKRD1</td><td align="center" rowspan="1" colspan="1">9000</td><td align="left" rowspan="1" colspan="1">chr10:92690950&#x02013;92691186</td><td align="center" rowspan="1" colspan="1">237</td><td align="center" rowspan="1" colspan="1">single</td></tr><tr><td align="center" rowspan="1" colspan="1">E4</td><td align="center" rowspan="1" colspan="1">NR2F2</td><td align="center" rowspan="1" colspan="1">434799</td><td align="left" rowspan="1" colspan="1">chr15:97311066&#x02013;97311265</td><td align="center" rowspan="1" colspan="1">200</td><td align="center" rowspan="1" colspan="1">3 single</td></tr><tr><td align="center" rowspan="1" colspan="1">E5</td><td align="center" rowspan="1" colspan="1">JPH1</td><td align="center" rowspan="1" colspan="1">143000</td><td align="left" rowspan="1" colspan="1">chr8:75090094&#x02013;75090360</td><td align="center" rowspan="1" colspan="1">267</td><td align="center" rowspan="1" colspan="1">4 single</td></tr><tr><td align="center" rowspan="1" colspan="1">E6</td><td align="center" rowspan="1" colspan="1">CCDC80</td><td align="center" rowspan="1" colspan="1">6000</td><td align="left" rowspan="1" colspan="1">chr3:112366054&#x02013;112366253</td><td align="center" rowspan="1" colspan="1">200</td><td align="center" rowspan="1" colspan="1">double</td></tr></tbody></table></alternatives></table-wrap><table-wrap id="pgen.1005465.t005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1005465.t005</object-id><label>Table 5</label><caption><title>Luciferase reporters (<xref rid="pgen.1005465.g002" ref-type="fig">Fig 2I</xref>).</title></caption><alternatives><graphic id="pgen.1005465.t005g" xlink:href="pgen.1005465.t005"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Name</th><th align="center" rowspan="1" colspan="1">Closest gene</th><th align="center" rowspan="1" colspan="1">Distance to gene (bp)</th><th align="center" rowspan="1" colspan="1">Genomic coordinates</th><th align="center" rowspan="1" colspan="1">Sequence mutation (bold)</th><th align="center" rowspan="1" colspan="1">Size (bp)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">No motif region #1</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">chr5:90656362&#x02013;90656495</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">134</td></tr><tr><td align="left" rowspan="1" colspan="1">No motif region #2</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">chr1:20764655&#x02013;20765577</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">152</td></tr><tr><td align="left" rowspan="1" colspan="1">Double motif region #1 wild type</td><td align="center" rowspan="1" colspan="1">S1PR1</td><td align="center" rowspan="1" colspan="1">36000</td><td align="left" rowspan="1" colspan="1">chr1:101666139&#x02013;101666289</td><td align="left" rowspan="1" colspan="1">GGAATG-CAG-GGAATG</td><td align="center" rowspan="1" colspan="1">151</td></tr><tr><td align="left" rowspan="1" colspan="1">Double motif region #1 single mutant #1</td><td align="center" rowspan="1" colspan="1">S1PR1</td><td align="center" rowspan="1" colspan="1">36000</td><td align="left" rowspan="1" colspan="1">chr1:101666139&#x02013;101666289</td><td align="left" rowspan="1" colspan="1">G<bold>TG</bold>A<bold>GA</bold>-CAG-GGAATG</td><td align="center" rowspan="1" colspan="1">151</td></tr><tr><td align="left" rowspan="1" colspan="1">Double motif region #1 single mutant #2</td><td align="center" rowspan="1" colspan="1">S1PR1</td><td align="center" rowspan="1" colspan="1">36000</td><td align="left" rowspan="1" colspan="1">chr1:101666139&#x02013;101666289</td><td align="left" rowspan="1" colspan="1">GGAATG-CAG-<bold>A</bold>G<bold>TGA</bold>G</td><td align="center" rowspan="1" colspan="1">151</td></tr><tr><td align="left" rowspan="1" colspan="1">Double motif region #1 double mutant</td><td align="center" rowspan="1" colspan="1">S1PR1</td><td align="center" rowspan="1" colspan="1">36000</td><td align="left" rowspan="1" colspan="1">chr1:101666139&#x02013;101666289</td><td align="left" rowspan="1" colspan="1">G<bold>TG</bold>A<bold>GA</bold>-CAG-<bold>A</bold>G<bold>TGA</bold>G</td><td align="center" rowspan="1" colspan="1">151</td></tr><tr><td align="left" rowspan="1" colspan="1">Double motif region #2 wild type</td><td align="center" rowspan="1" colspan="1">PAWR</td><td align="center" rowspan="1" colspan="1">49133</td><td align="left" rowspan="1" colspan="1">chr12:79941090&#x02013;79941289</td><td align="left" rowspan="1" colspan="1">CATTCC-TGT-CATTCC</td><td align="center" rowspan="1" colspan="1">200</td></tr><tr><td align="left" rowspan="1" colspan="1">Double motif region #2 single mutant #1</td><td align="center" rowspan="1" colspan="1">PAWR</td><td align="center" rowspan="1" colspan="1">49133</td><td align="left" rowspan="1" colspan="1">chr12:79941090&#x02013;79941289</td><td align="left" rowspan="1" colspan="1">
<bold>TC</bold>T<bold>CA</bold>C-TGT-CATTCC</td><td align="center" rowspan="1" colspan="1">200</td></tr><tr><td align="left" rowspan="1" colspan="1">Double motif region #2 single mutant #2</td><td align="center" rowspan="1" colspan="1">PAWR</td><td align="center" rowspan="1" colspan="1">49133</td><td align="left" rowspan="1" colspan="1">chr12:79941090&#x02013;79941289</td><td align="left" rowspan="1" colspan="1">CATTCC-TGT-C<bold>TCA</bold>C<bold>T</bold>
</td><td align="center" rowspan="1" colspan="1">200</td></tr><tr><td align="left" rowspan="1" colspan="1">Double motif region #2 double mutant</td><td align="center" rowspan="1" colspan="1">PAWR</td><td align="center" rowspan="1" colspan="1">49133</td><td align="left" rowspan="1" colspan="1">chr12:79941090&#x02013;79941289</td><td align="left" rowspan="1" colspan="1">
<bold>TC</bold>T<bold>CA</bold>C-TGT-C<bold>TCA</bold>C<bold>T</bold>
</td><td align="center" rowspan="1" colspan="1">200</td></tr></tbody></table></alternatives></table-wrap><p>For luciferase assays in YAP1 and TEADs-depleted cells, SF268 cells were transfected with the indicated siRNAs (see <xref rid="pgen.1005465.t006" ref-type="table">Table 6</xref>) at the day of seeding (1800 cells/well) in 384-well plates. The next day, the medium was changed and cells were transfected with DNA (pGL3 reporter constructs and pRenilla). Firefly and Renilla luminescence signals were measured at 24 hours after DNA transfection using Dual-Glo luciferase assay system (Promega). Firefly luminescence signals were normalized according to their corresponding Renilla signals resulting in relative luciferase activity. Each sample was transfected in triplicate, and each experiment was repeated independently at least three times.</p><table-wrap id="pgen.1005465.t006" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1005465.t006</object-id><label>Table 6</label><caption><title>siRNAs.</title></caption><alternatives><graphic id="pgen.1005465.t006g" xlink:href="pgen.1005465.t006"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Name</th><th align="center" rowspan="1" colspan="1">Target</th><th align="center" rowspan="1" colspan="1">Official name</th><th align="center" rowspan="1" colspan="1">Catalogue number</th><th align="center" rowspan="1" colspan="1">Vendor</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">siControl #1</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">ON-target plus siNontargeting#2</td><td align="left" rowspan="1" colspan="1">D-001810-02</td><td align="left" rowspan="1" colspan="1">Thermo Scientific</td></tr><tr><td align="left" rowspan="1" colspan="1">siControl #2</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">siAllStars negative control</td><td align="left" rowspan="1" colspan="1">SI03650318</td><td align="left" rowspan="1" colspan="1">Qiagen</td></tr><tr><td align="left" rowspan="1" colspan="1">siYAP1 #1</td><td align="left" rowspan="1" colspan="1">YAP1</td><td align="left" rowspan="1" colspan="1">ON-TARGETplus YAP1 #8</td><td align="left" rowspan="1" colspan="1">J-012200-08</td><td align="left" rowspan="1" colspan="1">Thermo Scientific</td></tr><tr><td align="left" rowspan="1" colspan="1">siYAP1 #2</td><td align="left" rowspan="1" colspan="1">YAP1</td><td align="left" rowspan="1" colspan="1">ON-TARGETplus YAP1 #7</td><td align="left" rowspan="1" colspan="1">J-012200-07</td><td align="left" rowspan="1" colspan="1">Thermo Scientific</td></tr><tr><td align="left" rowspan="1" colspan="1">siYAP1 #3</td><td align="left" rowspan="1" colspan="1">YAP1</td><td align="left" rowspan="1" colspan="1">YAP1_5 FlexiTube siRNA</td><td align="left" rowspan="1" colspan="1">SI02662954</td><td align="left" rowspan="1" colspan="1">Qiagen</td></tr><tr><td align="left" rowspan="1" colspan="1">siTEAD1 #1</td><td align="left" rowspan="1" colspan="1">TEAD1</td><td align="left" rowspan="1" colspan="1">ON-TARGETplus TEAD1 siRNA</td><td align="left" rowspan="1" colspan="1">J-012603-08</td><td align="left" rowspan="1" colspan="1">Thermo Scientific</td></tr><tr><td align="left" rowspan="1" colspan="1">siTEAD1 #2</td><td align="left" rowspan="1" colspan="1">TEAD1</td><td align="left" rowspan="1" colspan="1">TEAD1_5 FlexiTube siRNA</td><td align="left" rowspan="1" colspan="1">SI04181261</td><td align="left" rowspan="1" colspan="1">Qiagen</td></tr><tr><td align="left" rowspan="1" colspan="1">siTEAD2 #1</td><td align="left" rowspan="1" colspan="1">TEAD2</td><td align="left" rowspan="1" colspan="1">ON-TARGETplus TEAD2 siRNA</td><td align="left" rowspan="1" colspan="1">J-012611-09</td><td align="left" rowspan="1" colspan="1">Thermo Scientific</td></tr><tr><td align="left" rowspan="1" colspan="1">siTEAD2 #2</td><td align="left" rowspan="1" colspan="1">TEAD2</td><td align="left" rowspan="1" colspan="1">TEAD2_6 FlexiTube siRNA</td><td align="left" rowspan="1" colspan="1">SI04190249</td><td align="left" rowspan="1" colspan="1">Qiagen</td></tr><tr><td align="left" rowspan="1" colspan="1">siTEAD3 #1</td><td align="left" rowspan="1" colspan="1">TEAD3</td><td align="left" rowspan="1" colspan="1">ON-TARGETplus TEAD3 siRNA</td><td align="left" rowspan="1" colspan="1">J-012604-05</td><td align="left" rowspan="1" colspan="1">Thermo Scientific</td></tr><tr><td align="left" rowspan="1" colspan="1">siTEAD3 #2</td><td align="left" rowspan="1" colspan="1">TEAD3</td><td align="left" rowspan="1" colspan="1">TEAD3_7 FlexiTube siRNA</td><td align="left" rowspan="1" colspan="1">SI04329010</td><td align="left" rowspan="1" colspan="1">Qiagen</td></tr><tr><td align="left" rowspan="1" colspan="1">siTEAD4 #1</td><td align="left" rowspan="1" colspan="1">TEAD4</td><td align="left" rowspan="1" colspan="1">ON-TARGETplus TEAD4 siRNA</td><td align="left" rowspan="1" colspan="1">J-019570-08</td><td align="left" rowspan="1" colspan="1">Thermo Scientific</td></tr><tr><td align="left" rowspan="1" colspan="1">siTEAD4 #2</td><td align="left" rowspan="1" colspan="1">TEAD4</td><td align="left" rowspan="1" colspan="1">TEAD4_7 FlexiTube siRNA</td><td align="left" rowspan="1" colspan="1">SI04301346</td><td align="left" rowspan="1" colspan="1">Qiagen</td></tr></tbody></table></alternatives></table-wrap><p>SF268 cells stably expressing the MCAT-Luc YAP1/TEAD responsive reporter [<xref rid="pgen.1005465.ref044" ref-type="bibr">44</xref>] were transfected with siRNAs targeting YAP1, TEAD1, TEAD2, TEAD3, and TEAD4 with 8 siRNAs per gene (see <xref rid="pgen.1005465.t007" ref-type="table">Table 7</xref>). At 72 hours after transfection medium was aspirated and cells were incubated with fresh medium containing 1.4&#x003bc;M resazurin (SIGMA; MO, USA) for 2 hours before measuring fluorescence (Ex: 540 nm, Em: 590 nm) as a read-out for cell viability. Subsequently the cells were lysed in fresh medium containing 1:10 (v/v) Steady-Glo luciferase assay reagent (Promega; WI, USA). Luciferase measurements were taken according to the manufacturer's protocol. Fold change in MCAT-Luc reporter activity was calculated by normalizing luminescence signal to resazurin and to negative control siRNA. Each experiment was carried out in triplicate.</p><table-wrap id="pgen.1005465.t007" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1005465.t007</object-id><label>Table 7</label><caption><title>siRNAs (<xref rid="pgen.1005465.g003" ref-type="fig">Fig 3A</xref>).</title></caption><alternatives><graphic id="pgen.1005465.t007g" xlink:href="pgen.1005465.t007"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Target</th><th align="center" rowspan="1" colspan="1">Official name</th><th align="center" rowspan="1" colspan="1">Catalogue number</th><th align="center" rowspan="1" colspan="1">Vendor</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">TEAD1</td><td align="left" rowspan="1" colspan="1">ON-TARGETplus TEAD1 siRNA</td><td align="left" rowspan="1" colspan="1">J-012603-06</td><td align="left" rowspan="1" colspan="1">Dharmacon</td></tr><tr><td align="left" rowspan="1" colspan="1">TEAD1</td><td align="left" rowspan="1" colspan="1">ON-TARGETplus TEAD1 siRNA</td><td align="left" rowspan="1" colspan="1">J-012603-08</td><td align="left" rowspan="1" colspan="1">Dharmacon</td></tr><tr><td align="left" rowspan="1" colspan="1">TEAD1</td><td align="left" rowspan="1" colspan="1">ON-TARGETplus TEAD1 siRNA</td><td align="left" rowspan="1" colspan="1">J-012603-05</td><td align="left" rowspan="1" colspan="1">Dharmacon</td></tr><tr><td align="left" rowspan="1" colspan="1">TEAD1</td><td align="left" rowspan="1" colspan="1">ON-TARGETplus TEAD1 siRNA</td><td align="left" rowspan="1" colspan="1">J-012603-07</td><td align="left" rowspan="1" colspan="1">Dharmacon</td></tr><tr><td align="left" rowspan="1" colspan="1">TEAD1</td><td align="left" rowspan="1" colspan="1">TEAD1_8 FlexiTube siRNA</td><td align="left" rowspan="1" colspan="1">SI04279618</td><td align="left" rowspan="1" colspan="1">Qiagen</td></tr><tr><td align="left" rowspan="1" colspan="1">TEAD1</td><td align="left" rowspan="1" colspan="1">TEAD1_5 FlexiTube siRNA</td><td align="left" rowspan="1" colspan="1">SI04181261</td><td align="left" rowspan="1" colspan="1">Qiagen</td></tr><tr><td align="left" rowspan="1" colspan="1">TEAD1</td><td align="left" rowspan="1" colspan="1">TEAD1_6 FlexiTube siRNA</td><td align="left" rowspan="1" colspan="1">SI04237205</td><td align="left" rowspan="1" colspan="1">Qiagen</td></tr><tr><td align="left" rowspan="1" colspan="1">TEAD1</td><td align="left" rowspan="1" colspan="1">TEAD1_7 FlexiTube siRNA</td><td align="left" rowspan="1" colspan="1">SI04267200</td><td align="left" rowspan="1" colspan="1">Qiagen</td></tr><tr><td align="left" rowspan="1" colspan="1">TEAD2</td><td align="left" rowspan="1" colspan="1">ON-TARGETplus TEAD2 siRNA</td><td align="left" rowspan="1" colspan="1">J-012611-10</td><td align="left" rowspan="1" colspan="1">Dharmacon</td></tr><tr><td align="left" rowspan="1" colspan="1">TEAD2</td><td align="left" rowspan="1" colspan="1">ON-TARGETplus TEAD2 siRNA</td><td align="left" rowspan="1" colspan="1">J-012611-09</td><td align="left" rowspan="1" colspan="1">Dharmacon</td></tr><tr><td align="left" rowspan="1" colspan="1">TEAD2</td><td align="left" rowspan="1" colspan="1">ON-TARGETplus TEAD2 siRNA</td><td align="left" rowspan="1" colspan="1">J-012611-12</td><td align="left" rowspan="1" colspan="1">Dharmacon</td></tr><tr><td align="left" rowspan="1" colspan="1">TEAD2</td><td align="left" rowspan="1" colspan="1">ON-TARGETplus TEAD2 siRNA</td><td align="left" rowspan="1" colspan="1">J-012611-11</td><td align="left" rowspan="1" colspan="1">Dharmacon</td></tr><tr><td align="left" rowspan="1" colspan="1">TEAD2</td><td align="left" rowspan="1" colspan="1">TEAD2_8 FlexiTube siRNA</td><td align="left" rowspan="1" colspan="1">SI04360993</td><td align="left" rowspan="1" colspan="1">Qiagen</td></tr><tr><td align="left" rowspan="1" colspan="1">TEAD2</td><td align="left" rowspan="1" colspan="1">TEAD2_7 FlexiTube siRNA</td><td align="left" rowspan="1" colspan="1">SI04211704</td><td align="left" rowspan="1" colspan="1">Qiagen</td></tr><tr><td align="left" rowspan="1" colspan="1">TEAD2</td><td align="left" rowspan="1" colspan="1">TEAD2_5 FlexiTube siRNA</td><td align="left" rowspan="1" colspan="1">SI04178188</td><td align="left" rowspan="1" colspan="1">Qiagen</td></tr><tr><td align="left" rowspan="1" colspan="1">TEAD2</td><td align="left" rowspan="1" colspan="1">TEAD2_6 FlexiTube siRNA</td><td align="left" rowspan="1" colspan="1">SI04190249</td><td align="left" rowspan="1" colspan="1">Qiagen</td></tr><tr><td align="left" rowspan="1" colspan="1">TEAD3</td><td align="left" rowspan="1" colspan="1">ON-TARGETplus TEAD3 siRNA</td><td align="left" rowspan="1" colspan="1">J-012604-06</td><td align="left" rowspan="1" colspan="1">Dharmacon</td></tr><tr><td align="left" rowspan="1" colspan="1">TEAD3</td><td align="left" rowspan="1" colspan="1">ON-TARGETplus TEAD3 siRNA</td><td align="left" rowspan="1" colspan="1">J-012604-05</td><td align="left" rowspan="1" colspan="1">Dharmacon</td></tr><tr><td align="left" rowspan="1" colspan="1">TEAD3</td><td align="left" rowspan="1" colspan="1">ON-TARGETplus TEAD3 siRNA</td><td align="left" rowspan="1" colspan="1">J-012604-08</td><td align="left" rowspan="1" colspan="1">Dharmacon</td></tr><tr><td align="left" rowspan="1" colspan="1">TEAD3</td><td align="left" rowspan="1" colspan="1">ON-TARGETplus TEAD3 siRNA</td><td align="left" rowspan="1" colspan="1">J-012604-07</td><td align="left" rowspan="1" colspan="1">Dharmacon</td></tr><tr><td align="left" rowspan="1" colspan="1">TEAD3</td><td align="left" rowspan="1" colspan="1">TEAD3_8 FlexiTube siRNA</td><td align="left" rowspan="1" colspan="1">SI04375777</td><td align="left" rowspan="1" colspan="1">Qiagen</td></tr><tr><td align="left" rowspan="1" colspan="1">TEAD3</td><td align="left" rowspan="1" colspan="1">TEAD3_6 FlexiTube siRNA</td><td align="left" rowspan="1" colspan="1">SI04259570</td><td align="left" rowspan="1" colspan="1">Qiagen</td></tr><tr><td align="left" rowspan="1" colspan="1">TEAD3</td><td align="left" rowspan="1" colspan="1">TEAD3_5 FlexiTube siRNA</td><td align="left" rowspan="1" colspan="1">SI04207287</td><td align="left" rowspan="1" colspan="1">Qiagen</td></tr><tr><td align="left" rowspan="1" colspan="1">TEAD3</td><td align="left" rowspan="1" colspan="1">TEAD3_7 FlexiTube siRNA</td><td align="left" rowspan="1" colspan="1">SI04329010</td><td align="left" rowspan="1" colspan="1">Qiagen</td></tr><tr><td align="left" rowspan="1" colspan="1">TEAD4</td><td align="left" rowspan="1" colspan="1">ON-TARGETplus TEAD4 siRNA</td><td align="left" rowspan="1" colspan="1">J-019570-09</td><td align="left" rowspan="1" colspan="1">Dharmacon</td></tr><tr><td align="left" rowspan="1" colspan="1">TEAD4</td><td align="left" rowspan="1" colspan="1">ON-TARGETplus TEAD4 siRNA</td><td align="left" rowspan="1" colspan="1">J-019570-10</td><td align="left" rowspan="1" colspan="1">Dharmacon</td></tr><tr><td align="left" rowspan="1" colspan="1">TEAD4</td><td align="left" rowspan="1" colspan="1">ON-TARGETplus TEAD4 siRNA</td><td align="left" rowspan="1" colspan="1">J-019570-11</td><td align="left" rowspan="1" colspan="1">Dharmacon</td></tr><tr><td align="left" rowspan="1" colspan="1">TEAD4</td><td align="left" rowspan="1" colspan="1">ON-TARGETplus TEAD4 siRNA</td><td align="left" rowspan="1" colspan="1">J-019570-08</td><td align="left" rowspan="1" colspan="1">Dharmacon</td></tr><tr><td align="left" rowspan="1" colspan="1">TEAD4</td><td align="left" rowspan="1" colspan="1">TEAD4_5 FlexiTube siRNA</td><td align="left" rowspan="1" colspan="1">SI04131127</td><td align="left" rowspan="1" colspan="1">Qiagen</td></tr><tr><td align="left" rowspan="1" colspan="1">TEAD4</td><td align="left" rowspan="1" colspan="1">TEAD4_6 FlexiTube siRNA</td><td align="left" rowspan="1" colspan="1">SI04136069</td><td align="left" rowspan="1" colspan="1">Qiagen</td></tr><tr><td align="left" rowspan="1" colspan="1">TEAD4</td><td align="left" rowspan="1" colspan="1">TEAD4_8 FlexiTube siRNA</td><td align="left" rowspan="1" colspan="1">SI04360020</td><td align="left" rowspan="1" colspan="1">Qiagen</td></tr><tr><td align="left" rowspan="1" colspan="1">TEAD4</td><td align="left" rowspan="1" colspan="1">TEAD4_7 FlexiTube siRNA</td><td align="left" rowspan="1" colspan="1">SI04301346</td><td align="left" rowspan="1" colspan="1">Qiagen</td></tr><tr><td align="left" rowspan="1" colspan="1">YAP1</td><td align="left" rowspan="1" colspan="1">ON-TARGETplus YAP1</td><td align="left" rowspan="1" colspan="1">J-012200-06</td><td align="left" rowspan="1" colspan="1">Dharmacon</td></tr><tr><td align="left" rowspan="1" colspan="1">YAP1</td><td align="left" rowspan="1" colspan="1">ON-TARGETplus YAP1</td><td align="left" rowspan="1" colspan="1">J-012200-07</td><td align="left" rowspan="1" colspan="1">Dharmacon</td></tr><tr><td align="left" rowspan="1" colspan="1">YAP1</td><td align="left" rowspan="1" colspan="1">ON-TARGETplus YAP1</td><td align="left" rowspan="1" colspan="1">J-012200-08</td><td align="left" rowspan="1" colspan="1">Dharmacon</td></tr><tr><td align="left" rowspan="1" colspan="1">YAP1</td><td align="left" rowspan="1" colspan="1">ON-TARGETplus YAP1</td><td align="left" rowspan="1" colspan="1">J-012200-05</td><td align="left" rowspan="1" colspan="1">Dharmacon</td></tr><tr><td align="left" rowspan="1" colspan="1">YAP1</td><td align="left" rowspan="1" colspan="1">YAP1_1 FlexiTube siRNA</td><td align="left" rowspan="1" colspan="1">SI00084546</td><td align="left" rowspan="1" colspan="1">Qiagen</td></tr><tr><td align="left" rowspan="1" colspan="1">YAP1</td><td align="left" rowspan="1" colspan="1">YAP1_5 FlexiTube siRNA</td><td align="left" rowspan="1" colspan="1">SI02662954</td><td align="left" rowspan="1" colspan="1">Qiagen</td></tr><tr><td align="left" rowspan="1" colspan="1">YAP1</td><td align="left" rowspan="1" colspan="1">YAP1_4 FlexiTube siRNA</td><td align="left" rowspan="1" colspan="1">SI00084567</td><td align="left" rowspan="1" colspan="1">Qiagen</td></tr><tr><td align="left" rowspan="1" colspan="1">YAP1</td><td align="left" rowspan="1" colspan="1">YAP1_3 FlexiTube siRNA</td><td align="left" rowspan="1" colspan="1">SI00084560</td><td align="left" rowspan="1" colspan="1">Qiagen</td></tr></tbody></table></alternatives></table-wrap></sec><sec id="sec027"><title>Protein isolation and western blot analysis</title><p>SF268 cells were lysed in FT lysis buffer (20 mM Tris / HCl at pH 7.8, 600 mM NaCl, 20% glycerol, proteinase inhibitor), and proteins including histones were extracted by repeated freeze-thaw cycles followed by Benzonase (Novagen) treatment. Lysates were separated using Novex NuPAGE SDS-PAGE gel system transferred to Immobilon-P membranes (Millipore) and subjected to immunoblotting.</p></sec><sec id="sec028"><title>Immunofluorescence</title><p>Cells were fixed with 4% PFA (Paraformaldehyde 20% solution, EM grade #15713-S) for 15 minutes at room temperature. Subsequently cells were washed 1x PBS and permeabilized in PBS / 0.1% Triton X-100 at room temperature for 10 minutes. Cells were rinsed in PBS and incubated with anti-YAP1 diluted 1:300 in PBS / 1.5% BSA over-night at 4&#x000b0;C. Cells were washed with PBS and incubated with the secondary antibody, anti-rabbit Alexa647 (1:1000, Life Technologies) and Hoechst (1:10.000) for DNA staining for 2 hours at room temperature. After washing with PBS, staining was analyzed by fluorescence microscopy (Operetta, Perkin Elmer), 20x objective.</p></sec><sec id="sec029"><title>Expression analysis in tumor samples</title><p>We used as gene signature 70 genes that were 2-fold down-regulated in YAP1 depleted SF268 cells and had a YAP1/TEAD1 binding peak in their vicinity. Expression data were collected from cBioPortal [<xref rid="pgen.1005465.ref073" ref-type="bibr">73</xref>, <xref rid="pgen.1005465.ref097" ref-type="bibr">97</xref>] for 528 primary glioblastoma and 279 Head and neck squamous cell tumor samples generated by the TCGA Research Network. We used either all or the top and bottom 10% of samples according to the ranksum for <italic>YAP1</italic> expression and copy number. Over 1000 iterations we randomly divided the datasets into training and test subsets (2/3 and 1/3 respectively) and used a na&#x000ef;ve Bayes predictor from the Bioconductor package e1071 to predict the <italic>YAP1</italic> expression level (&#x0201c;high&#x0201d; or &#x0201c;low&#x0201d;). Prediction accuracy was measured using recall statistics and receiver-operating-characteristic (ROC) curves and performance statistics were generated using the ROCR package [<xref rid="pgen.1005465.ref098" ref-type="bibr">98</xref>].</p></sec><sec id="sec030"><title>Accession numbers</title><p>Raw and processed ChIP-seq data are deposited in the Gene Expression Omnibus (GEO) under the accession number GSE61852. The raw RNA-seq reads are available in the NCBI Short Read Archive under the accession number SRP056665.</p></sec></sec><sec sec-type="supplementary-material" id="sec031"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pgen.1005465.s001"><label>S1 Fig</label><caption><title>YAP1 protein levels in glioblastoma cell lines with (SF268) or without (LN229) <italic>YAP1</italic> amplification.</title><p>(EPS)</p></caption><media xlink:href="pgen.1005465.s001.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1005465.s002"><label>S2 Fig</label><caption><title>YAP1 antibody validation.</title><p>(A) Western blot analysis of YAP1 protein levels in control siRNA and YAP1 siRNA treated cells. &#x003b2;-Actin served as a loading control. (B) Immunoprecipitation (IP) efficiency of the YAP1 antibody determined by Immunoprecipitation (IP) followed by WB (IP-WB). S: supernatant after IP, E: eluat. (C) Validation of YAP1 binding to <italic>CYR61</italic> and <italic>ANKRD1</italic> promoters and a negative control region by ChIP-qPCR. Data are representative of at least three independent experiments. Data are shown as percent of input and error bars indicate the standard deviation of triplicate qPCR data.</p><p>(EPS)</p></caption><media xlink:href="pgen.1005465.s002.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1005465.s003"><label>S3 Fig</label><caption><title>Genomic views of YAP1, TEAD1, and H3K27ac peaks at <italic>YAP1</italic> and <italic>TEAD1</italic> genomic regions and at known YAP1/TEAD1 target genes.</title><p>(EPS)</p></caption><media xlink:href="pgen.1005465.s003.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1005465.s004"><label>S4 Fig</label><caption><title>TEAD1 antibody validation.</title><p>(A) Western blot analysis of TEAD1 protein level in cells treated with control siRNA and TEADs siRNA. &#x003b2;-Actin was used as a loading control. (B) IP efficiency of the TEAD1 antibody tested by IP-WB. S: supernatant after IP, E: eluat. (C) Validation of TEAD1 binding to <italic>CYR61</italic> and <italic>ANKRD1</italic> promoters and a negative control region by ChIP-qPCR. Data are representative of at least three independent experiments. Data are shown as percent of input and error bars indicate the standard deviation of triplicate qPCR data.</p><p>(EPS)</p></caption><media xlink:href="pgen.1005465.s004.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1005465.s005"><label>S5 Fig</label><caption><title>TEADs knockdown efficiency.</title><p>(A) Western blot analysis of TEAD1 and TEAD4 protein levels in SF268 cells 48h after siRNA transfection. TEAD2 and TEAD3 protein levels were not detectable. (B) Expression analysis of <italic>TEAD1</italic>, <italic>TEAD2</italic>, <italic>TEAD3</italic> and <italic>TEAD4</italic> determined 48h after siRNA transfection by RT-qPCR (normalized to <italic>UBC</italic>). Data are representative of at least three independent experiments. Error bars indicate the standard deviation of triplicate qPCR data.</p><p>(EPS)</p></caption><media xlink:href="pgen.1005465.s005.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1005465.s006"><label>S6 Fig</label><caption><title>Distribution of genomic features in the genome.</title><p>Promoter class defined as 2kb upstream of gene TSS.</p><p>(EPS)</p></caption><media xlink:href="pgen.1005465.s006.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1005465.s007"><label>S7 Fig</label><caption><title>siRNA-mediated depletion of YAP1 affects target gene expression and TEAD1 and H3K27ac chromatin occupancy.</title><p>(A) Knockdown efficiency of <italic>YAP1</italic> on mRNA level and expression of <italic>TEAD1</italic>, <italic>KISS1</italic>, <italic>NEXN</italic>, <italic>PAWR</italic>, <italic>S1PR1</italic>, and <italic>SNAPC1</italic> upon siRNA-mediated YAP1-depletion determined by RT-qPCR (72h; normalized to <italic>UBC)</italic>. Data are representative of at least three independent experiments. Error bars indicate the standard deviation of triplicate qPCR data. (B, C and D) Western blot analysis of (B) YAP1, (C) TEAD1, and (D) H3K27ac upon siRNA-mediated YAP1-depletion (72h). &#x003b2;-Actin and histone H3 served as loading controls. (E, F, G and H) Analysis of (E) YAP1, (F) TEAD1,(G) H3K27ac, and (H) p300 occupancy following siRNA-mediated YAP1 depletion (72h) at YAP1/TEAD1 peak regions and control regions by ChIP-qPCR. Data are representative of at least three independent experiments. Data are shown as percent of input and error bars indicate the standard deviation of triplicate qPCR data.</p><p>(EPS)</p></caption><media xlink:href="pgen.1005465.s007.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1005465.s008"><label>S8 Fig</label><caption><title>YAP1-binding sites in IMR90 and NCI-H2052 cells.</title><p>(A) Overlap of genes assigned from shared or of cell type specific peaks. (B) Distance of YAP1 peaks to closest gene TSS. (C) Number of peaks with motif. (D) number of peaks with forkhead box factor motif. (E) TEAD1-4 expression level in SF268, NCI-H2052 and IMR90 cells measured by RNA-seq.</p><p>(EPS)</p></caption><media xlink:href="pgen.1005465.s008.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1005465.s009"><label>S9 Fig</label><caption><title>YAP1 chromatin binding is mediated by TEAD in IMR90 and NCI-H2052 cells.</title><p>(A) TEAD dependent expression of potential target genes assessed by RT-qPCR upon siRNA-mediated depletion of TEADs (72h; normalized to <italic>UBC)</italic> in NCI-H2052 cells. (B and C) Validation of (B) YAP1 and (C) TEAD1 binding to shared and cell type-specific sites and a negative control region following siRNA depletion of TEADs in NCI-H2052 cells as compared to control siRNA treated cells by ChIP-qPCR. (D) TEAD dependent expression of potential target genes assessed by RT-qPCR upon siRNA-mediated depletion of TEADs (72h; normalized to <italic>UBC)</italic> in IMR90 cells. (E and F) Validation of (E) YAP1 and (F) TEAD1 binding to shared and cell type-specific sites and a negative control region following siRNA depletion of TEADs in IMR90 cells as compared to control siRNA treated cells by ChIP-qPCR. Data are representative of at least two independent experiments. Error bars indicate the standard deviation of triplicate qPCR data.</p><p>(EPS)</p></caption><media xlink:href="pgen.1005465.s009.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1005465.s010"><label>S10 Fig</label><caption><title>Validation of YAP1/TEAD target genes.</title><p>(A) Knockdown efficiency of <italic>YAP1</italic>, <italic>TEAD1</italic>, <italic>TEAD2</italic>, <italic>TEAD3</italic>, and <italic>TEAD4</italic> on mRNA level upon siRNA-mediated YAP1-depletion determined by RT-qPCR (72h; normalized to <italic>UBC)</italic>. Data are representative of at least three independent experiments. Error bars indicate the standard deviation of triplicate qPCR data. (B) YAP1 and TEAD dependent expression of potential target genes assessed by RT-qPCR upon siRNA-mediated depletion of YAP1 and TEADs (72h; normalized to <italic>UBC)</italic>. Data are representative of at least three independent experiments. Error bars indicate the standard deviation of triplicate qPCR data.</p><p>(EPS)</p></caption><media xlink:href="pgen.1005465.s010.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1005465.s011"><label>S11 Fig</label><caption><title>YAP1 targets key components of various signaling pathways.</title><p>(EPS)</p></caption><media xlink:href="pgen.1005465.s011.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1005465.s012"><label>S12 Fig</label><caption><title>RNA-seq expression analysis.</title><p>(A) Volcano plots of gene expression fold change versus adjusted p-value in all four YAP1 and control siRNA comparisons. (B) Reproducibility of fold change across YAP1 and control siRNA expression samples. (C) Knockdown efficiencies of YAP1 48h after siRNA transfection determined by RT-qPCR (normalized to <italic>UBC</italic>). Error bars indicate the standard deviation of triplicate qPCR data.</p><p>(EPS)</p></caption><media xlink:href="pgen.1005465.s012.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1005465.s013"><label>S13 Fig</label><caption><title>Receiver-operating-characteristic (ROC) curves.</title><p>Receiver-operating-characteristic (ROC) curves for glioblastoma and head and neck squamous cell tumor samples.</p><p>(EPS)</p></caption><media xlink:href="pgen.1005465.s013.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1005465.s014"><label>S1 Table</label><caption><title>Peak calling strategy for ChIP-seq datasets.</title><p>(PDF)</p></caption><media xlink:href="pgen.1005465.s014.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1005465.s015"><label>S2 Table</label><caption><title>YAP1/TEAD1 binding sites in SF268, NCI-H2052 and IMR90 cells.</title><p>(XLSX)</p></caption><media xlink:href="pgen.1005465.s015.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1005465.s016"><label>S3 Table</label><caption><title>TEAD motif preferences.</title><p>(PDF)</p></caption><media xlink:href="pgen.1005465.s016.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1005465.s017"><label>S4 Table</label><caption><title>Known motifs enriched in YAP1/TEAD1 peak regions.</title><p>(PDF)</p></caption><media xlink:href="pgen.1005465.s017.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1005465.s018"><label>S5 Table</label><caption><title>Enriched motif logos.</title><p>(PDF)</p></caption><media xlink:href="pgen.1005465.s018.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1005465.s019"><label>S6 Table</label><caption><title>Gene enrichment analyses in SF268 cells.</title><p>(XLSX)</p></caption><media xlink:href="pgen.1005465.s019.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1005465.s020"><label>S7 Table</label><caption><title>YAP1-target genes in SF268 cells.</title><p>(PDF)</p></caption><media xlink:href="pgen.1005465.s020.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank Sophie Dessus-Babus and Tim Roloff for processing ChIP-seq samples and for advice; Walter Carbone for processing the SF268 RNA-seq samples; members of the Sch&#x000fc;beler and Bauer laboratories for helpful discussions, and in particular Heather Sadlish for critical reading and help with editing the manuscript; Christian Parker for support, advice, critical reading and comments on the manuscript; Leslie Pond for support.</p></ack><ref-list><title>References</title><ref id="pgen.1005465.ref001"><label>1</label><mixed-citation publication-type="journal">
<name><surname>Pan</surname><given-names>D</given-names></name>. <article-title>The hippo signaling pathway in development and cancer</article-title>. <source>Dev Cell</source>. <year>2010</year>;<volume>19</volume>(<issue>4</issue>):<fpage>491</fpage>&#x02013;<lpage>505</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.devcel.2010.09.011">10.1016/j.devcel.2010.09.011</ext-link></comment>
<?supplied-pmid 20951342?><pub-id pub-id-type="pmid">20951342</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref002"><label>2</label><mixed-citation publication-type="journal">
<name><surname>Harvey</surname><given-names>KF</given-names></name>, <name><surname>Zhang</surname><given-names>X</given-names></name>, <name><surname>Thomas</surname><given-names>DM</given-names></name>. <article-title>The Hippo pathway and human cancer</article-title>. <source>Nat Rev Cancer</source>. <year>2013</year>;<volume>13</volume>(<issue>4</issue>):<fpage>246</fpage>&#x02013;<lpage>57</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nrc3458">10.1038/nrc3458</ext-link></comment>
<?supplied-pmid 23467301?><pub-id pub-id-type="pmid">23467301</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref003"><label>3</label><mixed-citation publication-type="journal">
<name><surname>Zhao</surname><given-names>B</given-names></name>, <name><surname>Tumaneng</surname><given-names>K</given-names></name>, <name><surname>Guan</surname><given-names>KL</given-names></name>. <article-title>The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal</article-title>. <source>Nat Cell Biol</source>. <year>2011</year>;<volume>13</volume>(<issue>8</issue>):<fpage>877</fpage>&#x02013;<lpage>83</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ncb2303">10.1038/ncb2303</ext-link></comment>
<?supplied-pmid 21808241?><pub-id pub-id-type="pmid">21808241</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref004"><label>4</label><mixed-citation publication-type="journal">
<name><surname>Gumbiner</surname><given-names>BM</given-names></name>, <name><surname>Kim</surname><given-names>NG</given-names></name>. <article-title>The Hippo-YAP signaling pathway and contact inhibition of growth</article-title>. <source>J Cell Sci</source>. <year>2014</year>;<volume>127</volume>(<issue>Pt 4</issue>):<fpage>709</fpage>&#x02013;<lpage>17</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1242/jcs.140103">10.1242/jcs.140103</ext-link></comment>
<?supplied-pmid 24532814?><pub-id pub-id-type="pmid">24532814</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref005"><label>5</label><mixed-citation publication-type="journal">
<name><surname>Hao</surname><given-names>Y</given-names></name>, <name><surname>Chun</surname><given-names>A</given-names></name>, <name><surname>Cheung</surname><given-names>K</given-names></name>, <name><surname>Rashidi</surname><given-names>B</given-names></name>, <name><surname>Yang</surname><given-names>X</given-names></name>. <article-title>Tumor suppressor LATS1 is a negative regulator of oncogene YAP</article-title>. <source>J Biol Chem</source>. <year>2008</year>;<volume>283</volume>(<issue>9</issue>):<fpage>5496</fpage>&#x02013;<lpage>509</lpage>.
<?supplied-pmid 18158288?><pub-id pub-id-type="pmid">18158288</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref006"><label>6</label><mixed-citation publication-type="journal">
<name><surname>Zhang</surname><given-names>J</given-names></name>, <name><surname>Smolen</surname><given-names>GA</given-names></name>, <name><surname>Haber</surname><given-names>DA</given-names></name>. <article-title>Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway</article-title>. <source>Cancer Res</source>. <year>2008</year>;<volume>68</volume>(<issue>8</issue>):<fpage>2789</fpage>&#x02013;<lpage>94</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1158/0008-5472.CAN-07-6205">10.1158/0008-5472.CAN-07-6205</ext-link></comment>
<?supplied-pmid 18413746?><pub-id pub-id-type="pmid">18413746</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref007"><label>7</label><mixed-citation publication-type="journal">
<name><surname>Zhao</surname><given-names>B</given-names></name>, <name><surname>Wei</surname><given-names>X</given-names></name>, <name><surname>Li</surname><given-names>W</given-names></name>, <name><surname>Udan</surname><given-names>RS</given-names></name>, <name><surname>Yang</surname><given-names>Q</given-names></name>, <name><surname>Kim</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control</article-title>. <source>Genes Dev</source>. <year>2007</year>;<volume>21</volume>(<issue>21</issue>):<fpage>2747</fpage>&#x02013;<lpage>61</lpage>.
<?supplied-pmid 17974916?><pub-id pub-id-type="pmid">17974916</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref008"><label>8</label><mixed-citation publication-type="journal">
<name><surname>Huang</surname><given-names>J</given-names></name>, <name><surname>Wu</surname><given-names>S</given-names></name>, <name><surname>Barrera</surname><given-names>J</given-names></name>, <name><surname>Matthews</surname><given-names>K</given-names></name>, <name><surname>Pan</surname><given-names>D</given-names></name>. <article-title>The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP</article-title>. <source>Cell</source>. <year>2005</year>;<volume>122</volume>(<issue>3</issue>):<fpage>421</fpage>&#x02013;<lpage>34</lpage>.
<?supplied-pmid 16096061?><pub-id pub-id-type="pmid">16096061</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref009"><label>9</label><mixed-citation publication-type="journal">
<name><surname>Camargo</surname><given-names>FD</given-names></name>, <name><surname>Gokhale</surname><given-names>S</given-names></name>, <name><surname>Johnnidis</surname><given-names>JB</given-names></name>, <name><surname>Fu</surname><given-names>D</given-names></name>, <name><surname>Bell</surname><given-names>GW</given-names></name>, <name><surname>Jaenisch</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>YAP1 increases organ size and expands undifferentiated progenitor cells</article-title>. <source>Curr Biol</source>. <year>2007</year>;<volume>17</volume>(<issue>23</issue>):<fpage>2054</fpage>&#x02013;<lpage>60</lpage>.
<?supplied-pmid 17980593?><pub-id pub-id-type="pmid">17980593</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref010"><label>10</label><mixed-citation publication-type="journal">
<name><surname>Dong</surname><given-names>J</given-names></name>, <name><surname>Feldmann</surname><given-names>G</given-names></name>, <name><surname>Huang</surname><given-names>J</given-names></name>, <name><surname>Wu</surname><given-names>S</given-names></name>, <name><surname>Zhang</surname><given-names>N</given-names></name>, <name><surname>Comerford</surname><given-names>SA</given-names></name>, <etal>et al</etal>
<article-title>Elucidation of a universal size-control mechanism in Drosophila and mammals</article-title>. <source>Cell</source>. <year>2007</year>;<volume>130</volume>(<issue>6</issue>):<fpage>1120</fpage>&#x02013;<lpage>33</lpage>.
<?supplied-pmid 17889654?><pub-id pub-id-type="pmid">17889654</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref011"><label>11</label><mixed-citation publication-type="journal">
<name><surname>Tremblay</surname><given-names>AM</given-names></name>, <name><surname>Missiaglia</surname><given-names>E</given-names></name>, <name><surname>Galli</surname><given-names>GG</given-names></name>, <name><surname>Hettmer</surname><given-names>S</given-names></name>, <name><surname>Urcia</surname><given-names>R</given-names></name>, <name><surname>Carrara</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>The Hippo transducer YAP1 transforms activated satellite cells and is a potent effector of embryonal rhabdomyosarcoma formation</article-title>. <source>Cancer Cell</source>. <year>2014</year>;<volume>26</volume>(<issue>2</issue>):<fpage>273</fpage>&#x02013;<lpage>87</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ccr.2014.05.029">10.1016/j.ccr.2014.05.029</ext-link></comment>
<?supplied-pmid 25087979?><pub-id pub-id-type="pmid">25087979</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref012"><label>12</label><mixed-citation publication-type="journal">
<name><surname>Mo</surname><given-names>JS</given-names></name>, <name><surname>Park</surname><given-names>HW</given-names></name>, <name><surname>Guan</surname><given-names>KL</given-names></name>. <article-title>The Hippo signaling pathway in stem cell biology and cancer</article-title>. <source>EMBO Rep</source>. <year>2014</year>;<volume>15</volume>(<issue>6</issue>):<fpage>642</fpage>&#x02013;<lpage>56</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.15252/embr.201438638">10.15252/embr.201438638</ext-link></comment>
<?supplied-pmid 24825474?><pub-id pub-id-type="pmid">24825474</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref013"><label>13</label><mixed-citation publication-type="journal">
<name><surname>Zhao</surname><given-names>B</given-names></name>, <name><surname>Li</surname><given-names>L</given-names></name>, <name><surname>Lei</surname><given-names>Q</given-names></name>, <name><surname>Guan</surname><given-names>KL</given-names></name>. <article-title>The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version</article-title>. <source>Genes Dev</source>. <year>2010</year>;<volume>24</volume>(<issue>9</issue>):<fpage>862</fpage>&#x02013;<lpage>74</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1101/gad.1909210">10.1101/gad.1909210</ext-link></comment>
<?supplied-pmid 20439427?><pub-id pub-id-type="pmid">20439427</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref014"><label>14</label><mixed-citation publication-type="journal">
<name><surname>Lorenzetto</surname><given-names>E</given-names></name>, <name><surname>Brenca</surname><given-names>M</given-names></name>, <name><surname>Boeri</surname><given-names>M</given-names></name>, <name><surname>Verri</surname><given-names>C</given-names></name>, <name><surname>Piccinin</surname><given-names>E</given-names></name>, <name><surname>Gasparini</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes</article-title>. <source>Oncotarget</source>. <year>2014</year>;<volume>5</volume>(<issue>9</issue>):<fpage>2608</fpage>&#x02013;<lpage>21</lpage>.
<?supplied-pmid 24810989?><pub-id pub-id-type="pmid">24810989</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref015"><label>15</label><mixed-citation publication-type="journal">
<name><surname>Hu</surname><given-names>X</given-names></name>, <name><surname>Xin</surname><given-names>Y</given-names></name>, <name><surname>Xiao</surname><given-names>Y</given-names></name>, <name><surname>Zhao</surname><given-names>J</given-names></name>. <article-title>Overexpression of YAP1 is Correlated with Progression, Metastasis and Poor Prognosis in Patients with Gastric Carcinoma</article-title>. <source>Pathol Oncol Res</source>. <year>2014</year>.</mixed-citation></ref><ref id="pgen.1005465.ref016"><label>16</label><mixed-citation publication-type="journal">
<name><surname>Liu</surname><given-names>JY</given-names></name>, <name><surname>Li</surname><given-names>YH</given-names></name>, <name><surname>Lin</surname><given-names>HX</given-names></name>, <name><surname>Liao</surname><given-names>YJ</given-names></name>, <name><surname>Mai</surname><given-names>SJ</given-names></name>, <name><surname>Liu</surname><given-names>ZW</given-names></name>, <etal>et al</etal>
<article-title>Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder</article-title>. <source>BMC Cancer</source>. <year>2013</year>;<volume>13</volume>:<fpage>349</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1471-2407-13-349">10.1186/1471-2407-13-349</ext-link></comment>
<?supplied-pmid 23870412?><pub-id pub-id-type="pmid">23870412</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref017"><label>17</label><mixed-citation publication-type="journal">
<name><surname>Song</surname><given-names>M</given-names></name>, <name><surname>Cheong</surname><given-names>JH</given-names></name>, <name><surname>Kim</surname><given-names>H</given-names></name>, <name><surname>Noh</surname><given-names>SH</given-names></name>. <article-title>Nuclear expression of Yes-associated protein 1 correlates with poor prognosis in intestinal type gastric cancer</article-title>. <source>Anticancer Res</source>. <year>2012</year>;<volume>32</volume>(<issue>9</issue>):<fpage>3827</fpage>&#x02013;<lpage>34</lpage>.
<?supplied-pmid 22993325?><pub-id pub-id-type="pmid">22993325</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref018"><label>18</label><mixed-citation publication-type="journal">
<name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Dong</surname><given-names>Q</given-names></name>, <name><surname>Zhang</surname><given-names>Q</given-names></name>, <name><surname>Li</surname><given-names>Z</given-names></name>, <name><surname>Wang</surname><given-names>E</given-names></name>, <name><surname>Qiu</surname><given-names>X</given-names></name>. <article-title>Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer</article-title>. <source>Cancer Sci</source>. <year>2010</year>;<volume>101</volume>(<issue>5</issue>):<fpage>1279</fpage>&#x02013;<lpage>85</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1349-7006.2010.01511.x">10.1111/j.1349-7006.2010.01511.x</ext-link></comment>
<?supplied-pmid 20219076?><pub-id pub-id-type="pmid">20219076</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref019"><label>19</label><mixed-citation publication-type="journal">
<name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Xie</surname><given-names>C</given-names></name>, <name><surname>Li</surname><given-names>Q</given-names></name>, <name><surname>Xu</surname><given-names>K</given-names></name>, <name><surname>Wang</surname><given-names>E</given-names></name>. <article-title>Clinical and prognostic significance of Yes-associated protein in colorectal cancer</article-title>. <source>Tumour Biol</source>. <year>2013</year>;<volume>34</volume>(<issue>4</issue>):<fpage>2169</fpage>&#x02013;<lpage>74</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s13277-013-0751-x">10.1007/s13277-013-0751-x</ext-link></comment>
<?supplied-pmid 23558963?><pub-id pub-id-type="pmid">23558963</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref020"><label>20</label><mixed-citation publication-type="journal">
<name><surname>Xia</surname><given-names>Y</given-names></name>, <name><surname>Chang</surname><given-names>T</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Li</surname><given-names>W</given-names></name>, <name><surname>Li</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>YAP promotes ovarian cancer cell tumorigenesis and is indicative of a poor prognosis for ovarian cancer patients</article-title>. <source>PLoS One</source>. <year>2014</year>;<volume>9</volume>(<issue>3</issue>):<fpage>e91770</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0091770">10.1371/journal.pone.0091770</ext-link></comment>
<?supplied-pmid 24622501?><pub-id pub-id-type="pmid">24622501</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref021"><label>21</label><mixed-citation publication-type="journal">
<name><surname>Kodaka</surname><given-names>M</given-names></name>, <name><surname>Hata</surname><given-names>Y</given-names></name>. <article-title>The mammalian Hippo pathway: regulation and function of YAP1 and TAZ</article-title>. <source>Cell Mol Life Sci</source>. <year>2014</year>.</mixed-citation></ref><ref id="pgen.1005465.ref022"><label>22</label><mixed-citation publication-type="journal">
<name><surname>Zhao</surname><given-names>B</given-names></name>, <name><surname>Ye</surname><given-names>X</given-names></name>, <name><surname>Yu</surname><given-names>J</given-names></name>, <name><surname>Li</surname><given-names>L</given-names></name>, <name><surname>Li</surname><given-names>W</given-names></name>, <name><surname>Li</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>TEAD mediates YAP-dependent gene induction and growth control</article-title>. <source>Genes Dev</source>. <year>2008</year>;<volume>22</volume>(<issue>14</issue>):<fpage>1962</fpage>&#x02013;<lpage>71</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1101/gad.1664408">10.1101/gad.1664408</ext-link></comment>
<?supplied-pmid 18579750?><pub-id pub-id-type="pmid">18579750</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref023"><label>23</label><mixed-citation publication-type="journal">
<name><surname>Ota</surname><given-names>M</given-names></name>, <name><surname>Sasaki</surname><given-names>H</given-names></name>. <article-title>Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling</article-title>. <source>Development</source>. <year>2008</year>;<volume>135</volume>(<issue>24</issue>):<fpage>4059</fpage>&#x02013;<lpage>69</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1242/dev.027151">10.1242/dev.027151</ext-link></comment>
<?supplied-pmid 19004856?><pub-id pub-id-type="pmid">19004856</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref024"><label>24</label><mixed-citation publication-type="journal">
<name><surname>Wu</surname><given-names>S</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Zheng</surname><given-names>Y</given-names></name>, <name><surname>Dong</surname><given-names>J</given-names></name>, <name><surname>Pan</surname><given-names>D</given-names></name>. <article-title>The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway</article-title>. <source>Dev Cell</source>. <year>2008</year>;<volume>14</volume>(<issue>3</issue>):<fpage>388</fpage>&#x02013;<lpage>98</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.devcel.2008.01.007">10.1016/j.devcel.2008.01.007</ext-link></comment>
<?supplied-pmid 18258486?><pub-id pub-id-type="pmid">18258486</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref025"><label>25</label><mixed-citation publication-type="journal">
<name><surname>Vassilev</surname><given-names>A</given-names></name>, <name><surname>Kaneko</surname><given-names>KJ</given-names></name>, <name><surname>Shu</surname><given-names>H</given-names></name>, <name><surname>Zhao</surname><given-names>Y</given-names></name>, <name><surname>DePamphilis</surname><given-names>ML</given-names></name>. <article-title>TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm</article-title>. <source>Genes Dev</source>. <year>2001</year>;<volume>15</volume>(<issue>10</issue>):<fpage>1229</fpage>&#x02013;<lpage>41</lpage>.
<?supplied-pmid 11358867?><pub-id pub-id-type="pmid">11358867</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref026"><label>26</label><mixed-citation publication-type="journal">
<name><surname>Zhang</surname><given-names>L</given-names></name>, <name><surname>Ren</surname><given-names>F</given-names></name>, <name><surname>Zhang</surname><given-names>Q</given-names></name>, <name><surname>Chen</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>B</given-names></name>, <name><surname>Jiang</surname><given-names>J</given-names></name>. <article-title>The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control</article-title>. <source>Dev Cell</source>. <year>2008</year>;<volume>14</volume>(<issue>3</issue>):<fpage>377</fpage>&#x02013;<lpage>87</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.devcel.2008.01.006">10.1016/j.devcel.2008.01.006</ext-link></comment>
<?supplied-pmid 18258485?><pub-id pub-id-type="pmid">18258485</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref027"><label>27</label><mixed-citation publication-type="journal">
<name><surname>Lamar</surname><given-names>JM</given-names></name>, <name><surname>Stern</surname><given-names>P</given-names></name>, <name><surname>Liu</surname><given-names>H</given-names></name>, <name><surname>Schindler</surname><given-names>JW</given-names></name>, <name><surname>Jiang</surname><given-names>ZG</given-names></name>, <name><surname>Hynes</surname><given-names>RO</given-names></name>. <article-title>The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2012</year>;<volume>109</volume>(<issue>37</issue>):<fpage>E2441</fpage>&#x02013;<lpage>50</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1212021109">10.1073/pnas.1212021109</ext-link></comment>
<?supplied-pmid 22891335?><pub-id pub-id-type="pmid">22891335</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref028"><label>28</label><mixed-citation publication-type="journal">
<name><surname>Tian</surname><given-names>W</given-names></name>, <name><surname>Yu</surname><given-names>J</given-names></name>, <name><surname>Tomchick</surname><given-names>DR</given-names></name>, <name><surname>Pan</surname><given-names>D</given-names></name>, <name><surname>Luo</surname><given-names>X</given-names></name>. <article-title>Structural and functional analysis of the YAP-binding domain of human TEAD2</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2010</year>;<volume>107</volume>(<issue>16</issue>):<fpage>7293</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1000293107">10.1073/pnas.1000293107</ext-link></comment>
<?supplied-pmid 20368466?><pub-id pub-id-type="pmid">20368466</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref029"><label>29</label><mixed-citation publication-type="journal">
<name><surname>Beyer</surname><given-names>TA</given-names></name>, <name><surname>Weiss</surname><given-names>A</given-names></name>, <name><surname>Khomchuk</surname><given-names>Y</given-names></name>, <name><surname>Huang</surname><given-names>K</given-names></name>, <name><surname>Ogunjimi</surname><given-names>AA</given-names></name>, <name><surname>Varelas</surname><given-names>X</given-names></name>, <etal>et al</etal>
<article-title>Switch enhancers interpret TGF-beta and Hippo signaling to control cell fate in human embryonic stem cells</article-title>. <source>Cell reports</source>. <year>2013</year>;<volume>5</volume>(<issue>6</issue>):<fpage>1611</fpage>&#x02013;<lpage>24</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.celrep.2013.11.021">10.1016/j.celrep.2013.11.021</ext-link></comment>
<?supplied-pmid 24332857?><pub-id pub-id-type="pmid">24332857</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref030"><label>30</label><mixed-citation publication-type="journal">
<name><surname>Shao</surname><given-names>DD</given-names></name>, <name><surname>Xue</surname><given-names>W</given-names></name>, <name><surname>Krall</surname><given-names>EB</given-names></name>, <name><surname>Bhutkar</surname><given-names>A</given-names></name>, <name><surname>Piccioni</surname><given-names>F</given-names></name>, <name><surname>Wang</surname><given-names>X</given-names></name>, <etal>et al</etal>
<article-title>KRAS and YAP1 Converge to Regulate EMT and Tumor Survival</article-title>. <source>Cell</source>. <year>2014</year>.</mixed-citation></ref><ref id="pgen.1005465.ref031"><label>31</label><mixed-citation publication-type="journal">
<name><surname>Mizuno</surname><given-names>T</given-names></name>, <name><surname>Murakami</surname><given-names>H</given-names></name>, <name><surname>Fujii</surname><given-names>M</given-names></name>, <name><surname>Ishiguro</surname><given-names>F</given-names></name>, <name><surname>Tanaka</surname><given-names>I</given-names></name>, <name><surname>Kondo</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes</article-title>. <source>Oncogene</source>. <year>2012</year>;<volume>31</volume>(<issue>49</issue>):<fpage>5117</fpage>&#x02013;<lpage>22</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/onc.2012.5">10.1038/onc.2012.5</ext-link></comment>
<?supplied-pmid 22286761?><pub-id pub-id-type="pmid">22286761</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref032"><label>32</label><mixed-citation publication-type="journal">
<name><surname>Del Re</surname><given-names>DP</given-names></name>, <name><surname>Yang</surname><given-names>Y</given-names></name>, <name><surname>Nakano</surname><given-names>N</given-names></name>, <name><surname>Cho</surname><given-names>J</given-names></name>, <name><surname>Zhai</surname><given-names>P</given-names></name>, <name><surname>Yamamoto</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>Yes-associated protein isoform 1 (Yap1) promotes cardiomyocyte survival and growth to protect against myocardial ischemic injury</article-title>. <source>J Biol Chem</source>. <year>2013</year>;<volume>288</volume>(<issue>6</issue>):<fpage>3977</fpage>&#x02013;<lpage>88</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M112.436311">10.1074/jbc.M112.436311</ext-link></comment>
<?supplied-pmid 23275380?><pub-id pub-id-type="pmid">23275380</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref033"><label>33</label><mixed-citation publication-type="journal">
<name><surname>Seo</surname><given-names>E</given-names></name>, <name><surname>Basu-Roy</surname><given-names>U</given-names></name>, <name><surname>Gunaratne</surname><given-names>PH</given-names></name>, <name><surname>Coarfa</surname><given-names>C</given-names></name>, <name><surname>Lim</surname><given-names>DS</given-names></name>, <name><surname>Basilico</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>SOX2 regulates YAP1 to maintain stemness and determine cell fate in the osteo-adipo lineage</article-title>. <source>Cell reports</source>. <year>2013</year>;<volume>3</volume>(<issue>6</issue>):<fpage>2075</fpage>&#x02013;<lpage>87</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.celrep.2013.05.029">10.1016/j.celrep.2013.05.029</ext-link></comment>
<?supplied-pmid 23791527?><pub-id pub-id-type="pmid">23791527</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref034"><label>34</label><mixed-citation publication-type="journal">
<name><surname>Zhang</surname><given-names>J</given-names></name>, <name><surname>Ji</surname><given-names>JY</given-names></name>, <name><surname>Yu</surname><given-names>M</given-names></name>, <name><surname>Overholtzer</surname><given-names>M</given-names></name>, <name><surname>Smolen</surname><given-names>GA</given-names></name>, <name><surname>Wang</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway</article-title>. <source>Nat Cell Biol</source>. <year>2009</year>;<volume>11</volume>(<issue>12</issue>):<fpage>1444</fpage>&#x02013;<lpage>50</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ncb1993">10.1038/ncb1993</ext-link></comment>
<?supplied-pmid 19935651?><pub-id pub-id-type="pmid">19935651</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref035"><label>35</label><mixed-citation publication-type="journal">
<name><surname>Xiao</surname><given-names>L</given-names></name>, <name><surname>Chen</surname><given-names>Y</given-names></name>, <name><surname>Ji</surname><given-names>M</given-names></name>, <name><surname>Dong</surname><given-names>J</given-names></name>. <article-title>KIBRA regulates Hippo signaling activity via interactions with large tumor suppressor kinases</article-title>. <source>J Biol Chem</source>. <year>2011</year>;<volume>286</volume>(<issue>10</issue>):<fpage>7788</fpage>&#x02013;<lpage>96</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M110.173468">10.1074/jbc.M110.173468</ext-link></comment>
<?supplied-pmid 21233212?><pub-id pub-id-type="pmid">21233212</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref036"><label>36</label><mixed-citation publication-type="journal">
<name><surname>Xu</surname><given-names>MZ</given-names></name>, <name><surname>Chan</surname><given-names>SW</given-names></name>, <name><surname>Liu</surname><given-names>AM</given-names></name>, <name><surname>Wong</surname><given-names>KF</given-names></name>, <name><surname>Fan</surname><given-names>ST</given-names></name>, <name><surname>Chen</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma</article-title>. <source>Oncogene</source>. <year>2011</year>;<volume>30</volume>(<issue>10</issue>):<fpage>1229</fpage>&#x02013;<lpage>40</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/onc.2010.504">10.1038/onc.2010.504</ext-link></comment>
<?supplied-pmid 21076472?><pub-id pub-id-type="pmid">21076472</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref037"><label>37</label><mixed-citation publication-type="journal">
<name><surname>Xie</surname><given-names>Q</given-names></name>, <name><surname>Chen</surname><given-names>J</given-names></name>, <name><surname>Feng</surname><given-names>H</given-names></name>, <name><surname>Peng</surname><given-names>S</given-names></name>, <name><surname>Adams</surname><given-names>U</given-names></name>, <name><surname>Bai</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>YAP/TEAD-mediated transcription controls cellular senescence</article-title>. <source>Cancer Res</source>. <year>2013</year>;<volume>73</volume>(<issue>12</issue>):<fpage>3615</fpage>&#x02013;<lpage>24</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1158/0008-5472.CAN-12-3793">10.1158/0008-5472.CAN-12-3793</ext-link></comment>
<?supplied-pmid 23576552?><pub-id pub-id-type="pmid">23576552</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref038"><label>38</label><mixed-citation publication-type="journal">
<name><surname>Song</surname><given-names>S</given-names></name>, <name><surname>Ajani</surname><given-names>JA</given-names></name>, <name><surname>Honjo</surname><given-names>S</given-names></name>, <name><surname>Maru</surname><given-names>DM</given-names></name>, <name><surname>Chen</surname><given-names>Q</given-names></name>, <name><surname>Scott</surname><given-names>AW</given-names></name>, <etal>et al</etal>
<article-title>Hippo coactivator YAP1 upregulates SOX9 and endows stem-like properties to esophageal cancer cells</article-title>. <source>Cancer Res</source>. <year>2014</year>.</mixed-citation></ref><ref id="pgen.1005465.ref039"><label>39</label><mixed-citation publication-type="journal">
<name><surname>Bulger</surname><given-names>M</given-names></name>, <name><surname>Groudine</surname><given-names>M</given-names></name>. <article-title>Functional and mechanistic diversity of distal transcription enhancers</article-title>. <source>Cell</source>. <year>2011</year>;<volume>144</volume>(<issue>3</issue>):<fpage>327</fpage>&#x02013;<lpage>39</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.cell.2011.01.024">10.1016/j.cell.2011.01.024</ext-link></comment>
<?supplied-pmid 21295696?><pub-id pub-id-type="pmid">21295696</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref040"><label>40</label><mixed-citation publication-type="journal">
<name><surname>Sakabe</surname><given-names>NJ</given-names></name>, <name><surname>Savic</surname><given-names>D</given-names></name>, <name><surname>Nobrega</surname><given-names>MA</given-names></name>. <article-title>Transcriptional enhancers in development and disease</article-title>. <source>Genome Biol</source>. <year>2012</year>;<volume>13</volume>(<issue>1</issue>):<fpage>238</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/gb-2012-13-1-238">10.1186/gb-2012-13-1-238</ext-link></comment>
<?supplied-pmid 22269347?><pub-id pub-id-type="pmid">22269347</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref041"><label>41</label><mixed-citation publication-type="journal">
<name><surname>Hnisz</surname><given-names>D</given-names></name>, <name><surname>Abraham</surname><given-names>BJ</given-names></name>, <name><surname>Lee</surname><given-names>TI</given-names></name>, <name><surname>Lau</surname><given-names>A</given-names></name>, <name><surname>Saint-Andre</surname><given-names>V</given-names></name>, <name><surname>Sigova</surname><given-names>AA</given-names></name>, <etal>et al</etal>
<article-title>Super-enhancers in the control of cell identity and disease</article-title>. <source>Cell</source>. <year>2013</year>;<volume>155</volume>(<issue>4</issue>):<fpage>934</fpage>&#x02013;<lpage>47</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.cell.2013.09.053">10.1016/j.cell.2013.09.053</ext-link></comment>
<?supplied-pmid 24119843?><pub-id pub-id-type="pmid">24119843</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref042"><label>42</label><mixed-citation publication-type="journal">
<name><surname>Akhtar-Zaidi</surname><given-names>B</given-names></name>, <name><surname>Cowper-Sal-lari</surname><given-names>R</given-names></name>, <name><surname>Corradin</surname><given-names>O</given-names></name>, <name><surname>Saiakhova</surname><given-names>A</given-names></name>, <name><surname>Bartels</surname><given-names>CF</given-names></name>, <name><surname>Balasubramanian</surname><given-names>D</given-names></name>, <etal>et al</etal>
<article-title>Epigenomic enhancer profiling defines a signature of colon cancer</article-title>. <source>Science</source>. <year>2012</year>;<volume>336</volume>(<issue>6082</issue>):<fpage>736</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.1217277">10.1126/science.1217277</ext-link></comment>
<?supplied-pmid 22499810?><pub-id pub-id-type="pmid">22499810</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref043"><label>43</label><mixed-citation publication-type="journal">
<name><surname>Atchison</surname><given-names>ML</given-names></name>. <article-title>Enhancers: mechanisms of action and cell specificity</article-title>. <source>Annu Rev Cell Biol</source>. <year>1988</year>;<volume>4</volume>:<fpage>127</fpage>&#x02013;<lpage>53</lpage>.
<?supplied-pmid 2848550?><pub-id pub-id-type="pmid">2848550</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref044"><label>44</label><mixed-citation publication-type="journal">
<name><surname>Michaloglou</surname><given-names>C</given-names></name>, <name><surname>Lehmann</surname><given-names>W</given-names></name>, <name><surname>Martin</surname><given-names>T</given-names></name>, <name><surname>Delaunay</surname><given-names>C</given-names></name>, <name><surname>Hueber</surname><given-names>A</given-names></name>, <name><surname>Barys</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>The tyrosine phosphatase PTPN14 is a negative regulator of YAP activity</article-title>. <source>PLoS One</source>. <year>2013</year>;<volume>8</volume>(<issue>4</issue>):<fpage>e61916</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0061916">10.1371/journal.pone.0061916</ext-link></comment>
<?supplied-pmid 23613971?><pub-id pub-id-type="pmid">23613971</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref045"><label>45</label><mixed-citation publication-type="journal">
<name><surname>Bardet</surname><given-names>AF</given-names></name>, <name><surname>Steinmann</surname><given-names>J</given-names></name>, <name><surname>Bafna</surname><given-names>S</given-names></name>, <name><surname>Knoblich</surname><given-names>JA</given-names></name>, <name><surname>Zeitlinger</surname><given-names>J</given-names></name>, <name><surname>Stark</surname><given-names>A</given-names></name>. <article-title>Identification of transcription factor binding sites from ChIP-seq data at high resolution</article-title>. <source>Bioinformatics</source>. <year>2013</year>;<volume>29</volume>(<issue>21</issue>):<fpage>2705</fpage>&#x02013;<lpage>13</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/bioinformatics/btt470">10.1093/bioinformatics/btt470</ext-link></comment>
<?supplied-pmid 23980024?><pub-id pub-id-type="pmid">23980024</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref046"><label>46</label><mixed-citation publication-type="journal">
<name><surname>Bailey</surname><given-names>TL</given-names></name>, <name><surname>Williams</surname><given-names>N</given-names></name>, <name><surname>Misleh</surname><given-names>C</given-names></name>, <name><surname>Li</surname><given-names>WW</given-names></name>. <article-title>MEME: discovering and analyzing DNA and protein sequence motifs</article-title>. <source>Nucleic Acids Res</source>. <year>2006</year>;<volume>34</volume>(Web Server issue):<fpage>W369</fpage>&#x02013;<lpage>73</lpage>.
<?supplied-pmid 16845028?><pub-id pub-id-type="pmid">16845028</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref047"><label>47</label><mixed-citation publication-type="journal">
<name><surname>Bottomly</surname><given-names>D</given-names></name>, <name><surname>Kyler</surname><given-names>SL</given-names></name>, <name><surname>McWeeney</surname><given-names>SK</given-names></name>, <name><surname>Yochum</surname><given-names>GS</given-names></name>. <article-title>Identification of {beta}-catenin binding regions in colon cancer cells using ChIP-Seq</article-title>. <source>Nucleic Acids Res</source>. <year>2010</year>;<volume>38</volume>(<issue>17</issue>):<fpage>5735</fpage>&#x02013;<lpage>45</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/nar/gkq363">10.1093/nar/gkq363</ext-link></comment>
<?supplied-pmid 20460455?><pub-id pub-id-type="pmid">20460455</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref048"><label>48</label><mixed-citation publication-type="journal">
<name><surname>Verfaillie</surname><given-names>A</given-names></name>, <name><surname>Imrichova</surname><given-names>H</given-names></name>, <name><surname>Atak</surname><given-names>ZK</given-names></name>, <name><surname>Dewaele</surname><given-names>M</given-names></name>, <name><surname>Rambow</surname><given-names>F</given-names></name>, <name><surname>Hulselmans</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state</article-title>. <source>Nature communications</source>. <year>2015</year>;<volume>6</volume>:<fpage>6683</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ncomms7683">10.1038/ncomms7683</ext-link></comment>
<?supplied-pmid 25865119?><pub-id pub-id-type="pmid">25865119</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref049"><label>49</label><mixed-citation publication-type="journal">
<name><surname>Jolma</surname><given-names>A</given-names></name>, <name><surname>Yan</surname><given-names>J</given-names></name>, <name><surname>Whitington</surname><given-names>T</given-names></name>, <name><surname>Toivonen</surname><given-names>J</given-names></name>, <name><surname>Nitta</surname><given-names>KR</given-names></name>, <name><surname>Rastas</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>DNA-binding specificities of human transcription factors</article-title>. <source>Cell</source>. <year>2013</year>;<volume>152</volume>(<issue>1&#x02013;2</issue>):<fpage>327</fpage>&#x02013;<lpage>39</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.cell.2012.12.009">10.1016/j.cell.2012.12.009</ext-link></comment>
<?supplied-pmid 23332764?><pub-id pub-id-type="pmid">23332764</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref050"><label>50</label><mixed-citation publication-type="journal">
<name><surname>Anbanandam</surname><given-names>A</given-names></name>, <name><surname>Albarado</surname><given-names>DC</given-names></name>, <name><surname>Nguyen</surname><given-names>CT</given-names></name>, <name><surname>Halder</surname><given-names>G</given-names></name>, <name><surname>Gao</surname><given-names>X</given-names></name>, <name><surname>Veeraraghavan</surname><given-names>S</given-names></name>. <article-title>Insights into transcription enhancer factor 1 (TEF-1) activity from the solution structure of the TEA domain</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2006</year>;<volume>103</volume>(<issue>46</issue>):<fpage>17225</fpage>&#x02013;<lpage>30</lpage>.
<?supplied-pmid 17085591?><pub-id pub-id-type="pmid">17085591</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref051"><label>51</label><mixed-citation publication-type="journal">
<name><surname>Jiang</surname><given-names>SW</given-names></name>, <name><surname>Desai</surname><given-names>D</given-names></name>, <name><surname>Khan</surname><given-names>S</given-names></name>, <name><surname>Eberhardt</surname><given-names>NL</given-names></name>. <article-title>Cooperative binding of TEF-1 to repeated GGAATG-related consensus elements with restricted spatial separation and orientation</article-title>. <source>DNA Cell Biol</source>. <year>2000</year>;<volume>19</volume>(<issue>8</issue>):<fpage>507</fpage>&#x02013;<lpage>14</lpage>.
<?supplied-pmid 10975468?><pub-id pub-id-type="pmid">10975468</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref052"><label>52</label><mixed-citation publication-type="journal">
<name><surname>Halder</surname><given-names>G</given-names></name>, <name><surname>Carroll</surname><given-names>SB</given-names></name>. <article-title>Binding of the Vestigial co-factor switches the DNA-target selectivity of the Scalloped selector protein</article-title>. <source>Development</source>. <year>2001</year>;<volume>128</volume>(<issue>17</issue>):<fpage>3295</fpage>&#x02013;<lpage>305</lpage>.
<?supplied-pmid 11546746?><pub-id pub-id-type="pmid">11546746</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref053"><label>53</label><mixed-citation publication-type="journal">
<name><surname>Gotea</surname><given-names>V</given-names></name>, <name><surname>Visel</surname><given-names>A</given-names></name>, <name><surname>Westlund</surname><given-names>JM</given-names></name>, <name><surname>Nobrega</surname><given-names>MA</given-names></name>, <name><surname>Pennacchio</surname><given-names>LA</given-names></name>, <name><surname>Ovcharenko</surname><given-names>I</given-names></name>. <article-title>Homotypic clusters of transcription factor binding sites are a key component of human promoters and enhancers</article-title>. <source>Genome Res</source>. <year>2010</year>;<volume>20</volume>(<issue>5</issue>):<fpage>565</fpage>&#x02013;<lpage>77</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1101/gr.104471.109">10.1101/gr.104471.109</ext-link></comment>
<?supplied-pmid 20363979?><pub-id pub-id-type="pmid">20363979</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref054"><label>54</label><mixed-citation publication-type="journal">
<name><surname>Jacquemin</surname><given-names>P</given-names></name>, <name><surname>Hwang</surname><given-names>JJ</given-names></name>, <name><surname>Martial</surname><given-names>JA</given-names></name>, <name><surname>Dolle</surname><given-names>P</given-names></name>, <name><surname>Davidson</surname><given-names>I</given-names></name>. <article-title>A novel family of developmentally regulated mammalian transcription factors containing the TEA/ATTS DNA binding domain</article-title>. <source>J Biol Chem</source>. <year>1996</year>;<volume>271</volume>(<issue>36</issue>):<fpage>21775</fpage>&#x02013;<lpage>85</lpage>.
<?supplied-pmid 8702974?><pub-id pub-id-type="pmid">8702974</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref055"><label>55</label><mixed-citation publication-type="journal">
<name><surname>Lian</surname><given-names>I</given-names></name>, <name><surname>Kim</surname><given-names>J</given-names></name>, <name><surname>Okazawa</surname><given-names>H</given-names></name>, <name><surname>Zhao</surname><given-names>J</given-names></name>, <name><surname>Zhao</surname><given-names>B</given-names></name>, <name><surname>Yu</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation</article-title>. <source>Genes Dev</source>. <year>2010</year>;<volume>24</volume>(<issue>11</issue>):<fpage>1106</fpage>&#x02013;<lpage>18</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1101/gad.1903310">10.1101/gad.1903310</ext-link></comment>
<?supplied-pmid 20516196?><pub-id pub-id-type="pmid">20516196</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref056"><label>56</label><mixed-citation publication-type="journal">
<name><surname>Zhang</surname><given-names>H</given-names></name>, <name><surname>Pasolli</surname><given-names>HA</given-names></name>, <name><surname>Fuchs</surname><given-names>E</given-names></name>. <article-title>Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2011</year>;<volume>108</volume>(<issue>6</issue>):<fpage>2270</fpage>&#x02013;<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1019603108">10.1073/pnas.1019603108</ext-link></comment>
<?supplied-pmid 21262812?><pub-id pub-id-type="pmid">21262812</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref057"><label>57</label><mixed-citation publication-type="journal">
<name><surname>Oh</surname><given-names>H</given-names></name>, <name><surname>Slattery</surname><given-names>M</given-names></name>, <name><surname>Ma</surname><given-names>L</given-names></name>, <name><surname>Crofts</surname><given-names>A</given-names></name>, <name><surname>White</surname><given-names>KP</given-names></name>, <name><surname>Mann</surname><given-names>RS</given-names></name>, <etal>et al</etal>
<article-title>Genome-wide association of Yorkie with chromatin and chromatin-remodeling complexes</article-title>. <source>Cell reports</source>. <year>2013</year>;<volume>3</volume>(<issue>2</issue>):<fpage>309</fpage>&#x02013;<lpage>18</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.celrep.2013.01.008">10.1016/j.celrep.2013.01.008</ext-link></comment>
<?supplied-pmid 23395637?><pub-id pub-id-type="pmid">23395637</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref058"><label>58</label><mixed-citation publication-type="journal">
<name><surname>Thurman</surname><given-names>RE</given-names></name>, <name><surname>Rynes</surname><given-names>E</given-names></name>, <name><surname>Humbert</surname><given-names>R</given-names></name>, <name><surname>Vierstra</surname><given-names>J</given-names></name>, <name><surname>Maurano</surname><given-names>MT</given-names></name>, <name><surname>Haugen</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>The accessible chromatin landscape of the human genome</article-title>. <source>Nature</source>. <year>2012</year>;<volume>489</volume>(<issue>7414</issue>):<fpage>75</fpage>&#x02013;<lpage>82</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nature11232">10.1038/nature11232</ext-link></comment>
<?supplied-pmid 22955617?><pub-id pub-id-type="pmid">22955617</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref059"><label>59</label><mixed-citation publication-type="journal">
<name><surname>Creyghton</surname><given-names>MP</given-names></name>, <name><surname>Cheng</surname><given-names>AW</given-names></name>, <name><surname>Welstead</surname><given-names>GG</given-names></name>, <name><surname>Kooistra</surname><given-names>T</given-names></name>, <name><surname>Carey</surname><given-names>BW</given-names></name>, <name><surname>Steine</surname><given-names>EJ</given-names></name>, <etal>et al</etal>
<article-title>Histone H3K27ac separates active from poised enhancers and predicts developmental state</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2010</year>;<volume>107</volume>(<issue>50</issue>):<fpage>21931</fpage>&#x02013;<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1016071107">10.1073/pnas.1016071107</ext-link></comment>
<?supplied-pmid 21106759?><pub-id pub-id-type="pmid">21106759</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref060"><label>60</label><mixed-citation publication-type="journal">
<name><surname>Rada-Iglesias</surname><given-names>A</given-names></name>, <name><surname>Bajpai</surname><given-names>R</given-names></name>, <name><surname>Swigut</surname><given-names>T</given-names></name>, <name><surname>Brugmann</surname><given-names>SA</given-names></name>, <name><surname>Flynn</surname><given-names>RA</given-names></name>, <name><surname>Wysocka</surname><given-names>J</given-names></name>. <article-title>A unique chromatin signature uncovers early developmental enhancers in humans</article-title>. <source>Nature</source>. <year>2011</year>;<volume>470</volume>(<issue>7333</issue>):<fpage>279</fpage>&#x02013;<lpage>83</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nature09692">10.1038/nature09692</ext-link></comment>
<?supplied-pmid 21160473?><pub-id pub-id-type="pmid">21160473</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref061"><label>61</label><mixed-citation publication-type="journal">
<name><surname>Heintzman</surname><given-names>ND</given-names></name>, <name><surname>Stuart</surname><given-names>RK</given-names></name>, <name><surname>Hon</surname><given-names>G</given-names></name>, <name><surname>Fu</surname><given-names>Y</given-names></name>, <name><surname>Ching</surname><given-names>CW</given-names></name>, <name><surname>Hawkins</surname><given-names>RD</given-names></name>, <etal>et al</etal>
<article-title>Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome</article-title>. <source>Nat Genet</source>. <year>2007</year>;<volume>39</volume>(<issue>3</issue>):<fpage>311</fpage>&#x02013;<lpage>8</lpage>.
<?supplied-pmid 17277777?><pub-id pub-id-type="pmid">17277777</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref062"><label>62</label><mixed-citation publication-type="journal">
<name><surname>Visel</surname><given-names>A</given-names></name>, <name><surname>Blow</surname><given-names>MJ</given-names></name>, <name><surname>Li</surname><given-names>Z</given-names></name>, <name><surname>Zhang</surname><given-names>T</given-names></name>, <name><surname>Akiyama</surname><given-names>JA</given-names></name>, <name><surname>Holt</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>ChIP-seq accurately predicts tissue-specific activity of enhancers</article-title>. <source>Nature</source>. <year>2009</year>;<volume>457</volume>(<issue>7231</issue>):<fpage>854</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nature07730">10.1038/nature07730</ext-link></comment>
<?supplied-pmid 19212405?><pub-id pub-id-type="pmid">19212405</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref063"><label>63</label><mixed-citation publication-type="journal">
<name><surname>Murakami</surname><given-names>H</given-names></name>, <name><surname>Mizuno</surname><given-names>T</given-names></name>, <name><surname>Taniguchi</surname><given-names>T</given-names></name>, <name><surname>Fujii</surname><given-names>M</given-names></name>, <name><surname>Ishiguro</surname><given-names>F</given-names></name>, <name><surname>Fukui</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>LATS2 is a tumor suppressor gene of malignant mesothelioma</article-title>. <source>Cancer Res</source>. <year>2011</year>;<volume>71</volume>(<issue>3</issue>):<fpage>873</fpage>&#x02013;<lpage>83</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1158/0008-5472.CAN-10-2164">10.1158/0008-5472.CAN-10-2164</ext-link></comment>
<?supplied-pmid 21245096?><pub-id pub-id-type="pmid">21245096</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref064"><label>64</label><mixed-citation publication-type="journal">
<name><surname>Dowell</surname><given-names>RD</given-names></name>. <article-title>Transcription factor binding variation in the evolution of gene regulation</article-title>. <source>Trends Genet</source>. <year>2010</year>;<volume>26</volume>(<issue>11</issue>):<fpage>468</fpage>&#x02013;<lpage>75</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.tig.2010.08.005">10.1016/j.tig.2010.08.005</ext-link></comment>
<?supplied-pmid 20864205?><pub-id pub-id-type="pmid">20864205</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref065"><label>65</label><mixed-citation publication-type="journal">
<name><surname>Nichols</surname><given-names>WW</given-names></name>, <name><surname>Murphy</surname><given-names>DG</given-names></name>, <name><surname>Cristofalo</surname><given-names>VJ</given-names></name>, <name><surname>Toji</surname><given-names>LH</given-names></name>, <name><surname>Greene</surname><given-names>AE</given-names></name>, <name><surname>Dwight</surname><given-names>SA</given-names></name>. <article-title>Characterization of a new human diploid cell strain, IMR-90</article-title>. <source>Science</source>. <year>1977</year>;<volume>196</volume>(<issue>4285</issue>):<fpage>60</fpage>&#x02013;<lpage>3</lpage>.
<?supplied-pmid 841339?><pub-id pub-id-type="pmid">841339</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref066"><label>66</label><mixed-citation publication-type="journal">
<name><surname>Hawkins</surname><given-names>RD</given-names></name>, <name><surname>Hon</surname><given-names>GC</given-names></name>, <name><surname>Lee</surname><given-names>LK</given-names></name>, <name><surname>Ngo</surname><given-names>Q</given-names></name>, <name><surname>Lister</surname><given-names>R</given-names></name>, <name><surname>Pelizzola</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Distinct epigenomic landscapes of pluripotent and lineage-committed human cells</article-title>. <source>Cell stem cell</source>. <year>2010</year>;<volume>6</volume>(<issue>5</issue>):<fpage>479</fpage>&#x02013;<lpage>91</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.stem.2010.03.018">10.1016/j.stem.2010.03.018</ext-link></comment>
<?supplied-pmid 20452322?><pub-id pub-id-type="pmid">20452322</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref067"><label>67</label><mixed-citation publication-type="journal">
<name><surname>Morikawa</surname><given-names>Y</given-names></name>, <name><surname>Zhang</surname><given-names>M</given-names></name>, <name><surname>Heallen</surname><given-names>T</given-names></name>, <name><surname>Leach</surname><given-names>J</given-names></name>, <name><surname>Tao</surname><given-names>G</given-names></name>, <name><surname>Xiao</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>Actin cytoskeletal remodeling with protrusion formation is essential for heart regeneration in Hippo-deficient mice</article-title>. <source>Science signaling</source>. <year>2015</year>;<volume>8</volume>(<issue>375</issue>):<fpage>ra41</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/scisignal.2005781">10.1126/scisignal.2005781</ext-link></comment>
<?supplied-pmid 25943351?><pub-id pub-id-type="pmid">25943351</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref068"><label>68</label><mixed-citation publication-type="journal">
<name><surname>Schwarzer</surname><given-names>W</given-names></name>, <name><surname>Spitz</surname><given-names>F</given-names></name>. <article-title>The architecture of gene expression: integrating dispersed cis-regulatory modules into coherent regulatory domains</article-title>. <source>Curr Opin Genet Dev</source>. <year>2014</year>;<volume>27</volume>:<fpage>74</fpage>&#x02013;<lpage>82</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.gde.2014.03.014">10.1016/j.gde.2014.03.014</ext-link></comment>
<?supplied-pmid 24907448?><pub-id pub-id-type="pmid">24907448</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref069"><label>69</label><mixed-citation publication-type="journal">
<name><surname>Sikora-Wohlfeld</surname><given-names>W</given-names></name>, <name><surname>Ackermann</surname><given-names>M</given-names></name>, <name><surname>Christodoulou</surname><given-names>EG</given-names></name>, <name><surname>Singaravelu</surname><given-names>K</given-names></name>, <name><surname>Beyer</surname><given-names>A</given-names></name>. <article-title>Assessing computational methods for transcription factor target gene identification based on ChIP-seq data</article-title>. <source>PLoS Comput Biol</source>. <year>2013</year>;<volume>9</volume>(<issue>11</issue>):<fpage>e1003342</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pcbi.1003342">10.1371/journal.pcbi.1003342</ext-link></comment>
<?supplied-pmid 24278002?><pub-id pub-id-type="pmid">24278002</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref070"><label>70</label><mixed-citation publication-type="journal">
<name><surname>Mauviel</surname><given-names>A</given-names></name>, <name><surname>Nallet-Staub</surname><given-names>F</given-names></name>, <name><surname>Varelas</surname><given-names>X</given-names></name>. <article-title>Integrating developmental signals: a Hippo in the (path)way</article-title>. <source>Oncogene</source>. <year>2012</year>;<volume>31</volume>(<issue>14</issue>):<fpage>1743</fpage>&#x02013;<lpage>56</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/onc.2011.363">10.1038/onc.2011.363</ext-link></comment>
<?supplied-pmid 21874053?><pub-id pub-id-type="pmid">21874053</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref071"><label>71</label><mixed-citation publication-type="journal">
<name><surname>Genevet</surname><given-names>A</given-names></name>, <name><surname>Wehr</surname><given-names>MC</given-names></name>, <name><surname>Brain</surname><given-names>R</given-names></name>, <name><surname>Thompson</surname><given-names>BJ</given-names></name>, <name><surname>Tapon</surname><given-names>N</given-names></name>. <article-title>Kibra is a regulator of the Salvador/Warts/Hippo signaling network</article-title>. <source>Dev Cell</source>. <year>2010</year>;<volume>18</volume>(<issue>2</issue>):<fpage>300</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.devcel.2009.12.011">10.1016/j.devcel.2009.12.011</ext-link></comment>
<?supplied-pmid 20159599?><pub-id pub-id-type="pmid">20159599</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref072"><label>72</label><mixed-citation publication-type="journal">
<name><surname>Hamaratoglu</surname><given-names>F</given-names></name>, <name><surname>Willecke</surname><given-names>M</given-names></name>, <name><surname>Kango-Singh</surname><given-names>M</given-names></name>, <name><surname>Nolo</surname><given-names>R</given-names></name>, <name><surname>Hyun</surname><given-names>E</given-names></name>, <name><surname>Tao</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis</article-title>. <source>Nat Cell Biol</source>. <year>2006</year>;<volume>8</volume>(<issue>1</issue>):<fpage>27</fpage>&#x02013;<lpage>36</lpage>.
<?supplied-pmid 16341207?><pub-id pub-id-type="pmid">16341207</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref073"><label>73</label><mixed-citation publication-type="journal">
<name><surname>Gao</surname><given-names>J</given-names></name>, <name><surname>Aksoy</surname><given-names>BA</given-names></name>, <name><surname>Dogrusoz</surname><given-names>U</given-names></name>, <name><surname>Dresdner</surname><given-names>G</given-names></name>, <name><surname>Gross</surname><given-names>B</given-names></name>, <name><surname>Sumer</surname><given-names>SO</given-names></name>, <etal>et al</etal>
<article-title>Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal</article-title>. <source>Science signaling</source>. <year>2013</year>;<volume>6</volume>(<issue>269</issue>):<fpage>pl1</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/scisignal.2004088">10.1126/scisignal.2004088</ext-link></comment>
<?supplied-pmid 23550210?><pub-id pub-id-type="pmid">23550210</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref074"><label>74</label><mixed-citation publication-type="journal">
<name><surname>Davidson</surname><given-names>I</given-names></name>, <name><surname>Xiao</surname><given-names>JH</given-names></name>, <name><surname>Rosales</surname><given-names>R</given-names></name>, <name><surname>Staub</surname><given-names>A</given-names></name>, <name><surname>Chambon</surname><given-names>P</given-names></name>. <article-title>The HeLa cell protein TEF-1 binds specifically and cooperatively to two SV40 enhancer motifs of unrelated sequence</article-title>. <source>Cell</source>. <year>1988</year>;<volume>54</volume>(<issue>7</issue>):<fpage>931</fpage>&#x02013;<lpage>42</lpage>.
<?supplied-pmid 2843293?><pub-id pub-id-type="pmid">2843293</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref075"><label>75</label><mixed-citation publication-type="journal">
<name><surname>Xiao</surname><given-names>JH</given-names></name>, <name><surname>Davidson</surname><given-names>I</given-names></name>, <name><surname>Matthes</surname><given-names>H</given-names></name>, <name><surname>Garnier</surname><given-names>JM</given-names></name>, <name><surname>Chambon</surname><given-names>P</given-names></name>. <article-title>Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1</article-title>. <source>Cell</source>. <year>1991</year>;<volume>65</volume>(<issue>4</issue>):<fpage>551</fpage>&#x02013;<lpage>68</lpage>.
<?supplied-pmid 1851669?><pub-id pub-id-type="pmid">1851669</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref076"><label>76</label><mixed-citation publication-type="journal">
<name><surname>Spitz</surname><given-names>F</given-names></name>, <name><surname>Furlong</surname><given-names>EE</given-names></name>. <article-title>Transcription factors: from enhancer binding to developmental control</article-title>. <source>Nature reviews Genetics</source>. <year>2012</year>;<volume>13</volume>(<issue>9</issue>):<fpage>613</fpage>&#x02013;<lpage>26</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nrg3207">10.1038/nrg3207</ext-link></comment>
<?supplied-pmid 22868264?><pub-id pub-id-type="pmid">22868264</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref077"><label>77</label><mixed-citation publication-type="journal">
<name><surname>Andersson</surname><given-names>R</given-names></name>, <name><surname>Gebhard</surname><given-names>C</given-names></name>, <name><surname>Miguel-Escalada</surname><given-names>I</given-names></name>, <name><surname>Hoof</surname><given-names>I</given-names></name>, <name><surname>Bornholdt</surname><given-names>J</given-names></name>, <name><surname>Boyd</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>An atlas of active enhancers across human cell types and tissues</article-title>. <source>Nature</source>. <year>2014</year>;<volume>507</volume>(<issue>7493</issue>):<fpage>455</fpage>&#x02013;<lpage>61</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nature12787">10.1038/nature12787</ext-link></comment>
<?supplied-pmid 24670763?><pub-id pub-id-type="pmid">24670763</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref078"><label>78</label><mixed-citation publication-type="journal">
<name><surname>Maurano</surname><given-names>MT</given-names></name>, <name><surname>Humbert</surname><given-names>R</given-names></name>, <name><surname>Rynes</surname><given-names>E</given-names></name>, <name><surname>Thurman</surname><given-names>RE</given-names></name>, <name><surname>Haugen</surname><given-names>E</given-names></name>, <name><surname>Wang</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>Systematic localization of common disease-associated variation in regulatory DNA</article-title>. <source>Science</source>. <year>2012</year>;<volume>337</volume>(<issue>6099</issue>):<fpage>1190</fpage>&#x02013;<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.1222794">10.1126/science.1222794</ext-link></comment>
<?supplied-pmid 22955828?><pub-id pub-id-type="pmid">22955828</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref079"><label>79</label><mixed-citation publication-type="journal">
<name><surname>Qing</surname><given-names>Y</given-names></name>, <name><surname>Yin</surname><given-names>F</given-names></name>, <name><surname>Wang</surname><given-names>W</given-names></name>, <name><surname>Zheng</surname><given-names>Y</given-names></name>, <name><surname>Guo</surname><given-names>P</given-names></name>, <name><surname>Schozer</surname><given-names>F</given-names></name>, <etal>et al</etal>
<article-title>The Hippo effector Yorkie activates transcription by interacting with a histone methyltransferase complex through Ncoa6</article-title>. <source>eLife</source>. <year>2014</year>;<volume>3</volume>.</mixed-citation></ref><ref id="pgen.1005465.ref080"><label>80</label><mixed-citation publication-type="journal">
<name><surname>Cebola</surname><given-names>I</given-names></name>, <name><surname>Rodriguez-Segui</surname><given-names>SA</given-names></name>, <name><surname>Cho</surname><given-names>CH</given-names></name>, <name><surname>Bessa</surname><given-names>J</given-names></name>, <name><surname>Rovira</surname><given-names>M</given-names></name>, <name><surname>Luengo</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>TEAD and YAP regulate the enhancer network of human embryonic pancreatic progenitors</article-title>. <source>Nat Cell Biol</source>. <year>2015</year>;<volume>17</volume>(<issue>5</issue>):<fpage>615</fpage>&#x02013;<lpage>26</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ncb3160">10.1038/ncb3160</ext-link></comment>
<?supplied-pmid 25915126?><pub-id pub-id-type="pmid">25915126</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref081"><label>81</label><mixed-citation publication-type="journal">
<name><surname>Heintzman</surname><given-names>ND</given-names></name>, <name><surname>Hon</surname><given-names>GC</given-names></name>, <name><surname>Hawkins</surname><given-names>RD</given-names></name>, <name><surname>Kheradpour</surname><given-names>P</given-names></name>, <name><surname>Stark</surname><given-names>A</given-names></name>, <name><surname>Harp</surname><given-names>LF</given-names></name>, <etal>et al</etal>
<article-title>Histone modifications at human enhancers reflect global cell-type-specific gene expression</article-title>. <source>Nature</source>. <year>2009</year>;<volume>459</volume>(<issue>7243</issue>):<fpage>108</fpage>&#x02013;<lpage>12</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nature07829">10.1038/nature07829</ext-link></comment>
<?supplied-pmid 19295514?><pub-id pub-id-type="pmid">19295514</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref082"><label>82</label><mixed-citation publication-type="journal">
<name><surname>Mahajan</surname><given-names>MA</given-names></name>, <name><surname>Samuels</surname><given-names>HH</given-names></name>. <article-title>Nuclear receptor coactivator/coregulator NCoA6(NRC) is a pleiotropic coregulator involved in transcription, cell survival, growth and development</article-title>. <source>Nuclear receptor signaling</source>. <year>2008</year>;<volume>6</volume>:<fpage>e002</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1621/nrs.06002">10.1621/nrs.06002</ext-link></comment>
<?supplied-pmid 18301782?><pub-id pub-id-type="pmid">18301782</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref083"><label>83</label><mixed-citation publication-type="journal">
<name><surname>Biggin</surname><given-names>MD</given-names></name>. <article-title>Animal transcription networks as highly connected, quantitative continua</article-title>. <source>Dev Cell</source>. <year>2011</year>;<volume>21</volume>(<issue>4</issue>):<fpage>611</fpage>&#x02013;<lpage>26</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.devcel.2011.09.008">10.1016/j.devcel.2011.09.008</ext-link></comment>
<?supplied-pmid 22014521?><pub-id pub-id-type="pmid">22014521</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref084"><label>84</label><mixed-citation publication-type="journal">
<name><surname>Weber</surname><given-names>M</given-names></name>, <name><surname>Hellmann</surname><given-names>I</given-names></name>, <name><surname>Stadler</surname><given-names>MB</given-names></name>, <name><surname>Ramos</surname><given-names>L</given-names></name>, <name><surname>Paabo</surname><given-names>S</given-names></name>, <name><surname>Rebhan</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome</article-title>. <source>Nat Genet</source>. <year>2007</year>;<volume>39</volume>(<issue>4</issue>):<fpage>457</fpage>&#x02013;<lpage>66</lpage>.
<?supplied-pmid 17334365?><pub-id pub-id-type="pmid">17334365</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref085"><label>85</label><mixed-citation publication-type="journal">
<name><surname>Langmead</surname><given-names>B</given-names></name>, <name><surname>Trapnell</surname><given-names>C</given-names></name>, <name><surname>Pop</surname><given-names>M</given-names></name>, <name><surname>Salzberg</surname><given-names>SL</given-names></name>. <article-title>Ultrafast and memory-efficient alignment of short DNA sequences to the human genome</article-title>. <source>Genome Biol</source>. <year>2009</year>;<volume>10</volume>(<issue>3</issue>):<fpage>R25</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/gb-2009-10-3-r25">10.1186/gb-2009-10-3-r25</ext-link></comment>
<?supplied-pmid 19261174?><pub-id pub-id-type="pmid">19261174</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref086"><label>86</label><mixed-citation publication-type="journal">
<name><surname>Kent</surname><given-names>WJ</given-names></name>, <name><surname>Sugnet</surname><given-names>CW</given-names></name>, <name><surname>Furey</surname><given-names>TS</given-names></name>, <name><surname>Roskin</surname><given-names>KM</given-names></name>, <name><surname>Pringle</surname><given-names>TH</given-names></name>, <name><surname>Zahler</surname><given-names>AM</given-names></name>, <etal>et al</etal>
<article-title>The human genome browser at UCSC</article-title>. <source>Genome Res</source>. <year>2002</year>;<volume>12</volume>(<issue>6</issue>):<fpage>996</fpage>&#x02013;<lpage>1006</lpage>.
<?supplied-pmid 12045153?><pub-id pub-id-type="pmid">12045153</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref087"><label>87</label><mixed-citation publication-type="journal">
<name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Liu</surname><given-names>T</given-names></name>, <name><surname>Meyer</surname><given-names>CA</given-names></name>, <name><surname>Eeckhoute</surname><given-names>J</given-names></name>, <name><surname>Johnson</surname><given-names>DS</given-names></name>, <name><surname>Bernstein</surname><given-names>BE</given-names></name>, <etal>et al</etal>
<article-title>Model-based analysis of ChIP-Seq (MACS)</article-title>. <source>Genome Biol</source>. <year>2008</year>;<volume>9</volume>(<issue>9</issue>):<fpage>R137</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/gb-2008-9-9-r137">10.1186/gb-2008-9-9-r137</ext-link></comment>
<?supplied-pmid 18798982?><pub-id pub-id-type="pmid">18798982</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref088"><label>88</label><mixed-citation publication-type="journal">
<name><surname>Bardet</surname><given-names>AF</given-names></name>, <name><surname>He</surname><given-names>Q</given-names></name>, <name><surname>Zeitlinger</surname><given-names>J</given-names></name>, <name><surname>Stark</surname><given-names>A</given-names></name>. <article-title>A computational pipeline for comparative ChIP-seq analyses</article-title>. <source>Nat Protoc</source>. <year>2012</year>;<volume>7</volume>(<issue>1</issue>):<fpage>45</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="pmid">22179591</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref089"><label>89</label><mixed-citation publication-type="journal">
<name><surname>Anders</surname><given-names>S</given-names></name>, <name><surname>Huber</surname><given-names>W</given-names></name>. <article-title>Differential expression analysis for sequence count data</article-title>. <source>Genome Biol</source>. <year>2010</year>;<volume>11</volume>(<issue>10</issue>):<fpage>R106</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/gb-2010-11-10-r106">10.1186/gb-2010-11-10-r106</ext-link></comment>
<?supplied-pmid 20979621?><pub-id pub-id-type="pmid">20979621</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref090"><label>90</label><mixed-citation publication-type="journal">
<name><surname>Sandelin</surname><given-names>A</given-names></name>, <name><surname>Alkema</surname><given-names>W</given-names></name>, <name><surname>Engstrom</surname><given-names>P</given-names></name>, <name><surname>Wasserman</surname><given-names>WW</given-names></name>, <name><surname>Lenhard</surname><given-names>B</given-names></name>. <article-title>JASPAR: an open-access database for eukaryotic transcription factor binding profiles</article-title>. <source>Nucleic Acids Res</source>. <year>2004</year>;<volume>32</volume>(Database issue):<fpage>D91</fpage>&#x02013;<lpage>4</lpage>.
<?supplied-pmid 14681366?><pub-id pub-id-type="pmid">14681366</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref091"><label>91</label><mixed-citation publication-type="journal">
<name><surname>Bailey</surname><given-names>TL</given-names></name>, <name><surname>Gribskov</surname><given-names>M</given-names></name>. <article-title>Methods and statistics for combining motif match scores</article-title>. <source>J Comput Biol</source>. <year>1998</year>;<volume>5</volume>(<issue>2</issue>):<fpage>211</fpage>&#x02013;<lpage>21</lpage>.
<?supplied-pmid 9672829?><pub-id pub-id-type="pmid">9672829</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref092"><label>92</label><mixed-citation publication-type="journal">
<name><surname>Ashburner</surname><given-names>M</given-names></name>, <name><surname>Ball</surname><given-names>CA</given-names></name>, <name><surname>Blake</surname><given-names>JA</given-names></name>, <name><surname>Botstein</surname><given-names>D</given-names></name>, <name><surname>Butler</surname><given-names>H</given-names></name>, <name><surname>Cherry</surname><given-names>JM</given-names></name>, <etal>et al</etal>
<article-title>Gene ontology: tool for the unification of biology. The Gene Ontology Consortium</article-title>. <source>Nat Genet</source>. <year>2000</year>;<volume>25</volume>(<issue>1</issue>):<fpage>25</fpage>&#x02013;<lpage>9</lpage>.
<?supplied-pmid 10802651?><pub-id pub-id-type="pmid">10802651</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref093"><label>93</label><mixed-citation publication-type="journal">
<name><surname>Kelder</surname><given-names>T</given-names></name>, <name><surname>van Iersel</surname><given-names>MP</given-names></name>, <name><surname>Hanspers</surname><given-names>K</given-names></name>, <name><surname>Kutmon</surname><given-names>M</given-names></name>, <name><surname>Conklin</surname><given-names>BR</given-names></name>, <name><surname>Evelo</surname><given-names>CT</given-names></name>, <etal>et al</etal>
<article-title>WikiPathways: building research communities on biological pathways</article-title>. <source>Nucleic Acids Res</source>. <year>2012</year>;<volume>40</volume>(Database issue):<fpage>D1301</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/nar/gkr1074">10.1093/nar/gkr1074</ext-link></comment>
<?supplied-pmid 22096230?><pub-id pub-id-type="pmid">22096230</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref094"><label>94</label><mixed-citation publication-type="journal">
<name><surname>Siepel</surname><given-names>A</given-names></name>, <name><surname>Bejerano</surname><given-names>G</given-names></name>, <name><surname>Pedersen</surname><given-names>JS</given-names></name>, <name><surname>Hinrichs</surname><given-names>AS</given-names></name>, <name><surname>Hou</surname><given-names>M</given-names></name>, <name><surname>Rosenbloom</surname><given-names>K</given-names></name>, <etal>et al</etal>
<article-title>Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes</article-title>. <source>Genome Res</source>. <year>2005</year>;<volume>15</volume>(<issue>8</issue>):<fpage>1034</fpage>&#x02013;<lpage>50</lpage>.
<?supplied-pmid 16024819?><pub-id pub-id-type="pmid">16024819</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref095"><label>95</label><mixed-citation publication-type="journal">
<name><surname>Trapnell</surname><given-names>C</given-names></name>, <name><surname>Salzberg</surname><given-names>SL</given-names></name>. <article-title>How to map billions of short reads onto genomes</article-title>. <source>Nat Biotechnol</source>. <year>2009</year>;<volume>27</volume>(<issue>5</issue>):<fpage>455</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nbt0509-455">10.1038/nbt0509-455</ext-link></comment>
<?supplied-pmid 19430453?><pub-id pub-id-type="pmid">19430453</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref096"><label>96</label><mixed-citation publication-type="journal">
<name><surname>Trapnell</surname><given-names>C</given-names></name>, <name><surname>Williams</surname><given-names>BA</given-names></name>, <name><surname>Pertea</surname><given-names>G</given-names></name>, <name><surname>Mortazavi</surname><given-names>A</given-names></name>, <name><surname>Kwan</surname><given-names>G</given-names></name>, <name><surname>van Baren</surname><given-names>MJ</given-names></name>, <etal>et al</etal>
<article-title>Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation</article-title>. <source>Nat Biotechnol</source>. <year>2010</year>;<volume>28</volume>(<issue>5</issue>):<fpage>511</fpage>&#x02013;<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nbt.1621">10.1038/nbt.1621</ext-link></comment>
<?supplied-pmid 20436464?><pub-id pub-id-type="pmid">20436464</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref097"><label>97</label><mixed-citation publication-type="journal">
<name><surname>Cerami</surname><given-names>E</given-names></name>, <name><surname>Gao</surname><given-names>J</given-names></name>, <name><surname>Dogrusoz</surname><given-names>U</given-names></name>, <name><surname>Gross</surname><given-names>BE</given-names></name>, <name><surname>Sumer</surname><given-names>SO</given-names></name>, <name><surname>Aksoy</surname><given-names>BA</given-names></name>, <etal>et al</etal>
<article-title>The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data</article-title>. <source>Cancer Discov</source>. <year>2012</year>;<volume>2</volume>(<issue>5</issue>):<fpage>401</fpage>&#x02013;<lpage>4</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1158/2159-8290.CD-12-0095">10.1158/2159-8290.CD-12-0095</ext-link></comment>
<?supplied-pmid 22588877?><pub-id pub-id-type="pmid">22588877</pub-id></mixed-citation></ref><ref id="pgen.1005465.ref098"><label>98</label><mixed-citation publication-type="journal">
<name><surname>Sing</surname><given-names>T</given-names></name>, <name><surname>Sander</surname><given-names>O</given-names></name>, <name><surname>Beerenwinkel</surname><given-names>N</given-names></name>, <name><surname>Lengauer</surname><given-names>T</given-names></name>. <article-title>ROCR: visualizing classifier performance in R</article-title>. <source>Bioinformatics</source>. <year>2005</year>;<volume>21</volume>(<issue>20</issue>):<fpage>3940</fpage>&#x02013;<lpage>1</lpage>.
<?supplied-pmid 16096348?><pub-id pub-id-type="pmid">16096348</pub-id></mixed-citation></ref></ref-list></back></article>